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Abstract 
The synthetic polymers reported in this thesis are able to bind the small 
molecule autoinducer-2 (AI-2) in the Quorum Sense (QS) pathways of the 
marine organism with high affinity, and some of the polymers are also able to 
sequester rapidly the same bacteria from suspension. Specifically, the Alizarin 
Red S (AR-S) assay was used to compare binding interactions of boric and 
boronic acid with diol species, and interactions were further probed by 
11
B-
NMR spectroscopy and Mass spectrometry. Dopamine was considered as a 
potential AI-2 scavenger for polymeric QS control owing to the high binding 
affinities for boron. Therefore, poly{N-(3,4-dihydroxyphenethyl) 
methacrylamide-co-N-[3-(dimethylamino)propyl] methacrylamide}  
[p(DMAm-c-DMAPMAm)] and poly(3,4-dihydroxy-L-phenylalanine 
methacrylamide) [p(L-DMAm)] were prepared via Reversible Addition 
Fragmentation Chain Transfer (RAFT) polymerization and characterized by 
1
H-NMR spectroscopy. The activities of these catechol polymers and 
carbohydrate-based poly(β-D-glucosyloxyethyl methacrylate) (p(GlcEMA)) in 
QS interference was demonstrated by bioluminescence assays with the Vibrio 
harveyi MM32 strain and by bacterial aggregation experiments.  
Polymersomes were then investigated as artificial protocells, with a view to 
establishing polymer vesicle containers as both reservoirs of QS mediated 
molecules, and of binding QS agents and bacteria. Hydrophobic monomers N-
(2-Ethylhexyl) acrylamide [p(2-EHAm)] and N-phenylacrylamide [p(PAm)] 
were therefore polymerized into block copolymers from p(L-DMAm)-RAFT 
agents. The membrane permeability of polymersomes was measured via 
encapsulation and release of dyes, while the morphologies were examined with 
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Dynamic Light Scattering (DLS) and Transmission Electron Microscopy 
(TEM). Polymersomes were also investigated for potency in QS quenching via 
the bioluminescence assay and bacterial aggregation experiments. Initial 
studies of a communication feedback loop between bacteria and polymersome-
encapsulated QS agents were performed again via bioluminescence assays. The 
results reveal that the investigated polymersomes exhibit potent activities in 
QS quenching, and further development might act as components of a synthetic 
biology approach to combating microbial pathogenicity. 
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Chapter 1. Introduction 
The overall aim of the work reported in this thesis was to generate polymers 
that could interfere with bacterial communication systems, as a potential route 
to novel anti-bacterial therapeutics. A secondary objective was to introduce 
additional functionality into the polymers, such that they might form 
supramolecular mimics of biological cells, enabling them to contain and 
release anti-bacterial signals. Accordingly, the key concepts underlying 
bacterial communication, inhibition of bacterial signaling by small molecules 
and polymers, and the formation of polymeric containers for encapsulation and 
release of antibacterial compounds, are covered in this Introduction.  
 
1.1 Bacterial chemical communication-Quorum Sensing (QS) 
Over the last few decades, studies have shown that bacteria can signal to each 
other to regulate community behavior, and can do this as multicellular 
organisms rather than behave as individuals.
[1]
 For example, activities such as 
biofilm formation,
[2]
 infection,
[3]
 virulence production,
[4]
 bioluminescence,
[5]
 
sporulation,
[6]
 swarming motility
[7]
 and exchange of DNA
[8]
 have all been 
shown to involve bacterial signaling. Most recently, cell-to-cell communication 
has been implicated in the mechanisms by which bacteria infect host organisms. 
Intervention in communication systems has therefore been considered as a 
potential approach to counter bacterial infections. Apart from direct cell-to-cell 
contact, bacterial communication is mediated via the secretion and detection of 
small signal molecules, known as autoinducers (AI). Once autoinducers reach a 
threshold concentration, bacteria are able to alter gene expression and 
correspondingly their behaviors in response. The overall system of coordinated 
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cell-to-cell behavior at a population level is generally termed quorum 
sensing.
[1a]
 Bacterial signaling is one component amongst several strategies 
(e.g. response to temperature, pH, osmolarity, oxidative stress, nutrient 
derivation) by which cells can optimize their survival and growth.
[1c]
 A number 
of different chemical ÔlanguagesÕ underlying the signaling mechanisms have 
now been identified. Considered together, these ÔlanguagesÕ form a 
comprehensive system for cell-to-cell Ôcross-talkÕ that enables coordination 
across many bacterial species.  
 
1.1.1 Mechanisms of bacterial Quorum Sensing networks 
In terms of signaling mechanisms, most AI molecules are specific to particular 
bacterial species (Figure 1-1). In general bacteria detect and respond to 
different extracellular signaling molecules and subsequently mediate distinct 
population behaviors. In Gram-negative bacteria, N-acylated homoserine 
lactones (AHL, AI-1) are common signals, while in Gram-positive bacteria 
oligopeptides (autoinducer peptides, AIP) usually act as autoinducers.
[1b, 1c]
 
Rather than using one single type of autoinducer to control community 
cooperation, bacteria prefer to coordinate one behavior with multiple 
signals.
[5c]
 Autoinducer-2 (AI-2) has been recognized as a key signal found 
across a remarkable wide variety of both Gram-negative and Gram-positive 
bacteria and accordingly this molecule has been described as a ÔuniversalÕ 
signal for interspecies communication.
[1, 9]
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Figure 1-1. Classification of autoinducers found in different bacterial species. 
Taken from Ref.
[1b]
 
 
The QS system of the Gram-negative, bioluminescent marine bacterium Vibrio 
harveyi was amongst the first to be characterized with multiple QS signals. 
There are three AI molecules and three cognate receptors in the V. harveyi QS 
system working in a parallel way to coordinate bioluminescence.
[5c]
 One of the 
three AI molecules is the acyl homoserine lactone, 3OHC4-homoserine lactone 
(HAI-1), which is a common signal in Gram-negative bacteria. This compound 
is biosynthesized by the synthase enzyme LuxM in V. harveyi, and binds to a 
membrane-bound sensor histidine kinase, LuxN.
[5b]
 The second signal in V. 
harveyi is CAI-1, produced by the CqsA enzyme, which interacts with another 
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membrane-bound sensor histidine kinase, CqsS.
[10]
 The third signal is the 
ÔuniversalÕ AI-2, which is a product of the LuxS enzyme.
[11]
 In V. harveyi, AI-2 
is bound in the periplasm by the protein LuxP to form a LuxP-AI-2 complex 
that interacts with another membrane-bound sensor histidine kinase, LuxQ.
[5c]
 
The detailed mechanism of such QS controlled behavior was explained in 
Figure 1-2, where arrows indicate the direction of phosphate flow in the low-
cell-density state, OM/IM means outer/inner membrane. When there is a lack 
of AI molecules, accompanied by low local cell density, by using these three 
sensors as kinases, phosphate is transferred to the cytoplasmic protein LuxU 
and then to the DNA-binding response regulator protein LuxO. The phospho-
LuxO induces the expression of the small RNAs responsible for destabilizing 
mRNA encoding the transcriptional activator, LuxR. When LuxR is degraded 
and does not activate transcription of the luciferase operon luxCDABE, the 
bacteria do not express the pathways leading to bioluminescence. In contrary, 
at high cell density and when AI molecules reach their threshold concentrations, 
interactions between AIs and their cognate membrane-bound sensor kinase will 
block the phosphate flow and thus Ôswitch on QSÕ. 
  16 
 
Figure 1-2. Scheme of V. harveyi bioluminescence mechanism, taken from 
Ref.
[1b]
 
 
1.1.1.1 AI-2-based signaling system 
The LuxS enzyme is responsible for metabolizing S-adenosyl-methionine 
(SAM) the major cellular methyl donor in the activated methyl cycle (AMC). 
By transferring the methyl groups provided by SAM, the toxic byproduct S-
adenosylhomocysteine (SAH) is produced. Then SAH is hydrolyzed to 
adenosine, S-ribosylhomocysteine (SRH) by the nucleosidase enzyme 5Õ 
methylthioadenosine/S-adenosylhomocysteine nucleosidase (Pfs). SRH 
subsequently is metabolized with LuxS as a catalyst to 4,5-dihydroxy-2,3-
pentanedione (DPD) and homocysteine
[12]
 (Figure 1-3). Different bacteria 
generate distinct DPD derivatives that are generically termed as AI-2. In fact, 
luxS encoding the AI-2 synthase exists in almost half of all bacterial genomes. 
Polymerase chain reaction (PCR), combined with AI-2 activity assays, for 
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LuxS mutants of most of these bacteria have not identified any available 
genome sequences. Hence, LuxS enzyme is the prerequisite for bacteria to 
produce AI-2 molecules, and a lack of which eliminates AI-2 production.  
 
Figure 1-3. Process of LuxS biosynthesis of AI-2, taken from Ref.
[1c]
 
 
The key AI-2 precursor DPD exists in several chemical forms in equilibrium in 
solution. The classical view of the active AI-2 signaling in V. harveyi is 
(2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetra-hydrofuran-bonate (S-THMF, 
borate), a novel furanosyl borate diester with no similarity to other 
autoinducers.
[13]
 Chen et al.
[9]
 demonstrated (by crystallizing its binding 
complex) that the active form of AI-2 which  binds LuxP (primary receptor of 
AI-2 in V. harveyi), is the furanosyl borate diester. It is surprising that a single 
boron atom exists in the AI-2 structure because few other examples exist of 
boron utilized in biological systems in this way.  
However, this is not the only bacterial signaling molecule derived from DPD. 
Miller et al.
[14]
 demonstrated that two different forms of autoinducers both 
derived from DPD were recognized by two different species of bacteria as 
communication signals (Figure 1-4). In Salmonella typhimurium with LuxS 
enzyme to biosynthesize DPD, LsrB protein, a periplasmic binding protein, 
was shown to bind a distinct DPD derivative (2R,4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran (R-THMF) in the absence of boron, using 
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crystallography and 
11
B-NMR to identify the structure of the LsrB ligand R-
THMF complex. Considering the real biological environment, it is perhaps not 
surprising that at least two AI-2 signaling systems have been characterized. In 
a marine environment the natural concentration of boron (as boric acid/borates) 
reaches as high as 0.4 mM compared with a much lower concentration in 
terrestrial waters. Accordingly, boric acid enhances AI-2 signaling in V. 
harveyi but inhibits AI-2 signaling in S. typhimurium due to the structural 
exchange between the inactive and active forms of AI-2 molecules of each 
bacterial types, reflecting their different native environments. These results 
reveal that the molecule generically titled ÔAI-2Õ is in fact a mixture of 
interconvertable molecules acting as interspecies signals.  
 
Figure 1-4. Structures of DPD and derivatives, taken from Ref. 
[1b, 9, 14]
 
 
As mentioned, AI-2 has been widely demonstrated as a signal that both Gram-
negative and Gram-positive bacteria use as a common ÔlanguageÕ to ÔtalkÕ with 
each other, in a way to effectively regulate their community-scale behaviors 
and finally survive and develop their populations. Among the numerous 
bacterial species, the role of AI-2 in V. harveyi was the first discovered and 
well established.
[5c]
 However, it is not readily understood the signaling 
functionality of AI-2 in the other bacteria.
[15]
 Since AI-2 always works together 
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with other regulators, there is inevitably difficulty for identification of its exact 
function. DNA microarray techniques have been used to show that AI-2 
controls numerous gene regulation behaviors including cell division, 
morphogenesis, and cell surface architecture.
[16]
  
In S. typhimurium bacteria, Xavier et al.
[17]
 identified that lsrK and glpD were 
functional in activating transcription of the lsr operon in response to AI-2. In 
both mutants, lsr could not actively express in the absence of phosphor-AI-2 
(due to lsrK deficient) and cyclic AMP-catabolite activator protein-dependent 
activation (due to glpD deficient), and therefore AI-2 dependent QS was 
quenched. Hence, this study gave sort of mechanism explanation of AI-2 
involved QS. 
AI-2 has been reported to control biofilm formation in Escherichia Coli 
through enhancing the cell motility.
[18]
 Three different E. coli strains (ATCC 
25404, DH5α the LuxS deficient strain and K12 wild strain) were selected in 
this report and in all cases results demonstrated that AI-2 enhanced the biofilm 
formation, in terms of both mass and thickness through B3022, an 
uncharacterized protein termed the motility QS regulator gene (the mqsR gene).  
Some recent work revealed the pleiotropic roles of Lux S and AI-2 in 
Actinobacillus pleuropneumoniae virulence features.
[19]
 From the microarray, 
significant differences in gene expression could be observed between the LuxS 
mutant and its parental strain. Results indicated that the LuxS mutant presented 
enhanced biofilm formation but reduced adhesion ability not because of 
absence of AI-2. In fact, both activities could be increased in the presence of 
exogenous AI-2. It is therefore possible to conclude that AI-2 can play a role in 
QS networks independent of its biosynthesis enzyme LuxS.  
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Significantly however, some reports challenged the role of AI-2 as a signal in 
QS network.
[20]
 As a signal molecule, AI-2 must not only be released from an 
individual cells and internalized into a neighbouring cell, but also evolve their 
own production in response to alternation of the receiverÕs gene expression and 
such behavior should benefit both the producer and receiver. However, AI-2 
was demonstrated to be the metabolic by-product and not responsible for 
activating any specific genes directly.
[1c]
 In this case, AI-2 was more accurately 
defined as an environmental cue to regulate gene expression rather than a 
signal, since the AI-2 producing cells was not evolved by the receiverÕs 
response. This definition of the role of AI-2 in QS interspecies communication 
is important for researchers to explain the mechanisms of some phenomenon in 
their experimental studies.  
 
1.1.1.2 Other signaling systems 
The interspecies signaling molecule AI-2-based QS communication system has 
been discussed above. As mentioned, specific signals exist in two major 
catalogues of bacteria (Gram-negative bacteria with both inner (plasma) and 
outer cell membranes, and Gram-positive bacteria only with an inner (plasma) 
membrane).  AHLs are found to be associated with most of the Gram-negative 
proteobacteria acting for intraspecies communications (Figure 1-1). There are 
similarities of this AHL-based system to AI-2-dependant QS network (Figure 
1-5), as two major proteins are involved: LuxI the autoinducer synthase 
responsible for AHLs biosynthesis and LuxR the cytoplasmic autoinducer 
receptor/DNA-binding transcriptional activator. The product (AHL) of LuxI 
diffuses and thus releases to the surrounding environment consequently 
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increasing its concentration in proportion to cell population. When the AHL 
concentration reaches a threshold, it is bound to its receptor protein LuxR to be 
uptaken into cells. The LuxR-AHL complex subsequently activates the 
transcription of the operon encoding luciferase (luxICDABE) and thus induces 
LuxI expression encoded in the luciferase operon so that AHLs also control 
their own biosynthesis.
[21]
  
 
Figure 1-5. AHLs-based QS progress in Vibrio fischeri. AI molecules (red 
triangles) produced by LuxR protein and detected by LuxI. IM: inner 
membrane and OM: outer membrane of cells. Taken from Ref.
[1b]
 
 
In fact, many bacterial species regulate their behaviors with multiple 
LuxR/LuxI families and even AHL.
[1c]
 AHLs are synthesized from S-adenosyl-
methionine (from SAM) and fatty acyl chains carried on acyl-acyl carrier 
protein (acyl-ACP) in the presence of LuxI protein catalyst.
[22]
 In most cases, 
AHL is identified as a homoserine lactone (HSL) ring N-acylated with a fatty 
acyl group at α-position.
[1b, 1c]
 Importantly, the fatty acyl group varies in chain 
length, backbone saturation and side-chain substitutions as specific LuxI 
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proteins only producing their cognate AHLs and binding to specific LuxR 
receptors.
[23]
 The structures and mechanisms are distinct from those of AI-2-
based systems, as AHLs are specific signals only to their corresponding 
bacteria species even in the environment of multiple AHLs produced by mixed 
bacteria.  
Significantly however, the adaptability and flexibility of bacteria enables them 
to choose the best way to survive and develop, and thus it is understandable 
that one type of bacterium can respond to an AHL signal that is produced by 
another type of bacterium.
[24]
 In most cases, the overall condition of the 
bacterial culture is crucial to the adaptability. In certain specific cultures, a 
given bacterium could adapt by producing several different types of AHLs that 
are detected as signals by another type of bacterium. Also the variability of its 
receptor protein LuxR homologues shows an alternative pathway for the 
bacterium to sense in response to exogenous AHLs (from other type of 
bacteria).
[24]
  
Another signaling system based predominately in Gram-positive bacteria has to 
be mentioned here (Figure 1-1). Since my PhD project is using Gram-negative 
bacteria (V. harveyi and E. coli) as bacterial models and its main aim is to 
interfere in QS-controlled bacteria behaviors via modulating AI-2 
concentrations in bacterial media, there will only give a brief introduction on 
autoinducing peptide (AIP) based communication. Gram-positive bacteria 
employ post-translationally modified oligopeptides (5-34 amino acids) as QS 
signal molecules, termed as AIPs. There are different AIP families and are 
naturally cataloged by their modified groups (lactone, thiolactone rings, 
lanthionines and isoprenyl groups). These specific AIP structures lead the 
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gram-positive bacteria to have similar mechanisms that Gram-negative bacteria 
use to regulate QS with AHL-LuxI/LuxR system. In this case, AIPs apparently 
confer specificity in intraspecies communication just as in the AHL-based QS 
circuits. The membrane bound receptors for AIP in gram-positive bacteria are 
involved in a two-component system (eg. AgrC and AgrA in Staphylococcus 
aureus
[1b, 1c]
). As peptide signals are macromolecules that are not able to 
diffuse across cell membranes, a third protein (eg. AgrB
[1b, 1c]
) is therefore 
responsible for processing and modification of signals in order to export 
signals to the extracellular environment. Similarly, there are several QS 
coordination behaviors in Gram-positive bacteria being modulated via multiple 
peptides together with other types of signals.  
 
1.1.2 Therapeutics of Quorum Sensing-related bacterial infection  
As mentioned above, some pathologically relevant events such as biofilm 
formation and bacterial virulence are under QS control,
[5a]
 and therefore 
development of QS mediators has the potential to be used in antibiotic therapy. 
Among a great deal of efforts on this area, the investigation of QS inhibitors 
has attracted most attentions.
[25]
 While initial research focused on QS inhibitors 
for AI-1 or AIP, more recent efforts have considered blocking AI-2 QS 
pathways.
[26]
 
All of the references mentioned in the above paragraph are about design and 
characterization of small molecules as QS inhibitors. However, much less 
efforts have been made to develop macromolecular QS quenching systems 
until very recently. Amara et al.
[27]
 reviewed research efforts on 
macromolecular inhibition of QS covering three aspect of proteins: enzymes, 
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antibodies and decoy receptors.  A number of the proteins mentioned in this 
review displayed promising potency to inhibit QS, but not all of them were 
clearly understood as regards to their quenching mechanisms. In this case, this 
review also highlighted the issues that need to be considered for future studies: 
1) selection pressure and resistance invoked in bacteria by antibiotics, 2) 
efficacy and rate of protein-mediated hydrolysis of autoinducers. Thus, the 
possibilities of using synthetic macromolecules as QS-quenchers or QS-
interference systems have not been explored to any great extent to date. 
Initial efforts in this direction have investigated polymeric materials that can be 
considered analogous to protein-based macromolecular QS inhibitors such as 
Molecularly Imprinted Polymers (MIPs). The group of Piletsky has developed 
some polymeric materials that were demonstrated to attenuate effectively some 
QS-controlled phenotypes. Polymers developed with the aid of molecular 
receptor-docking software were screened for their ability to specifically bind 
the signal molecule N-(β-ketocaproyl)-L-homoserine lactone (3-oxo-C6-AHL) 
of the marine bacteria V. fischeri and thus quench its QS-controlled  
bioluminescence without damaging the cells.
[28]
 Thereafter, a series of related 
molecular imprinted polymers that could bind the QS signal N-(3-
oxododecanoyl)-L-homoserine lactone (3-oxo-C12-AHL) in Pseudomonas 
aeruginosa pathogen and consequently attenuate its biofilm formation, were 
reported from their group based on the same strategy of specific QS signal 
sequestration.
[29]
 However, imprinted polymers in general suffer from 
problems of poor scalability and difficult characterization, therefore, soluble 
polymers that could bind multiple QS signals are more widely considered to 
provide potent anti-infective activity. Interestingly, instead of targeting QS 
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signals to inhibit QS-controlled phenotypes, JandaÕs group reported their 
efforts on investigation of multivalent dendrimers as Lsr-type AI-2 receptor 
probes.
[30]
 Accordingly, a series of DPD conjugating dendrimers (Figure 1-6) 
were demonstrated to inhibit QS in S. typhimurium. As described above, AI-2 
signal in this species is R-RHMF form of DPD and thus the cognate receptor 
protein on the cell surfaces would be blocked if in the presence of such DPD 
conjugating dendrimers. These specific QS targeting dendrimers, which 
exhibited the advantage of multivalency not only acted as probes for specific 
AI-2 binding receptors in S. typhimurium but were also demonstrated to be 
potent as inhibitors for Lsr-type QS systems.  
 
Figure 1-6. Structure of DPD conjugating dendrimer, adapted from Ref.
[30]
 
 
In recent years, considerable effort has been expended in developing more 
active or responsive therapeutic and anti-infective materials. Of particular 
interest have been polymers with dynamic properties, especially those that 
involve self-assembly and triggered release. Accordingly, some significant 
examples of responsive systems, controlled release polymer micelles and 
polymersomes, and release mechanisms are reviewed, as these provide an 
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important background for some potential novel means by which interference in 
QS could be achieved. 
 
1.2 Polymeric vesicles (polymersomes) 
Polymeric vesicles, commonly called polymersomes, are hollow, lamellar 
spherical shell structures that enclose a volume with a membrane made of 
amphiphilic block copolymers in which there is both a hydrophobic and a 
hydrophilic block. The hydrophobic groups have high affinity for non-polar 
solvents and hence tend to self-assemble in water-like polar solvents, while the 
more hydrophilic fragments prefer to face the selective polar (aqueous) 
medium. Polymersome resemble liposomes, which are vesicles prepared from 
natural cell-membrane phospholipids, in their gross architecture, but in general 
are tougher and more stable. This is due to the thicker vesicle wall, which is 
composed of high molecular weight block copolymers rather than 
phospholipids. In addition, through appropriate functional group chemistry, 
polymeric vesicles can exhibit more favourable biological properties, such as 
long blood circulation times.
[31]
  
The synthesis of block copolymers and polymersomes has become much more 
accessible through advances in controlled free radical polymerization 
chemistries. These enable many possibilities for preparing block copolymers 
with a much broader range of functional groups than those previously 
synthesized under living cationic or anionic polymerization.
[32]
 It is now 
possible to assemble monomers with side-chains of very different 
functionalities into polymers, which allows the resulting materials to have the 
superior properties of each individual component. On the other hand, by 
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changing monomer types and molecular weight of each fragment, a series of 
polymersomes with various membrane thicknesses and permeabilities are 
available.
[33]
 This advance in the precision of synthesis opens new 
opportunities for the use of polymers in applications such as encapsulation of 
therapeutic molecules, for example, proteins (enzymes), DNA/RNA fragments 
and both hydrophilic and hydrophobic drugs.
[34]
 
 
1.2.1 Formation of polymersomes   
Amphiphilic block copolymers are commonly composed of more than one type 
of monomer, typically one hydrophobic and one hydrophilic, so that the 
resulting molecules process regions that exhibit opposite affinities for an 
aqueous solvent. In aqueous solutions, amphiphilic molecules tend to achieve a 
state of minimum free energy by removing the hydrophobic blocks from the 
aqueous media. Depending on the system, amphiphilic block copolymers can 
yield different self-assembled superstructures with various morphologies, such 
as spherical micelles, cylindrical micelles or vesicles. Several factors including 
chemical constitution, the length of each individual block, the properties of the 
solvent and the environmental conditions of the solution such as pH, 
temperature, ions and concentration can control the size and shape of the 
aggregates.
[35]
 Theoretically, these varying morphologies are basically a result 
of the inherent molecular curvature (Figure 1-7).
[36]
 Based on the Eq. 1, a 
dimensionless Ôpacking parameterÕ, ÔpÕ, of a presented molecule shows its most 
likely self-assembled morphology. When p ≤ 1/3, spherical micelles are 
formed, when 1/3 ≤p ≤ 1/2, cylindrical micelles and polymersomes when 1/2 ≤ 
p ≤ 1. 
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Equation 1 
p =
!
" # l
 
    
In the equation, ÔγÕ represents the volume of the hydrophobic chains, ÔαÕ is the 
optimal area of the head group, and ÔlÕ means the length of the hydrophobic tail. 
The studies of polymersomes, the size of which can range from 100 nm to 
1000 nm due to the factors mentioned above, have been focused more recently 
in experimental papers compared to the prior theoretical work concerning 
vesicular assembles from block copolymers. Hence, no generally applied 
computational model has been presented yet. In spite of this limitation in 
theory, polymersomes can be made in dilute solution from variety of 
amphiphilic systems, not only in aqueous media but also in organic 
environment, such as in N, N-dimethylformamide (DMF), tetrahydrofuran 
(THF), methanol or mixture solvents.   
 
Figure 1-7. The relation between the inherent curvature of the amphiphilic 
block copolymers and their self-assembled structures, taken from Ref.
[37]
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Two typical and commonly used methods to make polymersomes are film 
rehydration and solvent-exchange techniques.
[38]
 Specifically, polymersomes 
can be prepared via a film rehydration technique by dissolving the copolymers 
in a volatile organic solvent in which both hydrophilic and hydrophobic 
fragments are properly dissolved, through evaporating the solvent to form a 
thin film and rehydrating it in the aqueous phase to yield submicron vesicles 
with a relatively broad size distribution. The polymersomes prepared this way 
therefore need to be separated based on size by sequential extrusion.
[39]
 
Another strategy is based on the solvent exchanging system. Similarly, a good 
volatile solvent for both hydrophilic and hydrophobic components is employed 
to dissolve the copolymers. Instead of forming a film, polymersomes can be 
prepared either by slowly adding this organic phase with copolymers to an 
aqueous phase or dropping aqueous solution into organic mixture. This way, 
the hydrophobic blocks are insoluble leading to the self-assembly and the 
precipitated structures remain stable after a few days of dialysis in water.
[40]
 
Except for the intrinsic properties of polymer compositions, the factors that 
influence the formation of polymersomes are varied from preparation methods, 
polymer concentrations, the type of organic solvent, the volume ratio of 
organic phase and aqueous phase, and even the solvent removing rate.
[41]
 In 
this case, the key to obtain well-defined polymersomes formed from newly 
investigated amphiphilic copolymers is selection of proper preparation 
methods and optimization of the preparation conditions.   
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1.2.2 Stimuli-responsive polymersomes 
Once formed, polymersomes have fluid-filled cores with walls made of 
amphiphilic block copolymers, isolating the core from the outside solution. 
Furthermore, when compared to micelles, which can only encapsulate 
hydrophobic molecules, polymersomes can be the container of both 
hydrophilic compounds within the aqueous interior and also capture 
hydrophobic molecules within the membrane. However, for many practical 
applications, such as controlled encapsulation and release applications, one 
might require a polymersome to have a dynamic or ÔswitchableÕ structure, such 
that molecules, drugs or chemical signals can flow in and out of the vesicle 
center domain or polymer bilayer membrane.  
Recently, the development of intelligent polymersomes responding to internal 
or external stimuli, especially pH, temperature, redox and light, has been 
attracting attention. To enhance the bioavailability of drugs, for example, and 
reduce any unwanted side effects, drug carriers should combine the properties 
of high incorporation of the therapeutic transit in the body, but rapid release at 
the target site. Polymersomes with stimuli-responsive groups might enable 
encapsulation and release of antibiotics or QS agents in a controlled manner. In 
this section, therefore, the issue of controlled release in stimuli-response 
polymersomes is considered. 
Due to the variation of pH in the body, for example, along the gastrointestinal 
(GI) tract the change in pH from acidic in the stomach (pH 2) to more basic in 
the intestine (pH 5-8),
[42]
 a pH-responsive polymersome is an obvious 
candidate as a carrier for controlled drug delivery. Moreover, the mildly acidic 
pH encountered in tumour and inflammatory tissues (pH 6.8) as well as in the 
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endosomal and lysosomal compartments of cells (pH 5-6), provides a potential 
trigger for the release of systemically administered drugs from a pH-sensitive 
carrier, since blood and normal tissues have a pH of 7.4.
[42-43]
  
A pH-responsive polymersome design allows for either polyacid or polybase 
blocks in their structures, so that their solubility in water can be changed by a 
pH variation. ArmesÕ group
[44]
 have described polymersomes formed by the 
self-assembly of a pH-responsive, hydrolytically self-cross-linkable copolymer, 
poly(ethylene oxide)-block-poly[2-(diethylamino)ethyl methacrylate-stat-3-
(trimethoxy-silyl)propyl methacrylate], [PEO-b-p(DEA-s-TMSPMA)] in 
THF/water mix solvent (Figure 1-8). In this research, the basic DEA in the 
polymer structure acts as the catalyst of TMSPMA hydrolysis. The hydrolysis 
of ÐSi(OCH3)3 to ÐSi(OH)3 enables the formation of siloxane cross-links. DEA 
exists as a weak cationic polyelectrolyte at low pH, but deprotonates when the 
solution is above pH 7, this property remains when replacing DEA residues 
with TMSPMA up to 50 mol %. And presumably, the permeability of 
polymersome membrane was demonstrated to be sensitive to pH change by 
DLS and fluorescence studies. These pH-responsive polymersomes are of 
particular interest because of the novel idea of self-catalysis.  
 
Figure 1-8. Schematic presentation of the formation of PEO-b-p(DEA-s-
TMSPMA) polymersomes, taken from Ref.
[44]
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Borsali and coworkers
[45]
 reported pH-responsive block copolymer vesicles 
could be conjugated to the hydrophobic nonsteroidal anti-inflammatory agent 
indomethacin (IND) via an ester bond. This system was also proven to be able 
to stabilize, transport and deliver physically encapsulated free-IND (F-IND). 
At neutral pH, F-IND was released in diffusing manner, because the ester bond 
between drug and the amphiphilic polymer was stable. At low pH, the bound 
IND could be released in a sustained way, due to the hydrolysis of the ester 
bonds. Thus, a controlled release system of IND was established in a pH 
dependent manner. FrechetÕs group
[46]
 have used linear poly(amidoamine)s as 
pH-sensitive polymer materials with a pH-sensitive bond in the backbone. This 
family of acid-degradable poly(amidoamine)s (Figure 1-9) were designed to 
remain stable at the physiological pH of 7.4 but degrade more quickly into 
many small molecules in the pH 5.0-6.0 environment of lysosomes, endosomes, 
or tumor tissues. Thus, on the basis of FrechetÕs results, systems with these 
linear pH-sensitive polymer materials could be applicable in controlled drug 
delivery.  
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Figure 1-9. Preparation of poly(amidoamine)s pH-responsive polymers, 
adapted from Ref.
[46]
 
 
The pH-responsive polymersomes have also been used as gene delivery 
systems, as reported by Song et al.
[47]
 In this research, a novel acid-labile pH-
responsive block copolymer composed of poly(ethylene glycol) (PEG) and 
poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA) segments connected 
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through a cyclic ortho ester linkage (PEG-acid-PDMAEMA) with a pH-
sensitive PEG shield was prepared. More recently, ÔsmartÕ polymeric vesicles 
of poly[2-(dimethylamino)ethyl methacrylate]-block-poly(glutamic acid) 
[p(DMAEMA)-b-p(GA)] with multiresponsive function have been obtained 
from self-assembly of double hydrophilic block copolymers, providing facile, 
tunable and durable ways to develop biological applications.
[48]
 
Additionally, studies in developing temperature responsive polymersomes are 
also of interest for many research groups. Temperature responsive 
polymersomes are commonly made from polymers those exhibit a phase 
transition at a certain temperature. Those polymers which exhibit a non-linear 
decrease in solubility upon heating are described as having a lower critical 
solution temperature (LCST), while those which become more soluble via a 
non-linear increase on heating have an upper critical solution temperature 
(UCST)
[49]
. Polymersomes composed of the temperature responsive poly(N-
isopropylacrylamide) (PNIPAAM) have a phase transitions close to body 
temperature and thus have been extensively investigated. PNIPAAM 
undergoes a reversible coil-to-globule transition at ~ 32 ¡C. Below LCST, the 
polymer is extended and soluble in water; above this temperature, it is in a 
water-insoluble conformation and forms more hydrophobic aggregates. When 
block copolymers composed of PNIPAAM and PEG were made to be the 
carrier material, vesicles were formed at temperatures above the LCST, which 
was demonstrated by encapsulation and release of fluorescent dye recorded by 
fluorescent microscopy and data information from DLS. When the temperature 
was decreased below the LCST, the PNIPAAm block became soluble and the 
vesicle disassembles. Therefore, encapsulated drugs were released from the 
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vesicle when the temperature decreases below the LCST.
[50]
 Leroux and 
coworkers
[51]
 reported that poly(organophosphazenes) with varying ratios of 
ethylene oxide and alkyl chains for thermosensitivity and free acid units for pH 
sensitivity, had a pH-dependent LCST ranging from 32 to 44¡C. Such 
copolymers were complexed to liposomes for the first time and released their 
contents upon a change in temperature and pH. McCormickÕs group
[52]
 focused 
their attention on the controlled polymerization of hydrophilic methacrylamide 
monomers and subsequent vesicle formation from self-assembly of 
amphiphilic block copolymers in aqueous solutions by variation of solution 
temperature. The diblock copolymer poly(N-(3-aminopropyl) methacrylamide 
hydrochloride)-block-poly(N-isopropylacrylamide) (PAPMAH-b-PNIPAM) 
was synthesized by the reversible addition fragmentation chain transfer 
(RAFT) polymerization method. The LCST can be tuned to a desired value by 
changing the composition of the block copolymer. The LCST of the block 
could be lower in longer NIPAM block. However if the NIPAM block length 
were kept constant, increasing the AMPA block length led to an increase in the 
LCST. These block copolymers exist as unimers in aqueous solution at room 
temperature, and self-assemble into vesicles above LCST. Interestingly, such 
vesicles can be structurally locked via adding an oppositely charged 
polyelectrolyte. Temperature responsive polymersomes with LCST phenomena 
have been the most investigated for drug delivery
[49, 53]
 but polymers with 
UCST behavior are also of potential in this application. 
The controlled release from polymersomes can be triggered with other stimuli 
other than temperature and pH. For example, the extracellular fluids and 
certain pathophysiological inflamed or tumor tissues exhibit oxidative 
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environments while other cellular environments can be reducing. Based on this, 
redox responsive triggers have been used for the release of entrapped drugs 
from the polymer carriers.
[54]
 In addition, polymersomes can be prepared to be 
photosensitive, so that the release of encapsulated cargo can be rapidly 
triggered at a selective time and targeted site via exposure to light. Azobenzene 
derivatives are the most extensively studied photochemical groups, as they can 
be reversible isomerized from trans to cis configurations by UV/Vis light and 
vice versa. Liu and Jiang
[55]
 demonstrated the transition between the 
interpolymer complexes and micelles can be achieved via reversible optical 
switching of self-assembly with the aid of hydrogen-bonding interaction 
between carboxylic acid and pyridine. Additionally, the formed micelles can 
response to light irradiation to further cross-link with 1,4-diiodobutene 
accompanied with morphological changes and become hollow spheres in a 
reversible manner (Figure 1-10).  
 
Figure 1-10. Illustration of the reversible photo-induced micellization and 
micelle-hollow-sphere transition of hydrogen-bonded polymers, taken from 
Ref.
[55b]
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1.2.3 ÔEvolvedÕ smart polymers and polymersomes in applications ranging 
from controlled release to synthetic biology 
Polymersomes composed of a variety of amphiphilic block copolymers can be 
modified by changing the structures of their component monomers, so that 
materials with a range of desirable properties can be obtained via chemical 
approaches. Additionally, polymersomes provide higher stability in the 
circulation than liposomes
[56]
 and also are capable of loading both hydrophilic 
molecules in the aqueous core and hydrophobic compounds in the bilayer 
membrane, which make polymersomes much more suitable than liposomes for 
biomedical applications.
[57]
 Obviously, most biomedical applications of block 
copolymers require biocompatible and biodegradable components.
[58]
 PalmerÕs 
group
[58b]
 developed biocompatible and biodegradable polymersomes from 
amphiphilic block copolymers composed of hydrophilic poly(ethylene oxide) 
(PEO) and hydrophobic block either poly(caprolactone) (PCL) or poly(lactide) 
(PLA). They successfully encapsulated hemoglobin in poly(ethylene oxide)-
poly(caprolactone) (PEO-PCL) or poly(ethylene oxide)-poly(lactide) (PEO-
PLA) polymersomes, without affecting oxygen binding properties of 
hemoglobin while retaining good release profiles. The anti-cancer drug 
paclitaxel has been encapsulated in self-assembled poly(butadiene)-block-
poly(ethylene oxide) (PB-block-PEO) polymersomes and worm-like micelles 
for inhibiting proliferation of MCF-7 human breast cancer cells.
[58f]
 The result 
of in vivo cytotoxicity assays indicated that the enhanced ability of paclitaxel-
loaded polymersomes inhibiting proliferation of MCF-7 human breast cancer 
cells was a consequence of the increase of paclitaxel loading concentration. 
Kim et al.
[58g]
 reported that loading and functional delivery of siRNA into 
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cancer cells in vitro and antisense oligonucleotides (AON) into muscle in vivo 
with non-ionic, nano-transforming polymersomes were developed. A series of 
copolymers were prepared into vesicles and quantitation of their loading 
efficiency was evaluated with fluorescent labeled complexes by using 
spectrofluorimetry. The advantage of such investigation was allowing delivery 
of negative changed complex in an exposed positive charged milieu.  
Potential applications of polymersomes are strongly biased towards carriers for 
drug/gene delivery, but there have been a number of more recent studies of 
potentially new functions. For example, the internal space of polymersomes 
can be considered as a biomimetic nanoreactor if a protein can be encapsulated 
and remain active in situ.
[59]
 Axthelm and his coworkers
[59a]
 developed 
nanovesicles from amphiphilic block copolymers composed of poly(2-
methyloxazoline)-poly(dimethylsiloxane)-poly(2-methyloxazoline) entrapped 
Cu, Zn superoxide dismutase (SOD) as antioxidant nanoreactors. To obtain the 
nanovesicles, the dissolved triblock copolymer in ethanol at 17% (w/w) was 
dropped slowly to the solution of SOD in phosphate-buffered saline (PBS) at 
room temperature. This shielding of SOD enabled biocompatibility and low 
non-specific protein binding ability. The resulting nanoreactor has the potential 
application in protecting compounds having antioxidant properties.   
Additionally, surface modification of polymersomes, for example by attaching 
targeting moieties, is very important for drug/gene delivery systems, especially 
for targeted/sustained delivery systems. Polymersomes used in biomedical 
applications are generally self-assembled amphiphilic block copolymers 
composed of biocompatible, biodegradable hydrophobic polymer blocks (e.g. 
PCL, PLA) covalently bonded to a biocompatible hydrophilic block, typically 
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PEG.
[60]
 It is generally known that PEG has the ability to prolong circulation 
time of nanoparticles and its high biocompatibility and hydrophilicity are also 
crucial properties for biomedical applications. Meng et al.
[61]
 prepared 
polymersomes of amphiphilic block copolymers based on PEG and 
biodegradable polyesters or polycarbonate as the carriers for biofunctional 
compounds (model: carboxyfluorescein, CF). By using a PEG spacer, 
antibodies can be attached onto a polymersome with control of local steric 
crowding, by coupling the distal end of PEG chain specifically. The developed 
polymersome could thus be considered as a membrane-controlled reservoir 
system, in effect a simple Ôartificial cellÕ mimic containing biofunctional 
compounds.  Polymersomes made from double hydrophilic block copolymers 
with pendant glycofunctionality have been shown to transfer dyes across their 
membranes when bound to bacteria, which may offer a new approach to target 
planktonic bacteria, which in turn may be a promising route for prevention of 
infectivity, treatment of disease, and to control of new tissue formation.
[62]
 In 
these systems poly(2-glucosyloxyethylmethacrylate) (PGEMA) and 
poly(diethyleneglycol methacrylate) (PDEGMA) were incorporated to form 
block copolymers which self-assembled into vesicles. Such containers with 
combined surface activity and biorecognition have the potential capability of 
transferring cargo to biological cells either via surface interaction, or via the 
release of the vesicle contents.  
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1.3 Aims and objectives of the project 
From consideration of the prior examples of polymers in biomedical 
applications, the project was conceived to develop in two phases. The first 
phase was to establish efficacy of polymers as agents to interfere in QS of 
bacteria, as a potential new anti-infective strategy. The second phase was to 
consider self-assembled polymersomes as both binding agents and containers 
for QS components, such that a controllable interference with bacterial 
communication could be addressed. The latter stages of the project envisaged 
whether these polymersomes might even act as simple artificial mimics of a 
cell, in order to form ÔintelligentÕ biomimetic materials. 
 
1.3.1 Polymers for interference in bacterial Quorum Sensing (1
st
 Phase) 
In order to develop polymers for anti-infective strategies, a brief discussion of 
the infection mechanisms employed by bacteria is included. Based on the 
typical strategies used to survive and infect host cells, bacteria can be roughly 
categorized into two groups. The first group, including pathogens such as 
Mycobacterium and Leishmania, passively enter the intracellular milieu via 
phagocytosis. These cells are able to subvert the hostÕs immune response and 
gain an intracellular niche as the consequence of altering phagosome 
maturation (Figure 1-11).
[63]
 In this way, the bacteria protect themselves from 
the innate immune response and can act as parasites in the host-cells, leading to 
subsequent diseases.
[63-64]
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Figure 1-11. Schematic explanation of typical phagosome maturation and 
strategies of intracellular pathogen survival, taken from Ref.
[63]
 
 
A second class of bacteria gain access to the hostÕs intracellular environment 
actively by invasion, using multiple processes to promote their own 
internalization in cells that are normally non phagocytic.
[63, 65]
 Invasive 
bacterial entry mechanisms (e.g. ÔZipperÕ and ÔSecretory SystemÕ mechanisms), 
and their consequences have been reviewed elsewhere.
[65-66]
 However, an 
understanding of invasion and colonization of host cells by bacteria is of 
importance to the work in this thesis, as this might inform the design of 
synthetic materials for bacterial infective therapeutics through targeting the 
Ôcontact and adherenceÕ step involved in the entry mechanisms. 
Significantly, although the entry mechanisms may vary in the successive steps 
depending on the bacterial species, invasive bacterial adhesion is the initial 
step in colonization
[65]
 and the formation of resistant biofilms
[67]
. The most 
widely accepted mechanism of initial bacterial attachment is based on 
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Derjaguin Landau Verwey Overbeek (DLVO) colloid theory.
[68]
 DLVO theory 
quantifies the roles of van der Waals and Coulomb force in the interaction of a 
colloidal particle with a surface. In principle, particles irreversibly attach on a 
surface when the two objects are close enough to allow van der Waals 
attractive forces to be dominant. In biological systems, adhesion of a charged 
particle on surfaces is also strongly related to ionic strength in the aqueous 
media.
[68-69]
 According to DLVO theory, the repulsive electrostatic energy 
between the electric bilayers of bacterial cells and the surfaces decrease as the 
ionic strength of media increases due to enhanced shielding of the surface 
charges by the ions in the electrical bilayers. Moreover, the thermodynamic 
approach based on the surface free energy theory helps to explain and extend 
DLVO theory such that hydrophobic/hydrophilic and osmotic interactions are 
also considered besides Lifshitz-van der Waals and electrostastic bilayer 
interactions.
[70]
 Lifshitz-van der Waals and electrostatic interactions are usually 
non-specific adhesion forces defined as a consequence of macroscopic, 
physicochemical surface properties over large separation distances between 
cells and surfaces, whereas hydrophobic force and directional interactions (e.g. 
H-bonding) are dominant at a small distance. The latter forces are more 
specific to particular cell surface interactions and are the predominant cause of 
strong and irreversible cell attachment.
[71]
  
On the other hand, from a biomedical point of view, although the general 
strategies of bacterial attachment to surfaces may vary in different species, 
bacteria with particular structures/components capable of binding host cell 
receptors represent a large group of specific interactions that might be 
disrupted to prevent infection. For instance, numerous bacterial species have 
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evolved machinery to attach to and eventually internalize into host cells, for 
example by expressing fimbriae that can bind carbohydrates present on the host 
cells.
[72]
 Also, it has been noted that many bacteria evolve and exploit more 
than one mechanism for invasion, allowing them to adhere to and subsequently 
enter into host cells to invoke infections. One example is that of Group A 
Streptococcus pyogenes (GAS), which utilizes the surface protein streptococcal 
fibronectin-binding protein I (SfbI) and its allelic variant F1 as the specific 
components to bind the fibronectin of the hostÕs extracellular matrix, but which 
also can exploit other cell entry routes.
[73]
 A recent review has provided an 
important overview of bacterial adhesion mechanisms covering 
physicochemical and cellular structural and chemical aspects, and also some 
novel technologies developed to address these adhesion mechanisms.
[67]
  
Synthetic polymers that interfere with bacteria-host interactions are therefore a 
potentially useful approach for controlling infectious diseases, because their 
affinities with cell surface receptors can be tailored through multivalent ligand 
display. In fact, the specific recognition of bacterial surface adhesion protein to 
tissue (host)-secreted carbohydrates is inherently multivalent binding in 
nature,
[74]
 and thus is an obvious candidate for Ôpolymer interferenceÕ. 
Carbohydrate-protein interactions are based on weak individual links when a 
single carbohydrate binds to a protein site, however, the progressive build-up 
of multivalent interactions for oligosaccharides involved in recognition 
processes enables much stronger binding to occur. For example, the exploited 
multivalent carbohydrates occupied the binding sites on the tissue surfaces 
prior to the adhesion protein on bacterium, and thus prevented bacterial from 
host invasion (Figure 1-12). Therefore, multivalency is an important design 
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factor for bacterial adhesion inhibitors. Since monovalent adhesion inhibitors 
always present limited affinities for target lectins, multivalent materials are 
good potential alternatives for therapeutic strategies against bacterial infection. 
A number of examples have been reported where multivalent ligands have 
been used advantageously compared to monovalent inhibitor.
[74b, 75]
 The 
polymers those could easily be modified with various functionalities are 
believed to have high flexibility combined with mutivalency effect by using 
polymer chemistry. 
 
Figure 1-12. Scheme of bacterial adhesion followed by infection (left) and 
inhibition by multivalent carbohydrates to prevent infection (right), taken from 
Ref.
[76]
 
 
However, many bacterial species employ additional strategies for 
environmental adaptation and host invasion, thus confounding therapies that 
depend on prevention of bacterial cell surface attachment or cell sequestration. 
Amongst these mechanisms are communication-systems such as quorum 
sensing (QS) described earlier.
[1b, 1c, 77]
 Inhibition of QS is itself a potential 
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further method of controlling bacterial infection,
[78]
 but targeting QS signals in 
isolation can still allow bacterial infection by alternative pathways. For 
instance, loss of QS can induce bacteria to switch on ÔswarmingÕ/aggregation 
responses to compensate, inducing in turn further infection mechanisms that 
can ÔoutmanoeuvreÕ conventional anti-adhesion therapeutics. Materials that 
could interfere with both communication mechanisms and cell 
adhesion/aggregation at the same time would allow greater flexibility in anti-
infective strategies. The first phase of the project therefore involved the design 
and synthesis of polymers aimed to combine potent activity in binding QS 
autoinducers with effective adhesion at bacterial surfaces (Figure 1-13). 
 
Figure 1-13. Scheme of investigated polymers interfering with both 
communication mechanism (QS Route, red) and cell adhesion/aggregation 
(Adhesion Route, blue) at the same time in anti-infective strategies  
 
1.3.2 Polymersomes as artificial cells to cross talk with bacterial cells (2
nd
 
Phase) 
Irrespective of organism complexity, the cell is the basic unit for all forms of 
life so far. The idea of establishing synthetic (and artificial) biology with 
polymers that might give structures and functions complementary to those in 
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nature, is of interest for both practical reasons (e.g. intelligent antibacterial 
agents), and for addressing more fundamental and philosophical questions (e.g. 
Ôwhat is life?Õ). While the concept of a ÔsmartÕ polymersome for controlled 
release of antibacterials is a simple extension of current ideas, albeit difficult to 
realize in practice, the consideration of a polymersome as a proto-cell is more 
challenging. To describe of the concept of Ôartificial cellularityÕ, a discussion 
paper extending the famous ÔTuring TestÕ
[79]
 of intelligent machines towards 
biomimetic applications was suggested in 2006.
[80]
 In the original Turing test, 
an Ôimitation gameÕ was introduced to identify if a machine can think or not 
(Figure 1-14, a). This test was performed between an intelligent interrogator (a 
human being) and two isolated subjects (a computer and another person). The 
interrogator was also separated from the intelligent subject (another human) 
and the computer/machine was allowed to ask questions in order to distinguish 
the two subjects between whether they were human or machine. If the 
computer gave an answer that was indistinguishable to the interrogator from an 
answer given by a human, Turing postulated that the machine could be 
considered as ÔintelligentÕ - at least from a practical viewpoint. This system 
subtly avoids the problems suffered when researchers were trying to define the 
principles for an intelligent machine, but simplifies all the rules in terms of 
comparing a computer with a standard model that is a real intelligent subject Ð 
i.e. a human being. The UK ÔChellÕ consortium (Cronin et al.
[80]
) considered 
the same fundamental problems in the area of artificial cell definition, and 
suggested a strategy related to the original Turing test to determine if a 
synthetic/chemical cell could be considered ÔintelligentÕ or not. (Figure 1-14, 
b)  
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Figure 1-14. Scheme of the original Turing test for artificial intelligence (AI) 
(a); and the developed biological version of Turing test for artificial cellularity 
(chemical cell Ð chell) (b), taken from Ref.
[80]
 
 
In this case, the roles of interrogator and intelligent human subject are replaced 
with two individual living cells, while artificial cells are tested instead of the 
computer machine to see if they could be judged as real alive cells so as to 
ÔfoolÕ the interrogator.  Specifically, the language suggested to be the tool of 
communication between the two participants is designed around cell signal 
molecules, in this case the autoinducers already mentioned above relating to 
bacterial chemical communication Ð i.e. the QS network. One could envisage 
that if the synthetic objects are able to detect and sense the signal molecules 
produced by the real cells and also ÔreplyÕ, for example by releasing certain 
mediators to regulate the behaviors of the living quorum, the communication 
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cycles between the real cell and the synthetic biomimicry might therefore be 
established. In such a way, the artificial cells so produced could probe the 
biological version of the Turing test, and thus circumvents the current lack of 
practical definitions in the area of artificial cellularity.  
Although such a biological version of the Turing test leads to a practical 
definition of artificial cellularity, there is still a need to consider the properties 
of natural cells that confer ÔlifeÕ to a living system. In this context, some of the 
key characteristics of alive cells have been considered in detail recently.
[81]
 As 
a general rule, all living systems have 1) cells which possess a membrane, 
which separates the interior of the cell from the environment, and which 
controls the passage of nutrient molecules into the cell and the passage of 
waste out of the cells; 2) all cells store their heredity information in the form of 
double-stranded DNA; 3) all cells use similar molecular mechanisms for 
transcribing and translating the genetic information encoded in the DNA; 4) all 
cells use catalytically active proteins (enzymes) to catalyze chemical reactions 
inside the cell, the sum total of these reactions being the cellÕs metabolism; 5) 
all cells are Ôbiochemical factoriesÕ that transform nutrient molecules via 
metabolic pathways into components of the cell leading to cell growth, to a 
copying of the heredity information and finally to cell division; 6) all cells are 
self-regulating systems that are able to respond to certain stimuli; 7) the shape 
of cells depends on their function and can vary considerably, as does the size of 
cells, which is often 1-5 µm in the case of bacteria, and 10-30 µm (and more) 
in the case of eukaryotic cells; and 8) all known cells use the Ôsame type of 
chemistryÕ and many processes inside the cell use the same type of molecules 
(e.g. water, ATP, citric acid, DNA, proteins etc.), among which the 
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macromolecules are composed of the same set of building blocks.Õ  It is not 
surprising therefore that it is still a challenge to build any type of artificial cell 
that can possess analogies of all the above features found in real cells.  
In this case, the concepts of minimal cells and protocells have to be mentioned. 
A minimal cell is commonly recognized as a cell with very small genome sizes, 
which internalizes nutrients from other (host) cells, i.e. minimal cells do not 
produce its own nutrients. Thus, to establish a minimal cell system, researchers 
often adapt the Ôtop-down strategyÕ by removing most of the genes from an 
existing organism but retaining those which maintains some key properties 
such as self-maintenance, self-reproduction and possibility to evolve.
[81]
 By 
contrast, a protocell is a simplified model only possessing some of the 
properties of a living cell but not necessarily all of them. Protocells may be 
more accessible for researchers as the first step towards synthetic artificial cells, 
adopting what is commonly defined as the Ôbottom-up synthesis strategyÕ.
[82]
 
Polymersomes that can self-assemble from amphiphilic block copolymers are 
especially useful in the formation of protocells. Furthermore, as discussed 
above, polymersomes can be encoded with stimuli-responsive properties such 
as alterable permeability, enabling them to act potentially as cell-like 
containers for constructing artificial cells.
[83]
 Examples of simple protocells 
have already been reported, including an intriguing multivesicular structure,
[84]
 
designed and synthesized by a double emulsion dispersion method. Such 
polymeric bilayer structures enable transfer of molecular ÔinformationÕ from 
the exterior to interior in a pH-controllable manner (Figure 1-15).   
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Figure 1-15. Structure of multivesicles composed of poly (acrylic acid-co-
distearin acrylate) [p(AAc-co-DSA)], top; and schemes of on and off -gate 
controlled by tuning pH, bottom. Taken from Ref.
[84]
 
 
Specifically, the channels linking the inter space and the outer environment 
switched off below pH 5.0 while opened above pH 8.0 via reversible 
transesterification of poly (acrylic acid-co-distearin acrylate) [p(AAc-co-
DSA)]. Actually, such pH-dependent transmembrane channels formation 
mainly occurred in the AAc-rich region because the ionization of AAc in this 
region is easier to deprotonate than those copolymerized with DSA (Figure 1-
13). This paper gives a good example of progress in synthetic biology 
applications particularly as an initial step towards the construction of artificial 
cell models.  
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For this thesis, it is the aim to establish a basic platform for understanding the 
principles of polymer-cell and polymer-signal molecule/boron interactions (1
st
 
stage, Chapter 2 and 3) in cell-cell communication processes, and then to 
develop a more meaningful test between real cells and artificial protocells. As 
reviewed above, polymersomes possessing continuous bilayer structures were 
able to be modified via tuning their hydrophobic and hydrophilic block 
compositions. They can also be decorated with functional groups to respond to 
cell signals, giving them potential to be exploited as the container components 
of artificial cells. In this case, polymersomes can be designed from hydrophilic 
blocks based on linear polymers investigated in Phase 1 of the PhD study 
combined with selected hydrophobic blocks, such that cell-like structures could 
form, which could also act as containers for QS interfering signals. In principle, 
the interaction of the polymersomes with real bacterial cells could form part of 
the QS network - detecting and responding/binding to bacterial signal 
molecules. However, considering the overall complexity of this study, to 
simplify the experiments it was first necessary to encapsulate only selected QS 
mediators, instead of reaction cascades that produce QS signals, and then to 
tune the cargo release rate via different kinds of hydrophobic monomers. 
However, if the full sets of chemistries in the PhD are achieved, and if the 
polymersomes can Ôcross-talkÕ with real cells, the construction of artificial 
protocells and the implementation of the biological Turing test principle 
(Figure 1-16) will be achieved.   
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Figure 1-16. Scheme of cell-polymersome interactions for implementation of the cell-Chell Turing test 
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Chapter 2. Preparation and Characterization of Monomers: Binding 
Affinities for Boron 
2. Introduction 
As outlined in the ÔIntroduction ChapterÕ, bacterial communication systems, 
prevalently termed quorum sensing (QS), regulate their community-scale 
behaviour to aid survival and develop their populations. Intervention in such 
systems has therefore been an attractive approach to treat bacterial infection.
[1]
 
In reality, the chemical ÔlanguageÕ autoinducer (AI) signal molecules for 
bacterial cell-to-cell ÔtalkÕ are generally species specific, and only autoinducer-
2 (AI-2) can be considered to be a global signal for interspecies 
communication in both Gram-negative and Gram-positive bacteria.
[2]
 Although 
bacteria coordinate their population-scale behaviours with multiple signals 
rather than a single type of AIs,
[3]
 targeting AI-2 signal molecules can still be a 
ÔuniversalÕ potential approach towards QS inhibition and also bacterial 
infection therapeutics. However, different bacteria generate distinct DPD 
derivatives that are generically termed as AI-2.
[2d, 4]
 The active form of AI-2 (1) 
in V. harveyi species is a furanosyl borate formed as the product of reaction 
between DPD and borate in marine environment (Figure 2-1). In order to target 
AI-2 (1), the screening of small monomer candidates capable of binding boron 
and reducing AI-2 (1) concentration in solution was considered as the 
preliminary objective of the PhD. 
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Figure 2-1. Structures of DPD derivatives and QS signal molecule AI-2 (1) in 
V. harveyi 
 
Boric/boronic acids bind strongly with diol-containing compounds via 
reversible boronate ester formation (Figure 2-2).
[5]
 Phenylboronic acid (PBA) 
converts from a trigonal boronic acid form to the tetrahedral boronate ion as 
the pH increases from below to above neutral pH (Figure 2-2). Although it was 
initially believed that a tetrahedral borate/boronate ion was the key reactant in 
alkaline solution of boric/boronic acid owing to its greater concentration 
compared to the trigonal state,
[6]
 trigonal boric
[7]
/boronic
[8]
 acid was eventually 
demonstrated to be the reactive form towards a diol-functional group even in 
alkaline solution. These results agreed with previous studies showing that the 
optimal pH value for diol-boron binding was not always above the pKa of the 
boric/boronic acid but around neutral value.
[9]
 Numerous efforts have been 
made on synthesis of boric/boronic acid receptors for sensing diol-containing 
targets (e.g. saccharides).
[9-10]
 Similarly, carbohydrate-binding agents, such as 
phenylboronic acids,
[11]
 have been identified as potential lead structures for 
antiviral therapeutics targeting highly glycosylated enveloped viruses such as 
HIV type-1.
[12]
 Interestingly, 3-aminophenylboronic acid was recently 
demonstrated as an rapid affinity sensor to detect total bacteria due to binding 
bacterial common cell wall component polysaccharide.
[13]
 Boronic acid as tools 
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for sensing and separation have been reviewed this year by Nishiyabu R. et 
al.
[14]
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Figure 2-2. Scheme of mechanism of binding between phenylboronic acid and 
diols, taken from Ref.
[9]
 
 
Understanding the factors that affect the stability of borate/boronate ester is 
essential for optimizing conditions that foster tight binding of boron-diol 
complexes. The Alizarin Red S (AR-S) assay can be used as a tool for 
measuring association constants of boron-diol complexes.
[15]
 The AR-S system 
is a three-component assay allowing determination of the binding affinities of 
boric/boronic acid even without intrinsically fluorescent structures.
[9]
 This 
assay is based on the affinity of two competing guests to one host.
[16]
 The 
analyte competitively binds the host or receptor from the indicator, causing 
change in readout of its spectroscopic properties. Specifically, no fluorescence 
can be observed when AR-S exist in a free-state, due to the transfer of the 
excited state proton from the phenol hydroxyl group of AR-S to the ketone 
oxygen.
[17]
 However, when AR-S forms complex with boron such fluorescence 
quenching was avoided. To briefly explain this assay, AR-S is used as the 
indicator that becomes fluorescent upon binding to boric/boronic acid 
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(host/receptor). However, diol-containing compounds (analyte) are also able to 
reversibly binding boron via boronate ester formation. In the presence of diol-
containing compounds, two competing binding equilibria are established in the 
media between receptor (boric/boronic acid) and indicator (AR-S), as well as 
receptor and analyte (diol) (Figure 2-3). The fluorescent intensity of 
boric/boronic acid-AR-S complex will be decreased due to the transfer of AR-
S complex to AR-S free molecule when the concentration of diol increases in 
the solution. By keeping the concentration of AR-S, boric/boronic acid and all 
the other contents the same but with different concentrations of diols, the 
relation between the diol concentration and fluorescent intensity can be 
established. Thus, the formation of a boronate ester between boric/boronic acid 
and diols controls the fluorescence of the whole system, which enables the 
determination of binding constants.
[9, 18]
 Recent work has described a new class 
of water-soluble fluorescent boronic acids that change their fluorescence 
properties significantly upon binding of diol-containing compounds at 
physiological pH. This has simplified the fluorescence reporting system and 
can be an alternative for the conventional AR-S assay.
[19]
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Figure 2-3. Scheme of mechanism of AR-S assay  
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In this chapter, representative diols will be investigated as potential AI-2 
scavengers via reversible boronate ester formation, with special attention to 
carbohydrate derivatives. The binding constants of boron (sodium borate and 
PBA) with a series of diols will be established via AR-S assay. Esterification 
of boron with catechols will be confirmed by both mass spectrometry and 
11
B-
NMR techniques, both of which are commonly used to identify boron-diol 
bindings for decades.
[20]
 Monomer candidates capable of QS quenching will be 
synthesized and characterized prior to subsequent polymer studies (Chapter 
3).   
 
2.1 Experiments 
2.1.1 Binding affinities for boron using Alizarin Red S (AR-S) assay 
Binding affinities were calculated at pH 7.4 and 37 ¼C following the protocol 
described by Wang et al.
[9, 21]
 In brief, Solution A, containing AR-S in 
phosphate buffer, Solution B, containing both AR-S (same concentration as 
solution A) and boronic acid in phosphate buffer, were mixed in different ratios 
in order to make solutions with a constant concentration of AR-S and a range 
of concentrations of the boronic acid. At least 8 different solutions were made 
in order to cover as much of the binding curve as possible. The experiments 
were carried out in triplicate and the plotted curves are derived from the mean 
value. The fluorescence intensities were measured with an excitation 
wavelength of 468 nm. The relationship between fluorescence intensity 
changes and the equilibrium constant can be expressed using the Benesi-
Hildebrand equation (Eq. 1) so that the association constant for the AR-S-
boronic acid complex (Ka1) can be obtained from the equation of the intercept 
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and the slope in a plot of 1/[B] vs 1/ΔIf
[9]
 Where If means the fluorescent 
intensity, Δkp0 is a constant derived from the intrinsic fluorescence and the 
laser power, [AR-S]0 represents the original concentration of AR-S and [B] is 
the concentration of boric/boronic acid at each measurement. (See Appendix 
for more information) 
Equation 1 
1
!I f
=
1
!k " p
0
"[AR
_
S]
0
"Ka1
"
1
[B]
+
1
!k " p
0
"[AR
_
S]
0
 
 
In order to calculate the binding affinities between the boronic acids and the 
different diols employed in this work, Solution B and Solution C (containing 
the same concentration of AR-S and boronic acid as Solution B and at least 20 
eq of the diol) were mixed in different ratios in order to make different 
solutions with a constant concentration of both AR-S and boric/boronic acid 
and a range of concentrations of the diols. At least 6 different solutions were 
made in order to cover as much of the binding curve as possible. Once again, 
the experiments were carried out in triplicate and the fluorescence intensities 
were measured with an excitation wavelength of 468 nm. The binding affinity 
(Ka) was determined by plotting 1/P vs Q (Eq. 2), where P according to Eq. 3 
and Eq. 4, [B]0 represents the original concentration of boric/boronic acid, 
[Diol]0 is the highest concentration of diols applied through the testing time, 
[AR-S-B] means the concentration of AR-S-boron binding complex at each 
measurement, and [AR-S] is the concentration of free AR-S at each 
measurement. For a more detailed description see Ref.
[9]
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2.1.2 Binding confirmation by mass spectrometry 
Samples of diols were initially dissolved in Na2B4O7 buffer (50 mM, pH 7.4). 
Aliquots (200 µL) of this solution were further diluted with a 1:1 mixture of 
H2O : Acetonitrile (200 µL). 
 
2.1.3 Binding confirmation by 
11
B-NMR 
A 25 mM solution of Na2B4O7 was prepared in phosphate buffer (250 mM, pH 
7.4) and 10% in volume of D2O was added. This borate/phosphate buffer was 
used to prepare samples with different amounts of the diols of interest and 
NMR spectra were acquired for each of them. A collection of 128 scans was 
averaged for each spectrum with a 0.20 s recycle time. 
For the competitive binding experiments, a 20 mM solution of DPD was 
prepared in borate/phosphate buffer (25 mM, 100 mM, pH 7.4, 10% in D2O) 
and an NMR spectrum was recorded. 2 eq of the diol were then dissolved in 
this DPD solution and a new NMR spectrum was recorded. 
 
2.1.4 Synthesis of diol-monomers  
2.1.4.1 Synthesis of N-(3,4-dihydroxyphenethyl) methacrylamide 
(DMAm)
[22]
 
+
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THF/Water, pH 8
HO
HO NH2
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H
O
dopamine methacrylic anhydride DMAm  
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The reaction media were prepared by adding Na2B4O7 (10 g, 26 mmol) and 
NaHCO3 (4.0 g, 48 mmol) to distilled water (100 mL). Both Na2B4O7 and 
NaHCO3 were saturated in water in these amounts, and demonstrated some 
insolubility. Dopamine hydrochloride (5.0 g, 26 mmol) was added to this 
solution. Methacrylic anhydride solution (4.7 mL, 32 mmol) in tetrahydrofuran 
(THF, 25 mL) was prepared separately and added dropwise into the aqueous 
dopamine solution. In order to keep the reaction mixture moderately basic (pH 
8 or above) sodium hydroxide (1.0 M) was added dropwise. The reaction 
mixture was stirred overnight at room temperature. At this time, a dark black 
slurry-like solution had formed; this was washed twice with ethyl acetate (50 
mL). The resulting solid was vacuum filtered and the obtained aqueous 
solution was acidified to pH 2 with hydrochloric acid solution (6.0 M). The 
crude product was extracted with ethyl acetate (50 mL) three times from the 
acidified aqueous solution and then dried over magnesium sulfate. The solution 
volume was reduced to 25 mL with a rotary evaporator. The obtained solution 
was added to hexane (250 mL) with vigorous stirring to precipitate a brownish 
slurry-like solid. Then the formed suspension was dissolved with ethyl acetate 
(50 mL). The solvent was removed with a rotary evaporator. Precipitation was 
carried out another time and the final white solid (3.9 g, 66%) was dried under 
vacuum overnight. 
1
H-NMR (DMSO-d6, 400 MHz) δ (ppm) 8.70 (br s, 2H, 
OH), 7.93 (s, 1H, NH), 6.62 (d, J = 2.0 Hz, 1H, Ar-H), 6.57 (d, J = 8.0 Hz, 1H, 
Ar-H), 6.42 (dd, J = 8.0, 2.0 Hz, 1H, Ar-H), 5.61 (s, 1H, C=CH), 5.29 (s, 1H, 
C=CH), 3.49-3.18 (m, 2H, N-CH2), 2.67-2.38 (m, 2H, Ar-CH2), 2.08 (s, 3H, 
CH3-MAm). 
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2.1.4.2 Synthesis of 3,4-dihydroxy-L-phenylamanine methacrylamide (L-
DMAm)
[22]
  
+
NaHCO3
THF/Water, pH 8
HO
HO
O
O O
Na2B4O7
HO
HO
OH
L-DOPA methacrylic anhydride
OH
O
NH2 HN
O
O
L-DMAm  
L-DMAm was prepared following the same procedure as described for 
synthesis of DMAm. In a typical experiment, 3,4-dihydroxy-L-phenylamanine 
(L-DOPA) (5.0 g, 25 mmol) in distilled water (100 mL) with Na2B4O7 (10 g, 
26 mmol) and NaHCO3 (4.0 g, 48 mmol) solution was prepared. Methacrylic 
anhydride solution (4.7 mL, 32 mmol) in tetrahydrofuran (THF, 25 mL) was 
prepared separately. The methacrylic anhydride solution was added dropwise 
into the aqueous solution. The mixture was then adjusted to pH 8 or above with 
sodium hydroxide (1.0 M). The reaction was carried out overnight at room 
temperature. The title compound L-DMAm was purified by extraction and 
precipitation and recovered as brown powder (4.3 g, 64%) after dried under 
vacuum overnight. 
1
H-NMR (DMSO-d6, 400 MHz) δ (ppm) 12.62 (s, 1H, 
COOH), 8.72 (br s, 2H, OH), 7.96 (d, J = 8.1, 1H, NH), 6.62 (d, J = 2.0 Hz, 1H, 
Ar-H), 6.60 (d, J = 8.0 Hz, 1H, Ar-H), 6.48 (dd, J = 8.0, 2.0 Hz, 1H, Ar-H), 
5.64 (s, 1H, C=CH), 5.34 (s, 1H, C=CH), 4.38-4.30 (m, 1H, N-CH), 2.96-2.75 
(m, 2H, CH-CH2), 1.80 (s, 3H, CH3-MAm). 
13
C-NMR (DMSO-d6, 100 MHz) δ 
(ppm) 173.7 (COOH), 167.9 (CONH), 145.3 (C-OH), 144.1 (C-OH), 139.9 (-
C=), 129.2 (Ar C-), 120.2 (Ar CH), 120.0 (=CH2), 116.8 (Ar CH), 115.7 (Ar 
CH), 54.5 (CH-NH), 36.1 (CH2), 19.0 (CH3). IR (KBr) ν (cm
-1
) 3517 (N-H), 
3382 (Carboxyl O-H), 3204 (Ar O-H), 1713 (Carboxyl C=O), 1654 (Amide 
C=O), 1537 and 1519 (N-H). ESI-MS: m/z 266.11 (MH
+
, 100%), 220.11 (MH
+
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- COOH, 38%). HR-MS Calcd for C13H16N1O5 (MH
+
): 266.1028 found: 
266.1122. 
 
2.2 Results and discussions 
2.2.1 Binding affinities for boron using Alizarin Red S (AR-S) assay 
In the initial study, phenylboronic acid (PBA) and sodium borate were 
examined as boron models and their affinities with AR-S were calculated by 
fitting the AR-S assay data with Benesi-Hildebrand equation (Eq. 1) (Figure 2-
4 to 2-7). As expected, the formation of a borate/boronate ester complex 
between boric/boronic acid and AR-S enabled AR-S to be fluorescent by 
removing the quenching structure in AR-S.
[17]
 The fluorescent intensity was 
getting strong with the increase of boron concentrations (AR-S concentration 
and all other conditions were constant all through the experiment), owing to the 
increased formation of AR-S-boron complex in the system (Figure 2-4 to 2-7, 
upper). Also, the color change of solution was observed varying from dark 
pink (no fluorescent free AR-S structure) to orange (fluorescent AR-S-boron 
complex form) upon addition of boric/boronic acid into AR-S/PBS buffer. The 
initial buffer composition and pH conditions followed previous reports by 
Wang and coworkers
[9]
 ([AR-S] = 0.009 mM, [PBA] = 2 mM, [Na2B4O7] = 2 
mM. [PO4
-
] = 100 mM) (Figure 3-4 and 3-5). Buffer composition and 
concentration were retained throughout each experiment, for the constant 
between AR-S and boric/boronic acid varies significantly when buffer 
conditions are changing.
[9]
 The same experiments were repeated with a 
modified buffer conditions in due course, which verified the prior conclusion 
that different associate constants were achieved under different testing 
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conditions ([AR-S] = 0.12 mM, [PBA] = 1 mM, [Na2B4O7] = 1 mM. [PO4
-
] = 
200 mM) (Figure 2-6 and 2-7). When AR-S concentration was fixed to 0.009 
mM, and PBS was 100 mM, the associate constant of PBA-AR-S binding was 
477.8 ± 10.3 M
-1
 and Na2B4O7-AR-S was 317.8 ± 35.8 M
-1
 (Figure 2-4 and 2-
5). However, if the buffer condition was changed (e.g. [AR-S] = 0.012mM, 
[PBS] = 200 mM], the binding affinity also altered (Ka1
 
(PBA) = 432.2 ± 15.7 
M
-1
; Ka1
 
(Na2B4O7) = 368.4 ± 48.4M
-1
) (Figure 2-6 and 2-7). Therefore, the 
binding constant is only applicable in its applied assay conditions. 
Specifically, by using the AR-S assay, the binding constants (Ka1) of AR-S 
with phenyboronic acid (PBA) and Na2B4O7 were determined, respectively. 
The titration of PBA/Na2B4O7 from 86.3 to 222.7 equivalents (Figure 2-4 and 
2-5) or 1.1 to 8.3 equivalents (Figure 2-6 and 2-7) of AR-S was employed 
under constant conditions (AR-S, PBS, pH and temperature) (Here the 
ÔequivalentÕ was defined as the value of PBA/Na2B4O7 concentration divided 
by AR-S concentration). The concentration range of boron applied in solution 
was slightly different under the two different buffer conditions, which would 
not impact the calculated value of the constants as long as different boron 
concentrations were employed and induced big enough fluorescent change. 
Analyzing fluorescence data at different wavelengths made it possible to cover 
as wide range of fluorescence as possible and minimize intrinsic instrument 
errors. Therefore, three sets of data have been selected for inclusion in Eq. 1 
(Figure 2-4 to 2-7, bottom). These three are: the fluorescence intensity at 592 
nm wavelength (emission wavelength for AR-S), intensities at 572 nm 
wavelength and average intensities in the range of 573-614 nm. All the three 
sets were analyzed independently. The constants shown here are the average 
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values of the three. In addition, this assay was carried out twice independently 
under the two different solution conditions.  
  70
 
Figure 2-4. Fluorescence profile of AR-S and phenylboronic acid (PBA) and 
the corresponding fitting plots. [AR-S] = 0.009 mM, [PBA] = 2 mM, [PO4
-
] = 
100 mM; Ka1
 
(PBA) = 477.8 ± 10.3 M
-1
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Figure 2-5. Fluorescence profile of AR-S and sodium borate and the 
corresponding fitting plots. [AR-S] = 0.009 mM, [Na2B4O7] = 2 mM, [PO4
-
] = 
100 mM; Ka1
 
(Na2B4O7) = 317.8 ± 35.8 M
-1
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Figure 2-6. Fluorescence profile of AR-S and phenylboronic acid (PBA) and 
the corresponding fitting plots. [AR-S] = 0.12 mM, [PBA] = 1 mM, [PO4
-
] = 
200 mM; Ka1
 
(PBA) = 432.2 ± 15.7 M
-1
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Figure 2-7. Fluorescence profile of AR-S and sodium borate and the 
corresponding fitting plots. [AR-S] = 0.12 mM, [Na2B4O7] = 1 mM, [PO4
-
] = 
200 mM; Ka1
 
(Na2B4O7) = 368.4 ± 48.4M
-1
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Based on the AR-S three-composition system, the binding affinity constants 
(Ka) of a series of diol-containing compounds including DPD molecules to 
boron were established at pH 7.4 in PBS buffer fitting with Eq. 2, 3 & 4 (see 
Appendix for more details). Linear diols such as 3-methoxy-1,2-propanediol, 
2-methyl-1,3-propanediol and 2-amino-1,3-propanediol (Figure 3-8) have very 
low affinities ranging from 0.212 M
-1
 to 12.7 M
-1
 for PBA and from 0.169 M
-1
 
to 9.86 M
-1
 for sodium borate. Methoxy-β-D-glucopyranoside and methoxy-β-
D-galactopyranoside (Figure 3-8) have moderate Ka values: 0.765 M
-1
 and 
0.882 M
-1
 for PBA and 0.444 M
-1
 and 1.07 M
-1
 for sodium borate, respectively. 
Catechols such as dopamine and L-DOPA (Figure 3-8) have high affinities for 
both PBA and sodium borate with Ka values in the range of 32.5 M
-1
-108 M
-1
. 
These results were in accord with prior reports i.e.: linear diols < cyclic diols 
(sugars) < aromatic diols or catechols.
[9, 23]
 Even though DPD (Figure 3-8) (Ka: 
81 for PBA and 84.5 for sodium borate) has a similar structure to 
carbohydrates, its affinity was much higher than that obtained for the other 
saccharides analyzed, and only the catechols (Dopamine and L-DOPA) gave 
comparable affinities. On the other hand, the binding affinity of dopamine with 
boric acid was much higher than its derivative structure L-DOPA and also 
higher than its own affinity but with the other boron model PBA.  This value 
was demonstrated to be more or less the same for the different repeats. The 
reason for this unexpected high value was not very clear. However, through 
this AR-S experiments, dopamine and its derivative molecule L-DOPA were 
believed to be selectively important, for they gave higher ability to 
competitively bind boron from DPD than the other analyzed diols. And thus, 
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dopamine and L-DOPA were considered as the potential candidates involved 
in ÔQS quenchingÕ system.  
3-MeO-1,2-PDO
OH
OH
O
2-Me-1,3-PDO
OHHO
2-NH2-1,3-PDO
OHHO
NH2
MeO-b-D-Glc
O
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HO
O
HO O
MeO-b-D-Gal
O
OH
OH
HO
O
HO O
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NH2HO
HO
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NH2HO
HO OHO
O
O
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O
OHHO
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HO
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Figure 2-8. Binding affinities of DPD, model diols and polymers for 
phenylboronic acid (PBA - Blue bars) and boric acid (Green Bars). (PDO = 
Propanediol, Glc = Glucopyranoside, Gal = Galactopyranoside) 
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Specifically, the graphs below (Figure 2-9 to 2-24) gave the detailed 
information to explain how the above binding affinity values (Figure 2-8) 
came. The full scan profiles (500 nm to 750 nm wavelength) of fluorescence 
were recorded with fluorimeter under the condition of constant concentration 
of PBS, AR-S and PBA/Na2B4O7, but a series concentration of diols (Figure 2-
9 to 2-24, upper). Such graphs gave a direct view that fluorescent intensity 
decreased with the increase of diol concentration due to the competitive 
binding of boron from AR-S induced quenching of AR-S-boron fluorescence. 
Again, the concentrations of diols employed were not the same, as displayed 
on the legend, for each type of diols (e.g. Figure 2-9 and Figure 2-11). 
However, this has nothing to do with their binding affinity values, as long as 
significant fluorescent change was obtained with a series concentration of 
diols. This is obviously because that binding affinity represents the intrinsic 
binding ability of one type of molecule to another, which should be constant 
through out the same testing conditions. And also, even with the same type of 
diol molecule and similar diol concentrations, the fluorescence could be 
different (e.g. Figure 2-11 and Figure 2-12). This is expected that 
phenylboronic acid (PBA) has only one binding site for one boron-containing 
molecule, but sodium borate has two. And thus, their affinities for one specific 
type of diol molecule can be different. In addition, these fluorescence data at 
three different wavelengths (572 nm, 592 nm and 573 to 614 nm) were then 
fitting with Benesi-Hildebrand equation (Eq. 2, 3 &4) to form the equation 
profiles (Figure 2-9 to 2-24, bottom). The binding affinities (Ka) of each type 
of diol with each type of boron model at each wavelength were calculated 
  77
individually (Figure 2-9 to 2-24) (see more details in Appendix). The values 
of binding affinity were the average of the three and concluded in Figure 2-8.  
 
Figure 2-9. Fluorescence profile of PBA and DPD titration and the 
corresponding fitting plot. [AR-S] = 0.06 mM, [PBA] = 0.5 mM, [DPD] = 
11.4 mM, [PO4
-
] = 100 mM. Ka = 81.0 ± 0.1 M
-1
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Figure 2-10. Fluorescence profile of Sodium Borate and DPD titration and the 
corresponding fitting plot. [AR-S] = 0.06 mM, [Na2B4O7]=0.5 mM, [DPD] = 
11.4 mM, [PO4
-
] = 100 mM. Ka = 84.5 ± 0.1 M
-1
. 
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Figure 2-11. Fluorescence profile of PBA and 3-Methoxy-1,2-propanediol 
(MeO-PDO) titration and the corresponding fitting plot. [AR-S] = 0.12 mM, 
[PBA] = 1 mM, [MeO-PDO] = 1749.6 mM, [PO4
-
] = 200 mM. Ka = 0.4 ± 
0.006 M
-1
. 
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Figure 2-12. Fluorescence profile of Sodium Borate and 3-Methoxy-1,2-
propanediol (MeO-PDO) titration and the corresponding fitting plot. [AR-S] = 
0.12 mM, [Na2B4O7] = 1 mM, [MeO-PDO] = 2099.5 mM, [PO4
-
] = 200 mM. 
Ka = 0.5 ± 0.003 M
-1
. 
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Figure 2-13. Fluorescence profile of PBA and 2-Methyl-1,3-propanediol (Me-
PDO) titration and the corresponding fitting plot. [AR-S] = 0.12 mM, [PBA] = 
1 mM, [Me-PDO] = 3917.5 mM, [PO4] = 200 mM. Ka = 0.2 ± 0.006 M
-1
. 
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Figure 2-14. Fluorescence profile of Sodium Borate and 2-Methyl-1,3-
propanediol (Me-PDO) titration and the corresponding fitting plot. [AR-S] = 
0.12 mM, [Na2B4O7] = 1 mM, [Me-PDO] = 4505.1 mM, [PO4
-
] = 200 mM. 
Ka = 0.2 ± 0.001 M
-1
. 
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Figure 2-15. Fluorescence profile of PBA and 2-Amino-1,3-propanediol 
(Amino-PDO) titration and the corresponding fitting plot. [AR-S] = 0.12 mM, 
[PBA] = 1 mM, [Amino-PDO] = 65.9 mM, [PO4
-
] = 200 mM. Ka = 12.7 ± 0.3 
M
-1
. 
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Figure 2-16. Fluorescence profile of Sodium Borate and 2-Amino-1,3-
propanediol (Amino-PDO) titration and the corresponding fitting plot. [AR-S] 
= 0.12 mM, [Na2B4O7] = 1 mM, [Amino-PDO] = 79.6 mM, [PO4
-
] = 200 mM. 
Ka = 9.9 ± 0.2 M
-1
. 
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Figure 2-17. Fluorescence profile of PBA and MeO-β-glucopyranoside (MeO-
β-Glc) titration and the corresponding fitting plot. [AR-S] = 0.12 mM, [PBA] 
= 1 mM, [MeO-β-Glc] = 1043.9 mM, [PO4
-
] = 200 mM. Ka = 0.8 ± 0.017 M
-1
. 
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Figure 2-18. Fluorescence profile of Sodium Borate and MeO-β-
glucopyranoside (MeO-β-Glc) titration and the corresponding fitting plot. 
[AR-S] = 0.12 mM, [Na2B4O7] = 1 mM, [MeO-β-Glc] = 1782.7 mM, [PO4
-
] = 
200 mM. Ka = 0.4 ± 0.006 M
-1
. 
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Figure 2-19. Fluorescence profile of PBA and MeO-β-galactopyranoside 
(MeO-β-Gal) titration and the corresponding fitting plot. [AR-S] = 0.12 mM, 
[PBA] = 1 mM, [MeO-β-Gal] = 902.3 mM, [PO4
-
] = 200 mM. Ka = 0.9 ± 0.1 
M
-1
. 
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Figure 2-20. Fluorescence profile of Sodium Borate and MeO-β-
galactopyranoside (MeO-β-Gal) titration and the corresponding fitting plot. 
[AR-S] = 0.12 mM, [Na2B4O7] = 1 mM, [MeO-β-Gal] = 1055.7 mM, [PO4
-
] = 
200 mM. Ka = 1.1 ± 0.014 M
-1
. 
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Figure 2-21. Fluorescence profile of PBA and Dopamine Hydrochloride 
(Dopamine) titration and the corresponding fitting plot. [AR-S] = 0.12 mM, 
[PBA] = 1 mM, [Dopamine] = 9.5 mM, [PO4
-
] = 200 mM. Ka = 36.4 ± 0.9 M
-
1
. 
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Figure 2-22. Fluorescence profile of Sodium Borate and Dopamine 
Hydrochloride (Dopamine) titration and the corresponding fitting plot. [AR-S] 
= 0.12 mM, [Na2B4O7] = 1 mM, [Dopamine] = 7.0 mM, [PO4
-
] = 200 mM. Ka 
= 108.0 ± 0.1 M
-1
. 
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Figure 2-23. Fluorescence profile of PBA and 3,4-Dihydroxy-L-phenylalanine 
(L-DOPA) titration and the corresponding fitting plot. [AR-S] = 0.12 mM, 
[PBA] = 1 mM, [L-DOPA] = 17.5 mM, [PO4
-
] = 200 mM, Ka = 32.5 ± 0.1 M
-
1
. 
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Figure 2-24. Fluorescence profile of Sodium Borate and 3,4-Dihydroxy-L-
phenylalanine (L-DOPA) titration and the corresponding fitting plot. [AR-S] = 
0.12 mM, [Na2B4O7] = 1 mM, [L-DOPA] = 16.5 mM, [PO4
-
] = 200 mM. Ka = 
39.9 ± 0.1 M
-1
. 
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2.2.2 Binding confirmation by mass spectrometry 
The complexes formed between catechol and sodium borate in neutral buffer 
were also confirmed by MS spectrometry. As shown, the complexes existed in 
two forms: 196.07886 m/z corresponded to 1 to 1 binding between dopamine 
and sodium borate and 178.06810 m/z was also the 1 to 1 binding complex but 
the amine group was involved to form a eight-member cyclic structure which 
was of interest and not anticipated. The free ionized dopamine was observed at 
152.07170 m/z. Also, L-DOPA and sodium borate binding complexes showed 
two forms of existence (m/z: 240.06849 and 220.05793) and its free ionized 
molecule appeared at m/z 196.0794. (Figure 2-25) 
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Figure 2-25. MS spectra showing the presence of 1:1 complexes formed 
between a) dopamine and b) L-DOPA and Na2B4O7. Complexes for MeO-β-
glucopyranoside could not be detected under the same conditions. 
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2.2.3 Binding confirmation by 
11
B-NMR 
The observation of complex formation was also confirmed by 
11
B-NMR. B-
diol complexes could not be detected in the case of any of the monosaccharides 
analyzed. For instance, complexes for MeO-β-glucopyranoside could not be 
detected even in the presence of 30 eq of the saccharide. 
11
B-NMR technique 
confirmed the presence of 1:1 and 1:2 complexes between boric acid and 
dopamine or L-DOPA. As shown, the peak at 18.3 ppm corresponded to the 
excess of Na2B4O7. With increasing addition of catechols, a signal appeared at 
6.9 ppm (dopamine) and 7.9 ppm (L-DOPA) for formation of 1:1 complex. As 
more catechol was added, a second peak at 12.4 ppm (dopamine) or 13.5 ppm 
(L-DOPA) became predominant and represented 1:2 complexes. With the 
molar ratio of catechol : borate of approximately 2:1, the sodium borate peak 
(18.3 ppm) disappeared. Theoretically, only the peak assigned to the 2:1 
complex should remain. The limitation of aqueous solubility of the catechols 
did not allow confirmation of 2:1 complex formation in all cases.  
 
Figure 2-26. 
11
B-NMR of N2B4O7 titration with different amounts of a) 
dopamine and b) L-DOPA  
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The ability of the catechol molecules to quench the ÔactiveÕ AI-2 (1) (Figure 2-
1) was also verified using 
11
B-NMR. When a solution of DPD in a 
borate/phosphate buffer at pH 7.4 was treated with 2 eq of the catechols, 
complete suppression of the signals at 4.8 and 6.2 ppm, corresponding to the 
AI-2 (1) (Figure 2-1),
[24]
 occurred, while new signals at 6.9 and 7.9 ppm, 
assigned to the dopamine and L-DOPA 1:1 to sodium borate complexes 
respectively, could be observed. The peak at 18.3 ppm, corresponding to the 
excess of Na2B4O7 has been left out for a better comparison. 
 
Figure 2-27. Quenching of AI-2 boronated form by a) dopamine and b) L-
DOPA as shown by 
11
B-NMR  
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2.2.4 Synthesis of diol-monomers 
According to the above assay results, catechols were demonstrated to give 
highest affinities to boric and boronic acid among all the small molecules 
analyzed, DMAm
[22]
 and L-DMAm
[22]
 were therefore synthesized as the 
monomer candidates. Specifically, L-DMAm was designed to confer better 
water-solubility in neutral aqueous solutions, as DMAm was reported to be 
insoluble in such conditions.
[22b]
 L-DMAm is a monomer product whose 
synthesis has not been published before and was prepared based on the 
previous report for synthesis of DMAm.
[22b]
 The reaction was performed under 
moderately basic conditions between 3,4-dihydroxy-L-phenylamanine (L-
DOPA) and methacrylic anhydride in an aqueous solution of saturated sodium 
borate and sodium bicarbonate. The presence of sodium borate was aimed to 
protect the catechol moiety by forming a transient borate ester. The synthesized 
L-DMAm monomer was a water-soluble solid white powder. The final product 
was fully characterized by 
1
H-NMR, 
13
C-NMR (Figure 2-28), MS spectrum 
and FT-IR (see Appendix).   
+
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HO
HO
O
O O
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Figure 2-28. 
1
H NMR (upper) and 
13
C NMR (bottom) spectrum of L-DMAm in 
DMSO-d6 
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2.3 Conclusions 
In this chapter, representative diols were investigated as potential AI-2 
scavengers via reversible ester formation with boric and boronic acids, with 
special attention to carbohydrate derivatives. Titration studies at pH 7.4 using 
the AR-S assay established binding affinities for boron-diol species, which 
were in accord with prior reports i.e.: linear diols < cyclic diols (sugars) < 
aromatic diols or catechols.
[9, 23]
 Even though DPD has a similar structure to 
carbohydrates, its affinity was much higher than that obtained for the other 
saccharides analyzed, and only the catechols gave comparable affinities. These 
observations were confirmed by using mass spectrometry and 
11
B-NMR 
spectroscopy. 
These experiments suggested that dopamine was the best candidate for 
polymeric QS control, showing a similar affinity for boron compared to DPD 
and the potential ability to decrease the concentration of AI-2 (1) (Figure 2-1) 
in solution. Two catechol monomers with different water-solubility were 
therefore synthesized and characterized in order to be ready for the polymer 
synthesis. 
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Chapter 3. Preparation and Characterization of Linear Polymers: Dual-
action Polymers for Simultaneous Bacterial Sequestration and Quorum 
Sense (QS) Interference 
3. Introduction 
Invasive bacteria gain their access to the intracellular milieu through actively 
inducing their own uptake, and subsequently exploit the hostÕs immune system, 
replicate and also disseminate in an actin-based motility process between host 
cells.
[1]
 Although the entry mechanisms and their intracellular life cycle may 
vary from different bacterial species,
[1]
 bacterial adhesion is the initial step in 
colonization and the formation of biofilm.
[2]
 Therefore, anti-adhesion strategies 
have been developed to reduce contact between host and pathogens, by the 
means of preventing adhesion of the potential intruders.
[3]
 Hori and 
Matsumoto
[2]
 suggested that antimicrobial agents (antibiotics, oxidants and 
biocides) could be employed in advance of biofilm formation in order to 
control bacterial adhesion effectively, but the limitations of their utilization in 
anti-infection, such as the need for high concentrations to achieve an effective 
therapy as well as harmful by-products, and also the occurrence of bacterial 
resistance invoked from their continuous administration, were also described. 
Significantly, the disconcerting fact on therapeutics of infectious pathogens is 
the appearance of resistance in response to selection pressure by drugs and the 
possible discontinuation of current drug regimens.
[4]
 The general mechanisms 
of resistance are mutation, recombination, or horizontal gene transfer.
[5]
 
Compared to the other two strategies, mutation is an approach to give rise to 
resistance in almost every disease, while the use of antimicrobials is a powerful 
selective force for promoting the emergence of resistant mutants in 
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epidemiological history.
[6]
 Additionally, the prolonged use of antibiotics 
clearly causes the cumulative effect of resistance to the whole organisms, and 
thus asymptomatic colonization typically happens even before infection.
[7]
 On 
the other hand, some researchers noticed that the resistance in bacteria invoked 
by antibiotics has become a global issue.
[8]
 Evolution of multidrug resistance 
(MDR) has increased as a result of excessive antibiotic use and environmental 
factors (greater movement of people and increased industrialization).
[8]
  
As noted earlier, synthetic polymers that interfere with bacteria-host 
interactions are an attractive approach for controlling infectious diseases 
without selection pressure and resistance invoked in bacteria by antibiotics, 
since adhesion of bacteria to tissues of host is one of the initial stages of the 
infectious process and resistance are seldom arisen by non-bactericidal 
materials.
[3]
 In this study, the ÔsmartÕ polymer materials combined dual-actions 
of bacterial sequestration and at the same time interfering with bacterial QS 
signalling, will be developed (Figure 3-1).  
 
Figure 3-1. The scheme of investigated polymers interfering with both 
communication mechanism (QS Route, red) and cell adhesion/aggregation 
(Adhesion Route, blue) at the same time in anti-infective strategies   
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In this chapter, polymers are designed to attach to Vibrio species (such as the 
human pathogen V. cholera), while at the same time binding specific 
autoinducers for QS. For this, marine bacterium V. harveyi is selected as the 
bacterial model, because QS in this species not only controls virulence but also 
bioluminescence, thereby facilitating readout of the effects of polymers on the 
QS network. It is considered that if polymers are able to bind bacteria while at 
the same time sequester borate, the levels of ÔactiveÕ AI-2 should be reduced 
and QS, as reported by bioluminescence, should be suppressed. 
Bacteria strongly bind cationic surfaces
[9]
 and glycopolymers
[10]
, but less is 
known about the ability of polymers to quench AI-2 in Vibrio species.
[11]
 As 
discussed in Chapter 2, dopamine was found to be the best candidate for 
polymeric QS control, showing a similar affinity for boron compared to DPD 
and the ability to decrease the concentration of AI-2 in solution. To test for 
effects on both bacterial adhesion and QS interference, DMAm
[12]
 will be 
copolymerized with N-[3-(dimethylamino)propyl]methacrylamide 
(DMAPMAm) to form a cationic polymer. The amine functionality is designed 
to confer water solubility at neutral pH and bacterial adhesion, as well as 
coordinate boronic acids.
[13]
 Since dopamine and L-DOPA showed similar 
affinities for borate, L-DMAm will be polymerized, thereby generating novel 
anionic water-soluble homopolymers, which should bind AI-2 strongly but 
attach less readily to bacterial surfaces because of charge-charge repulsion. 
Also, carbohydrate-based poly(β-D-glucosyloxyethyl methacrylate) 
(p(GlcEMA)) will be used in bacterial assays, for it showed a highly active 
bacterial sequestration ability in prior assays.
[14]
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Structures of Dual-action Linear Polymers Investigated in this Chapter: 
Polymer 1 Polymer 2 Polymer 3 
HN O
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HO OH
*
OHN
HN
 
HN O
*
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O
O
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*
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O O
O
O
OH
OH
OH
HO
n
 
DMAm : DMAPMAm a: n = 15; b: n = 26 n = 16 
a: 14 : 86; b: 29 : 71   
 
3.1 Experiments 
3.1.1 Synthesis of polymers 
General protocol for RAFT polymerization:
[15]
 
Polymerizations were conducted in round bottom flasks sealed with a rubber 
septum and parafilm. An NMR spectrum was recorded at the beginning of the 
experiment. The polymerization solutions were degassed using argon for at 
least 10 min and transferred to an oil bath preheated to 70 ¡C. After reaction, 
the solution was quenched by cooling in ice-water and opening to air. Another 
NMR spectrum was recorded to enable calculation of degree of conversion. 
For the removal of CTA, the reaction was carried out at 70 ¼C, and the absence 
of CTA was confirmed by UV spectroscopy. 
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3.1.1.1 p(DMAm): poly(N-dopamine methacrylamide) 
HN O
N
CN
N
CN
COOHHOOC
HN O
S
S
n
DMF
70 oC
+
HO OH
HO OH
S S
OH
S
S
OH
HN O
N
CN
N
CN
COOHHOOC
HN O
S
S
HO n
DMF
70 oC
+
HO OH
HO OH
S
S S
S
OH
O
DMAm p(DMAm)
DMAm p(DMAm)
benzyl 2-hydroxyethyl carbonotrithioate
2-(decylthiocarbonothioylthio)-2-methylpropanoic acid
O
CTA 2
CTA 3
 
In a typical experiment, DMAm (500 mg, 2.3 mmol, 2.7 M) in DMF (0.84 
mL), CTA (0.023 mmol, 0.12 M) in DMF (0.19 mL) and V-501 (3.2 mg, 0.011 
mmol, 0.060 M) in DMF (0.19 mL) were prepared separately and then mixed 
together (to make a final 0.27 M concentration of DMAm). The polymerization 
was carried out overnight.  
 
3.1.1.2 p(DMAm-c-DMAPMAm): poly{N-(3,4-dihydroxyphenethyl) 
methacrylamide-co-N-[3-(dimethylamino)propyl] methacrylamide}  
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DMAm DMAPMAm CTA 2
p(DMAm-c-DMAPMAm)
OH
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In a typical experiment, DMAm (50 mg, 0.23 mmol, 2.5 M) in DMF (0.091 
mL), N-[3-(dimethylamino)propyl] methacrylamide (DMAPMAm) (0.37 mL, 
2.0 mmol), CTA (5.5 mg, 0.023 mmol, 0.12 M) in DMF (0.19 mL) and V-501 
(3.2 mg, 0.011 mmol, 0.060 M) in DMF (0.19 mL) were prepared separately 
and then mixed together (to make a final 0.27 M concentration of DMAm). 
The polymerization was carried out overnight. The polymer products were 
purified by dialysis against water and recovered as a light brown powder (0.18 
g, 45 %) after freeze-drying from water (dark, 2 days). Solutions of the 
polymer (148 mg, 0.019 mmol, 0.010 M) in H2O (1.8 mL) and V-501 (151 mg, 
0.54 mmol, 1.4 M) in ethanol (0.40 mL) were prepared separately and then 
mixed together (to make a final ratio 1 : 30 of polymer to initiator). In order to 
remove CTA, this mixture was degassed and allowed to react at 80 ¼C 
overnight. The title compound p(DMAm-co-DMAPMAm) was purified by 
dialysis against water and recovered as a light brown powder (0.12 g, 81 %) 
after freeze-drying from water (dark, 2 days) 
1
H-NMR (D2O/TFA 5 : 1, 400 
MHz) δ (ppm) 7.55-6.36 (m, 3H, Ar-H), 3.52-3.34 (m, 2H, CH2-N DMAm), 
3.33-2.95 (m, 4H, CH2-N DMAPMAm), 2.93-2.66 (m, > 8H, N-CH2-CH2 
DMAm + CH3 DMAP), 2.15-1.53 (m, > 5H, CH3-MAm + HN-CH2-CH2-
DMAPMAm), 1.24-0.63 (m, 2H, CH2-MAm backbone) Mw (GPC) 6.6 KDa, 
PDI (GPC) 1.05. 
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- Macro-CTA-1 (polymer 1 with active trithiocarbonate end group) 
HN O
N
CN
N
CN
COOHHOOC
t-BuOH/Acetate buffer 50mM, pH5.5
EtOH
70 ¼C
+
HO OH
S S
OH
S
HN O +
N
HN O
HO OH
S
OHN
N
S
S
HO OH
O
HO
O
DMAm DMAPMAm CTA 1 p(DMAm-c-DMAPMAm)  
In a typical experiment, DMAm (150 mg, 0.68 mmol, 0.21 M) in t-
BuOH/acetate buffer (50 mM, pH 5.5, 0.62 mL), N-[3-(dimethylamino) 
propyl] methacrylamide (DMAPMAm) (1.1 mL, 6.1 mmol), RAFT agent (17 
mg, 0.068 mmol, 0.12 M) in EtOH (0.57 mL) and V-501 (3.8 mg, 0.014 mmol, 
0.060 M) in EtOH (0.23 mL) were prepared separately and then mixed 
together. The pH of mixture was ajusted with HCl (10 M, 0.50 mL; 5.0 M, 
0.070 mL) and NaOH (4.0 M, 0.15 mL) to 5.5 and to make a final 0.21 M 
concentration of DMAm. The polymerization was carried out overnight. The  
macro-RAFT agent compound p(DMAm-c-DMAPMAm) was purified by 
dialysis against water and recovered as a light brown powder (0.40 g, 33%) 
after freeze-drying from water (dark, 2 days). 
1
H-NMR (D2O, 400 MHz) δ 
(ppm) 6.83-6.40 (m, 3H, Ar-H), 3.18-2.89 (m, 2H, CH2-N-DMAm), 2.79-2.56 
(m, 4H, CH2-N-DMAPMAm), 2.56-2.22 (m, >8H, N-CH2-CH2-DMAm + CH3-
DMAP), 1.94-1.43 (m, >5H, CH3-MAm + HN-CH2-CH2-DMAPMAm), 1.11-
0.53 (m, 2H, CH2-MAm backbone) Mw (GPC) 12.9 KDa, PDI (GPC) 1.36 
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3.1.1.3 p(L-DMAm): poly(3,4-dihydroxy-L-phenylalanine 
methacrylamide)  
- Polymer 2 
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In a typical experiment, L-DMAm (500 mg, 1.9 mmol, 3.1 M) in sodium 
hydroxide (1.0 M, 0.62 mL), CTA (23 mg, 0.094 mmol, 0.12 M) in DMF (0.79 
mL) and V-501 (13 mg, 0.047 mmol, 0.060 M) in DMF (0.79 mL) were 
prepared separately and then mixed together (to make a final 0.86 M 
concentration of L-DMAm). The polymerization was carried out overnight. 
The polymer products were purified by dialysis against water and recovered as 
a white powder (0.31 g, 62 %) after freeze-drying from water (dark, 2 days). 
Solutions of the polymer (310 mg, 0.079 mmol, 0.020 M) in NaOH solution 
(0.12 M, 3.4 mL) and V-501 (663 mg, 2.4 mmol, 1.7 M) in ethanol (1.4 mL) 
were prepared separately and then mixed together (to make a final ratio 1:30 of 
polymer to initiator). In order to remove CTA, this mixture was degassed and 
allowed to react at 80 ¼C overnight. The title compound p(L-DMAm) was 
purified by dialysis against water and recovered as a white powder (0.23 g, 
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74 %) after freeze-drying from water (dark, 2 days) 
1
H-NMR (D2O/NaOH (1.0 
M) 5 : 1, 400 MHz) δ (ppm) 7.44-5.80 (m, 3H, Ar-H), 4.38-3.76 (m, 1H, N-
CH), 3.23-1.90 (m, > 5H, CH-CH2 + CH3-MAm), 1.83-0.00 (m, 2H, CH2-
MAm backbone).  
 
3.1.2 Synthesis of Reversible Addition-Fragmentation Chain Transfer 
(RAFT) Agent / (CTA) 
3.1.2.1 2-((2-hydroxyethylthio)carbonothioylthio)-2-methylpropanoic 
acid
[16]
 
+
HO
SH +
S
C
S
OH
O
Br
HO
S S
S
OH
O
K3PO4
Acetone
2-mercaptoethanol carbon disulfide 2-bromoisobutyric acid 2-((2-
hydroxyethylthio)carbonothioylthio)-
2-methylpropanoic acid  
2-mercaptoethanol (2.0 g, 25 mmol) and a suspension of K3PO4 (6.0 g, 28 
mmol) were mixed in acetone (60 mL) and stirred for 10 min. CS2 (5.2 g, 68 
mmol) was added to the above mixture. After 10 min stirring, 2-
bromoisobutyric acid (4.2g, 25 mmol) was added. The mixture was stirred for 
13 hour (overnight). The solution was bubbled under N2 for 30 min to remove 
CS2. Solvent was removed under reduced pressure. The residue was extracted 
into CH2Cl2 from 1.0 M HCl and washed with H2O and NaCl (Sat). Again, the 
solvent was removed under reduced pressure. The crude product was purified 
by column chromatography on silica using ethyl acetate/hexane gradient ratio 
from 2 : 1 to 3 : 2 to yield a bright yellow solid (17 %) that crystallized upon 
cooling. 
1
H-NMR (CDCl3, 400 MHz) δ (ppm) 4.96 (br, 1H, HO-CH2-CH2), 
3.89 (t, J = 6.4 Hz, 2H, HO-CH2-CH2), 3.55 (t, J = 6.4, 2H, HO-CH2-CH2), 
1.75 (s, 6H, CH3). 
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3.1.3 Binding affinities for boron using Alizarin Red S (AR-S) assay 
Similarly to small molecule analysis, in order to calculate the binding affinities 
between the boronic acids and polymers investigated in this work, Solution B 
and Solution C (containing the same concentration of AR-S and boronic acid 
as Solution B and at least 20 eq of the diol) were mixed in different ratios in 
order to make varying solutions with a constant concentration of both AR-S 
and boric/boronic acid, and a range of concentrations of the diols. At least 6 
different solutions were made in order to cover as much of the binding curve as 
possible. The experiments were carried out in triplicate and the fluorescence 
intensities were measured with an excitation wavelength of 468 nm. For the 
polymers, due to their multivalent nature, binding affinities (Ka) were 
determined using the Hill Equation (Eq. 1), where ΔIf is again the change in 
fluorescence intensity, ΔI∞ the change in fluorescence upon saturation, and n is 
the Hill coefficient.
[17]
 
Equation 1 
!I f =
!I
"
1+ [
1
[Diol]#Ka
]
n
 
 
3.1.4 Binding confirmation by 
11
B-NMR 
A 25 mM solution of Na2B4O7 was prepared in phosphate buffer (250 mM, pH 
7.4) and 10% in volume of D2O was added. This borate/phosphate buffer was 
used to prepare samples with different amounts of the diols of interest and 
NMR spectra were acquired for each of them. A collection of 128 scans was 
averaged for each spectrum with a 0.20 s recycle time. 
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For the competitive binding experiments, a 20 mM solution of DPD was 
prepared in borate/phosphate buffer (25 mM, 100 mM, pH 7.4, 10% in D2O) 
and an NMR spectrum was recorded. Polymers were then dissolved in this 
DPD solution and a new NMR spectrum was recorded.  
 
3.1.5 Bacterial aggregation assay 
3.1.5.1 UV spectrum 
V. harveyi MM32 grown on Luria Bertani (LB) agar plate containing 
kanamycin (50 µg/ml) and chloramphenicol (10 µg/ml), were used to inoculate 
2 mL Assay Broth (AB) from a fresh plate. The bacteria were then grown with 
aeration at 30¼C overnight. 285 µL of the medium were placed in a UV cuvette 
and combined with 15 µL of the samples to be analyzed. Optical density (OD, 
600 nm) was recorded at 30 ¼C every 30 seconds for at least 40 min. Because 
of the difficulties found in reproducing exactly the same initial bacteria 
conditions, experiments were carried out in duplicate. Aggregation Index (XAg) 
was determined using Eq. 2, where [P] was the concentration of polymer 
expressed in weight percentage and %Ag, the percentage of aggregation of 
each sample calculated according to Eq. 3. Because of V. HarveyiÕs fast 
sedimentation, its aggregation was subtracted from that observed in the 
presence of polymers. For a better comparison XAg has been normalized to the 
lowest value. 
LB Medium: 10 g/L of tryptone, 5 g/L of yeast extract and 10 g/L of NaCl. AB 
Medium: 0.3 M NaCl, 0.05 M MgSO4 
.
 7H2O, 0.2% vitamin-free casamino 
acids, 1 mM L-arginine, 1% glycerol, 0.01 M K2HPO4, pH 7.0. Both Solutions 
are autoclaved at 120 ¼C for 20 min. 
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Equation 2 Equation 3 
XAg =
%Ag
[P]
 %Ag =
OD
0
!OD
OD
0
 
 
Aggregation was also investigated in PBS (10 mM, pH 7.4). This way, V. 
Harveyi were sampled in the midexponential phase, washed twice, and 
resuspended in sterile PBS to a final OD (600 nm) of ∼1.9. This medium were 
placed in UV cuvettes and combined with the polymer water solution to be 
analyzed. The final concentration of polymers were 0.25 mg/mL in all cases, 
except poly (β-D-glucosyloxyethyl methacrylate) (p(GlcEMA) (Polymer 3) 
which was set to 0.05 mg/mL due to the limited amount of material.  
In order to investigate the effect of polymer concentration, the same 
experimental procedure was undertaken, but the cell suspension in PBS and a 
p(DMAm14-co-DMAPMAm86) (Polymer 1a) solution were mixed in different 
ratios in order to make different solutions with a range of concentrations of the 
polymer. In addition, aggregation in the presence of different concentrations of 
PVA was also investigated. 
 
3.1.5.2 Microscopy 
For optical microscopy, Aliquots (10 µL) of the previous samples in AB 
medium were collected with a micropipette, mounted on a glass slide with a 
cover slip on top and examined with an optical microscope. 
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3.1.6 Bioluminescence assay with V. harveyi species 
3.1.6.1 MM32 assay 
Protocol 1:  
1. Vibrio harveyi MM32 was grown from frozen stock in LB medium (2 mL) 
with kanamycin (antibiotic, 30 µg/mL) at 30 ¡C, shaking in an incubator 
overnight.  
2. 50% glycerol (400 µL), K2HPO4 (200 µL of 1 M) and arginine (200 µL of 
0.1 M) were added to 19.0 mL of autoinducer bioassay media (AB medium, 
see below), and inoculated with 4 µL of the overnight culture of MM32. DPD 
(195 µL of 2.27 mM commercial available) filtered through sterile membrane 
(0.2 µM) was added into the above media to have a concentration of 22 µM. 
3. 180 µL aliquots were placed in a 96 well plate. 
4. 20 µL of supernatants were added to the aliquots of inoculated AB media, 
separately (triplicate for each supernatant sample), such that DPD reached a 
final concentration of 19.9 µM.  
5. A 96-well plate was then put in a combined luminometer/spectrometer, 
recording OD (600 nm) and light output every 30 minutes for 22 h. 
(AB medium: sodium chloride (17.52 g/L), MgSO4 (12.33 g/L) and casamino 
acids (2.0 g/L), pH adjusted to 7.5 with KOH.)  
 
Protocol 2: - Boron concentration controlled  
1. Vibrio harveyi MM32 was grown from frozen stock in LB medium (2mL) 
with kanamycin (antibiotic, 30µg/mL) at 30 ¡C, shaking in an incubator 
overnight.  
  115
2. 50% glycerol (400 µL), B(OH)3 (300 µL of 29.6 mM, 11.3 mg/mL), 
K2HPO4 (200 µL of 1M) and arginine (200 µL of 0.1M) were added to 18.7 
mL of autoinducer bioassay media (AB medium, see below), and inoculated 
with 4 µL of the overnight culture of MM32. DPD (195 µL of 2.27 mM 
commercial available) filtered through sterile membrane (0.2 µM) was added 
into the above media to have a concentration of 22 µM. 
3. 180 µL aliquots were placed in a 96-well plate. 
4. 20 µL of supernatants were added to the aliquots of inoculated AB media, 
separately (triplicate for each supernatant sample) 4 h after keeping 96-well 
plate in 30 ¡C incubator, so that DPD reached a final concentration of 19.9 µM 
and B(OH)3 reached a final concentration of 400 µM. 
5. A 96-well plate was then put in a combined luminometer/spectrometer, 
recording OD (600 nm) and light output every 30 minutes for 22 h. 
(AB medium: sodium chloride (17.52 g/L), MgSO4 (12.33 g/L) and casamino 
acids (2.0 g/L), pH adjusted to 7.5 with KOH.)  
 
Protocol 3:
[18]
 -Boron concentration and media evaperation controlled 
1. Vibrio harveyi MM32 (2.5 µL) was grown from frozen stock in LB medium 
(5mL) with kanamycin (antibiotic, 50 mg/mL, 5 µL) at 30 ¡C, shaking in an 
incubator 12 h. Finally OD was controlled to be 0.9~1.0 (600 nm). 
2. 50% glycerol (400 µL), B(OH)3 (300 µL of 29.6 mM, 11.3 mg/mL), 
K2HPO4 (200 µL of 1M) and arginine (200 µL of 0.1 M) were added to 18.7 
mL of autoinducer bioassay media (AB medium, see below), and inoculated 
with 4 µL of the overnight culture of MM32. DPD (195 µL of 2.27 mM 
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synthesized) filtered through sterile membrane (0.2 µM) was added into the 
above media to have a concentration of 22 µM. 
3. 180 µL aliquots were placed in a 96 well plate. 
4. 20 µL of supernatants were added to the aliquots of inoculated AB media, 
separately (triplicate for each supernatant sample), so that DPD reached a final 
concentration of 19.9 µM and B(OH)3 reached a final concentration of 400 µM. 
5. A 96-well plate was sealed with aluminum cover then put in a combined 
luminometer/spectrometer, recording OD (490 nm) and light output every 2 h 
manually for 16 h. 
(AB medium: sodium chloride (10.52 g/L), MgSO4 (0.36 g/L) and casamino 
acids (1.2 g/L), pH adjusted to 7.5 with NaOH.)  
 
Protocol 4: -Boron concentration and media evaperation controlled with 
modification 
a. Borate-depleted procedure:
[19]
  
V. harveyi was grown in borate-depleted autoinducer bioassay (AB) medium. 
To remove borate, the media were filtered through a borate anion-specific resin, 
Amberlite IRA743 (Sigma-Aldrich). Specifically, 100 mL of medium was 
passed three times through 6 mL of resin (suspended in distilled water) and the 
column was regenerated between each passage according to the method 
described as follows.
[20]
 
In a plastic separation column, 6 mL of Amberlite resin (suspended in distilled 
water) was treated, in sequence, with the following: 30 mL 3 mol/L ammonia 
hydroxide, 120 mL distilled water, 60 mL of 1 mol/L hydrochloric acid, 30 mL 
distilled water, 60 mL of 0.16 mol/L nitric acid, 120 mL distilled water 
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followed by 100 mL of media. All liquid was allowed to filter through the resin 
at an effluent rate of ~2 drops/s. Media were collected in a plastic bottle, filter-
sterilized and stored at 4 ¡C until used.  
Following filtration, the pH of the medium was adjusted to 7.5 using KOH 
made with borate-depleted water.  
 
b. DPD concentration optimization assay 
1. V. harveyi MM32 was grown from frozen stock in LB medium (2 mL) with 
kanamycin (antibiotic, 30 µg/mL) at 30 ¡C, shaking in an incubator overnight.  
2. Boron-depleted glycerol (400 µL of 50%, v/v), boron-depleted K2HPO4 (200 
µL of 1 M) and boron-depleted arginine (200 µL of 0.1 M) were added to 18.9 
mL of boron-depleted AB medium.  
3. B(OH)4 (300 µL of 29.6 mM, 11.3 mg/mL) made with borate-depleted water 
and 4 µL of the overnight culture of MM32 were added to above media. 
4. 180 µL aliquots were placed in a 96 well plate 
5. 20 µL of DPD solution were added to the aliquots of inoculated AB media, 
separately (triplicate for each DPD concentration), so that B(OH)4 reached a 
final concentration of 400 µM. 
6. A 96-well plate sealed with aluminum tape was incubated for 4 h. 
7. A 96-well plate was then put in a combined luminometer/spectrometer, 
recording OD and light output every 30 minutes for 22 hours. 
(AB medium: sodium chloride (17.52 g/L), MgSO4 (12.33 g/L) and casamino 
acids (2.0 g/L), pH adjusted to 7.5 with KOH.)  
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c. Polymer assay 
1. V. harveyi MM32 was grown from frozen stock in LB medium (2 mL) with 
kanamycin (antibiotic, 30 µg/mL) at 30 ¡C, shaking in an incubator overnight.  
2. Boron-depleted glycerol (400 µL of  50%, v/v), boron-depleted K2HPO4 
(200 µL of 1 M) boron-depleted arginine (200 µL of 0.1 M), B(OH)3 (prepared 
from boron-depleted H2O, 300 µL  of 29.6 mM, 11.3 mg/mL) were added to 
18.6 mL of boron-depleted AB medium. The overnight culture of MM32 (4 
µL, OD adjusted to 1.0) and DPD (119 µL of 3.7 mM) were added to above 
media. (All of the above solution/media were filtered through sterile membrane 
(0.2 µM) before mixing.) 
3. 180 µL aliquots were placed in a 96 well plate. 
5. 20 µL of polymer supernatants were added to the aliquots of inoculated AB 
media, separately (triplicate for each sample), so that DPD reached a final 
concentration of 19.9 µM and B(OH)3 reached the final concentration of 400 
µM. 
6. A 96-well plate sealed with aluminum tape was incubated for 4 h at 30 ¡C. 
7. A 96-well plate was then put in a combined luminometer/spectrometer, 
recording OD and light output every 30 minutes for 22 hours. 
(AB medium: sodium chloride (17.52 g/L), MgSO4. 7H2O (25.18 g/L) and 
casamino acids (2.0 g/L), pH adjusted to 7.5 with KOH.) 
 
3.1.6.2 BB170 assay 
1. BB170 was grown from frozen stock on LB plate with kanamycin (30 
µg/mL) at 30 ¡C. 
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2. 2 mL overnight culture was set up (LB with Km at 30 µg/mL) inoculating 
from fresh plate, shaking in an incubator at 30 ¡C. 
3. 50% glycerol (400 µL), HEPES (500 µL of 1 M, pH 7.8), K2PO4 (200 µL of 
1 M) and arginine (200 µL of 0.1 M) were added to 18.7 mL of autoinducer 
bioassay media (AB media - sodium chloride 17.52 g/L, MgSO4 12.33 g/L, 
casamino acids 2.0 g/L, pH adjusted to 7.5 with KOH, autoclaved), and 
inoculated with 4 µL of the overnight culture of BB170. 
4. 180 µL aliquots were placed in a 96-well plate. 
5. 20 µL of supernatants were added to the aliquots of inoculated AB media 
(triplicate for each supernatant sample and also blank sample) 
6. A 96-well plate was then put in a combined luminometer / spectrometer, 
recording OD and light output every 30 min for 12 h. 
 
3.2 Results and discussions 
3.2.1 Polymer synthesis 
3.2.1.1 Synthesis of p(DMAm)  
P(DMAm) homopolymers was synthesized by using the general 
polymerization procedure at the very beginning of the project. In the initial 
reaction conditions, CTP (Figure 3-5, 4) was used as CTA and V-501 was used 
as a water-soluble initiator. DMAm monomer was initially dissolved in H2O. 
CTP and V-501 were dissolved in ethanol to reach the concentration of 0.12 M 
and 0.06 M respectively as stock solutions. The above three portions were 
mixed to get a final molar ratio: 100 : 1 : 0.5 (monomer : CTP : V-501) and 
monomer concentration 0.86 M. After overnight reaction, the mixture was 
cloudy and hard to dissolve in any solvent. This phenomenon suggested that 
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polymerization was occurred. However, the polymer produced under these 
conditions exhibited poor solubility in most of the organic solvents and 
aqueous solutions. In order to improve polymer solubility, different solvents 
(e.g. DMF, DMSO, H2O with Na2B4O7/Na2OH to adjust pH > 6) were 
employed to adjust polymerization conditions. The stock solutions of CTA and 
initiator were fresh made for each polymerization. Also, the oxygen-excluding 
process was checked and carried out very carefully. Temperature was 
controlled to be 70 ¡C all through the reaction.  However, the solubility of 
RAFT-prepared p(DMAm) did not improve in all the tested solutions. On the 
other hand, p(DMAm) with improved solubility in DMF was made 
successfully via repeating the standard free radical polymerization conditions 
reported in the literature.
[21]
  
It was well known that the key to a successful RAFT polymerization was the 
proper choice of CTA. In this case, the last attempt to improve polymer 
properties was to use different CTAs. The monomer conversion (calculated by 
comparing the integration of vinyl proton signals from the monomers to the 
aromatic groups in 
1
H-NMR, see Appendix for details) was increased to 
59.9% and 79.9% by using benzyl 2-hydroxyethyl carbonotrithioate (Figure 3-
5, 2) and 2-(dodecylthiocarbonothioylthio)-2-methylpropanoic acid (Figure 3-5, 
3) as CTAs, respectively, in DMF solvent. However, the poor solubility of the 
resultant polymer product in most of the organic solvent (methanol, THF, 
methylene chloride and dichloromethane) as well as aqueous media at neutral 
pH was still limited. Therefore, no further work was carried out with this 
polymer.  
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3.2.1.2 Synthesis of p(DMAm-c-DMAPMAm) hydrophilic statistic 
copolymers and p(L-DMAm) homopolymers 
As discussed above, in order to improve the water-solubility of homo-
p(DMAm) polymer in neutral pH as well as testing for effects on both bacterial 
adhesion and QS interference, two strategies have been explored here: 1) 
DMAm
[12]
 was copolymerized with DMAPMAm to form a cationic polymer. 
The amine functionality is designed to confer water solubility at neutral pH and 
bacterial adhesion, as well as coordinate to boronic acids.
[13]
 2) Since dopamine 
and L-DOPA showed similar affinities for borate, L-DMAm was also 
synthesized and polymerized to homopolymer, thereby generating novel 
anionic water-soluble homopolymers, which should still bind AI-2 strongly but 
attach less readily to bacterial surfaces because of charge-charge repulsion. 
In order to have different binding affinities to either bacteria surfaces or QS 
signals, a series of hydrophilic polymers with various monomer composition 
and/or degree of polymerization were prepared. All the prepared polymers 
were screened based on their solubility in neutral aqueous media. A series of 
synthetic polymers with distinct water-solubility was presented in Table 3-1 
and 3-2. However, only polymer 1a, 1b (statistic copolymer with randomly 
polymerized DMAm and DMAPMAm constructions) and polymer 2a, 2b 
(homopolymer) gave promising solubility in water at neutral pH, and therefore 
remained as potential candidates for dual-intervention of both bacteria to host 
invasion and QS network. Also, it was notable that the final composition 
percentage calculated from 
1
H-NMR (Table 3-1, values in brackets) of DMAm 
was bigger than the target value (Table 3-1, values outside the brackets), while 
such final composition percentage of DMAPMAm was smaller than its target 
  122
one. This gave an insight into kinetics of the polymerization progress that 
DMAm was polymerized faster than DMAPMAm monomer in the applied 
conditions. In addition, to optimize polymerization conditions, different CTAs 
(Figure 3-5, 1 and 2) and solvents (DMF, DMSO, aqueous acetic acid pH 2 
with t-butanol) were employed. Finally, the polymerization conditions to 
prepare p(DMAm-c-DMAPMAm)-CTA were modified (t-BuOH and acetate 
buffer (50 mM) at pH 5.5, with CTA 1 stock solution in EtOH) in order to keep 
the macro-CTA active to grow the second block of copolymer, because the 
alkaline conditions are known to quench CTA easily.  
Table 3-1  
No. DMAm DMAPMAm 
Conversion 
(
1
H-NMR) 
Mn 
(GPC) 
PDI 
1a 
a
 10 % (14 %) 90 % (86 %) 45 % 6633 1.05 
1b 
a
 20 % (29 %) 80 % (71 %) 35 % 9911 1.05 
1c
b
 40 % 60 % - - - 
1d
b
 50 % 50 % - - - 
a
 The composition percentage in brackets is the final value calculated from 
1
H-NMR; 
b
 
Polymer products were not dissolved in any solvent available in our lab.  
 
Aqueous GPC was used to characterize polymer 2. However, it gave poor 
solubility at pH 7.4 buffer solution and very low concentration remained after 
being filtered through 0.2 µm membrane. The low solubility of polymers 2 at 
concentrations needed for GPC prevented them from being characterized by 
means of aqueous GPC, and therefore the PDI of the polymers could not be 
calculated. The polymers were also insoluble in other common solvents 
employed for GPC, such as DMF (0.1% LiBr), CHCl3 or THF. Although the 
poor solubility of polymer 2 in neutral aqueous media was not expected, the 
low concentration in solution was assumed to be high enough to interfere with 
QS and cell activities (see Ôaggregation assayÕ and Ôbioluminescence assayÕ). 
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Table 3-2 
No. Monomer DP 
a
 
Conversion 
(
1
H-NMR) 
Mn 
b
 
(
1
H-NMR) 
2a L-DMAm 20 (15) 74 % 3934 
2b L-DMAm 40 (26) 66 % 6989 
2c L-DMAm 100 (89) 89 % 23510 
a
 The degree of polymerization (DP) in the brackets is the final value calculated from 
1
H-NMR, 
b
 A proper solvent for GPC analysis was not found.  
 
The overall monomer conversion was calculated from 
1
H-NMR by comparing 
the vinyl proton signals from the monomers (5.6 and 6.1 ppm) to the overall 
integration from the aromatic groups (6.5-6.8 ppm). For the copolymers the 
composition of DMAm in the polymer was calculated from the 
1
H-NMR 
spectra of the purified polymer in D2O, by comparing the integral of the two 
protons a, α to the amido group in DMAm (3.6 ppm) to the protons c and d in 
DMAPMAm (3.2 ppm) (Figure 4-2).  
 
Figure 3-2. Representative example of copolymer composition calculation: 
1
H-
NMR spectra of monomer DMAm (blue) and DMAPMAm (green), and 
copolymer p(DMAm-c-DMAPMAm) - Polymer 1b (red, bottom) in D2O.  
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3.2.2 DLS analysis 
Polymers 1 and 2 were also characterized by dynamic light scattering (DLS) in 
H2O (Figure 3-3 and Figure 3-4). The results indicated that at high 
concentrations (0.5 mg/ml polymer 1 and 0.2 mg/mL polymer 2) polymer 1 
and 2 led to self-assembled aggregates that resulted in lower diffusion rates. 
Polymer 1 induced self-aggregation as expected, for DMAm and DMAPMAm 
shows distinct hydrophilic properties in H2O. The particles formed from 
polymer 2 - p(L-DMAm) homopolymers may be attributed to their intrinsic 
low solubility in neutral aqueous solutions. 
Polymer 1 Polymer 2 
HN O
*
HO OH
*
OHN
HN
 
HN O
*
* n
O
O
HO
OH
 
DMAm : DMAPMAm a: n = 15; b: n = 26 
a: 14 : 86; b: 29 : 71  
 
 
Figure 3-3. DLS data for polymer 1a (top) and 1b (bottom) (0.5 mg/mL H2O) 
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Figure 3-4. DLS data for polymer 2a (top) and 2b (bottom) (0.2 mg/mL H2O) 
 
3.2.3 Chain transfer agent (CTA) 
As discussed in the Introduction Chapter, RAFT operates on a conventional 
free radical polymerization process with degenerative chain transfer. The key 
to a successful RAFT process is to choose an appropriate CTA or so-called 
RAFT agent for selected monomers. Hence, appropriate choice of CTA for a 
given monomer/monomer family is important and has been well-reviewed 
recently.
[22]
 Among the major employed thiocarbonylthio families, 4-
cyanopentanoic acid dithiobenzoate (CTP) (Figure 3-5, 4) has been proved to 
be extremely useful for diverse monomers and has been employed for the 
synthesis of water-soluble polymers directly in both aqueous solution and 
organic solvents. Specifically, some CTAs are more effective under certain 
polymerization conditions and/or for certain types of monomers.
[23]
 In this case, 
a series of CTAs (Figure 3-5, 1-5) was ready for polymer preparation, for the 
purpose of establishing proper polymerization conditions and thus achieving 
well-defined water-soluble polymers.
[23]
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Figure 3-5. Structures of CTA being considered and/or used in RAFT 
polymerization in this Chapter 
 
R XH + + R' Br
Base
Acetone
R
X S
R'
S
C
S
S
R, R' = alkyl or aryl X = S, O, N  
Figure 3-6. General approach of CTA synthesis
[16]
  
 
Since to appropriately choose CTAs is key to a successful RAFT 
polymerization process, synthesis of CTAs with distinct functional groups was 
required.
[22a, 22c, 22d, 24]
 The CTAs presented here were synthesized via the 
method developed by OÕReilly (Figure 3-6).
[16]
 There apparently exist 
advantages of this strategy: 1) no need to exclude oxygen from the reactions, 2) 
comparable high product yields, 3) applicable to prepare various types of 
CTAs, 4) one step one pot reaction, facile. CTA 1 (Figure 3-5) was therefore 
synthesized and characterized by 
1
H-NMR. However, the yield was not as high 
as reported (approximately 83%). Some of the crude product was remained in 
the aqueous phase while extracted by CH2Cl2 and washed with H2O. This was 
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anticipated that the polarity of the product was in between of the employed 
organic and aqueous phase. And thus, the product could not be extracted 
thoroughly. No further exploration was made to optimize purification 
conditions and skills, for our interest only focused on its application in the 
following polymerization process.  
The reasons for design and synthesis of CTA 1 are as follows: CTAs with 
alcohol, amine or carboxylic acid functionality are able to facilitate post-
polymerization coupling or further functionalization of polymers;
[16]
 S-
dodecyl-S-(α,α-dimethyl-α-acetic acid) trithiocarbonate (DDMAT) has been 
demonstrated as CTA for acrylamides polymerization;
[16]
 for the synthesis of 
hydrophilic polymers, alcohol end group that is also hydrophilic will facilitate 
polymer morphology in aqueous media rather than hydrophobic alkyl or 
phenyl groups.  
 
3.2.4 Binding affinities for Boron 
As described in Chapter 2, binding affinities of investigated polymer 1 and 
polymer 2 were calculated via fitting the AR-S assay data with equations. 
Briefly, a series concentration of each polymer was applied in constant 
concentration of AR-S, boric/boronic acid and PBS solution at pH 7.4. The 
fluorescence data at each selected wavelength (572 nm, 592 nm and 573 to 615 
nm) were recorded under fluorimeter and fitted with equations to achieve the 
binding affinity (Ka) for boron. The final Ka value reported (Figure 3-7) was 
the average of the three calculated from different wavelength data and the 
standard deviation was also for the three Ka at different wavelength. As shown 
in Figure 3-8 and 3-9, the fluorescence was not significantly decreased with 
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the concentration of polymer 1 employed in this assay. Unlike its small 
molecule analogues, polymer analysis was limited by the lack of saturation in 
some of the cases. This has been mainly attributed to the low amount of 
material and/or low affinity. For polymer 2, higher concentration was applied 
and therefore more significant decrease of fluorescence can be obtained 
(Figure 3-10 to 3-13). However, a new band at 545 nm from the catechol 
structures in polymer can be observed with the increase of polymer 
concentrations that could overlap with that of AR-S (592 nm) preventing its 
further analysis (Figure 3-10 to 3-13). For the same reason, the standard 
deviations of Ka for polymer 2 were much bigger than those of its small 
molecule analogues (Figure 3-7). Also, the binding affinities of polymer 1 and 
sodium borate were not accessible under our assay conditions. This may be 
because one sodium borate provides two binding positions for diols. Thus the 
formation of 1:1 or 1:2 complexes in the solution were exchanging depending 
on the ratio of diol to sodium borate. In another word, there is a chance that 
fluorescence would not decrease with the increase of diol concentration, which 
made the analysis of experimental data more complicated. To simplify, for 
those polymers where binding saturation could be achieved, due to their 
multivalent nature, binding affinities (Ka) were determined using the Hill 
Equation (Eq. 1) (Figure 3-10 to 3-13). 
However, according to the data all polymers quenched significantly the 
fluorescence signal corresponding to the AR-S : B complex, and in most cases 
affinities were higher than those calculated for the small molecule analogues 
(Figure 3-7). Due to the low amount of polymer 3 available, saturation of 
binding could not be achieved during the titration of the AR-S : B complex. 
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Nevertheless, the enhancement of affinity is clearly apparent, as similar 
changes in fluorescence could be obtained with 20 eq of diol in polymer 3 and 
100 eq of methyl-β-D-glucopyranoside. Thus, a 5-fold increase in affinity was 
observed when comparing polymer 3 to methyl-β-D-glucopyranoside, 
suggesting that, at least in the case of the carbohydrates, multivalency could 
play a significant role in the binding with boronic acids, and therefore in QS-
control. 
 
Figure 3-7. Binding affinities of DPD, model diols and polymers for 
phenylboronic acid (PBA, blue bars) and boric acid (green bars).  
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Figure 3-8. Fluorescence profile of PBA and polymer 1a (p(DMAm-co-
DMAPMAm) 14%-86%) titration and the corresponding fitting plot. [AR-S] 
= 0.009 mM, [PBA] = 2 mM, [DMAm] = 0.02 mM, [PO4
-
] = 100 mM. Ka = 
164.3 ± 2.3 M
-1 
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Figure 3-9. Fluorescence profile of PBA and polymer 1b (p(DMAm-co-
DMAPMAm) 29%-71%) titration and the corresponding fitting plot. [AR-S] 
= 0.009 mM, [PBA] = 2 mM, [DMAm] = 0.04 mM, [PO4
-
] = 100 mM. Ka = 
177.1 ± 9.9 M
-1
. 
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Figure 3-10. Fluorescence profile of PBA and polymer 2a (p(L-DMAm) 
DP15) titration and the corresponding fitting plot. [AR-S] = 0.009 mM, [PBA] 
= 2 mM, [L-DMAm] = 18.8 mM, [PO4
-
] = 100 mM. Ka = 126.0 ± 25.3 M
-1
, n 
= 1.50 ± 0.31. 
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Figure 3-11. Fluorescence profile of Sodium Borate and polymer 2a (p(L-
DMAm) DP15) titration and the corresponding fitting plot. [AR-S] = 0.009 
mM, [Na2B4O7] = 2 mM, [L-DMAm] = 21.8 mM, [PO4
-
] = 100 mM. Ka = 
103.7 ± 59.7 M
-1
, n = 1.00 ± 0.32. 
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Figure 3-12. Fluorescence profile of PBA and polymer 2b (p(L-DMAm) 
DP26) titration and the corresponding fitting plot. [AR-S] = 0.009 mM, [PBA] 
= 2 mM, [L-DMAm] = 19.0 mM, [PO4
-
] = 100 mM. Ka = 274.0 ± 34.4 M
-1
, n 
= 1.03 ± 0.13. 
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Figure 3-13. Fluorescence profile of Sodium Borate and polymer 2b (p(L-
DMAm) DP26) titration and the corresponding fitting plot. [AR-S] = 0.009 
mM, [Na2B4O7] = 2 mM, [L-DMAm] = 22.6 mM, [PO4
-
] = 100 mM. Ka = 
481.1 ± 122.9 M
-1
, n = 1.28 ± 0.66. 
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3.2.5 Binding confirmation by 
11
B-NMR 
Experiments by 
11
B-NMR were carried out with polymers 1a and 2a in order to 
confirm binding between AI-2 molecule and designed polymers. 
Unfortunately, polymer solubility at the concentrations employed for the NMR 
analysis (up to 25 mg/mL), limited the amount of diol that could be added, 
especially in the case of polymer 1a. Also, the baseline of 
11
B-NMR spectra 
became noisy while increasing the polymer concentrations, which caused 
difficulty to compare the signal intensities. In addition, polymers 1 and 2 led to 
self-assembled aggregates (Figures 3-3 and 3-4, DLS data) at high 
concentrations, resulting in lower diffusion rates and decreased signals in the 
NMR, limiting the significance of the assay.  
However, polymer 2a was able to reduce the concentration of AI-2 in solution. 
As shown in Figure 3-14, when a solution of DPD in a borate/phosphate buffer 
at pH 7.4 was treated with 1 eq of diols in polymer 2a, a decrease of the signals 
at 4.8 and 6.2 ppm, corresponding to the AI-2 (1)
[25]
 occurred, while such an 
observation was more significant when diol to sodium boronate ratio was 
increased to 2.5 eq in the media (Figure 3-14). These data indicated that 
11
B-
NMR could be an alternative technique to characterize such competitive 
binding, but only for cases where aqueous solubility of the polymers was 
sufficient.  
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Figure 3-14. Quenching of AI-2 boronated form by a) Polymer 1a and b) 
Polymer 2a acid as shown by 
11
B-NMR (The peak corresponding to the excess 
of Na2B4O7 has been left out for a better comparison. Number in parenthesis 
corresponds to the concentration of polymer) 
 
3.2.6 Bacterial aggregation assay 
3.2.6.1 UV spectrum 
The bacterial aggregation rate was quantified by measuring the bacterial 
optical density (OD) at a wavelength of 600 nm. It was assumed that all the 
aggregates should be precipitated to the bottom of the UV cuvets and thus the 
suspended cells and the OD would decrease. This is because in UV/Vis 
spectrometer light goes through the cuvet from front to back window and OD 
referring to the amount of light transmitted or reflected from an object (here 
were cells) would therefore become small when cells were precipitated from 
suspension. Therefore, by measuring the decrease of OD (at 600 nm) in the 
absence and presence of polymers, the function that polymers give to sequester 
cells could be quantified. In order to compare the binding affinities of polymer 
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to bacterial MM32 cells, the same set of data was presented in three different 
ways: OD at 600 nm as a function of time (Figure 3-15 and 3-16, a), which 
showed an overall view of the whole process; aggregation percentage, which 
showed the aggregation rate compared to blank (i.e. a measure of polymer 
sequestration affinity) (Figure 3-15 and 3-16, b); the value of aggregation 
percentage divided by polymer concentration, as an alternative way to show 
the binding rate for unit polymer concentration (Figure 3-15 and 3-16, c). All 
the polymers tested here (Polymer 1a, 1b, 2a, 2b and 3) induced bacterial 
aggregation compared to the ÔblankÕ (no addition of polymers) in both AB 
(Figure 3-15) and PBS (Figure 3-16) medium via giving decreases of OD (600 
nm) with time in graph a) and high aggregation percentage value in graph b) 
(Figure 3-15 and 3-16). Importantly, these results also showed that the strength 
of the binding affinity of polymer to bacteria surfaces could be tuned with 
different monomer compositions. On the other hand, these behaviors were 
confirmed again with dose-dependent cell sequestration action in the presence 
of different concentrations of polymer 1a (Figure 3-17).  Interestingly, XAg of 
homopolymer p(L-DMAm) (Polymer 2a and Polymer 2b) was always smaller 
than those of Polymer 1 and Polymer 3 in either solution, maybe indicating that 
Polymer 2 attached bacteria more rapidly, but with a relatively low affinity 
compared to the other two polymer types (Figure 3-15 and 3-16, c).  
In order to understand the mechanism of polymer to bacteria binding, one more 
experiment with a series of PVA solutions as the control polymer was 
performed under the same conditions. These demonstrated that the abilities of 
Polymer 2a and Polymer 2b to sequester bacteria adhesion were not due to 
non-specific association of polymeric alcohols with V. harveyi, as no 
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significant bacterial aggregation was observed in the presence of different 
concentrations of PVA solutions (Figure 3-18).  
Polymer 1 Polymer 2 Polymer 3 PVA 
HN O
*
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*
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* n
O
O
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*
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O
O
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OH
OH
HO
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*
*
OH
n
 
DMAm : DMAPMAm a: n = 15 n = 16 n = 13000~23000 
a: 14 : 86; b: 29 : 71 b: n = 26   
 
 
Figure 3-15. a) OD (600nm) as a function of time in the absence and presence 
of polymers, and amplification of the first 10 min, b) %Ag as a function of 
time and c) XAg for the 2 duplicates in AB media 
 
Figure 3-16. a) OD (600 nm) as a function of time in the absence and presence 
of polymers, b) %Ag as a function of time and c) XAg in PBS. 
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DMAm : DMAPMAm a: n = 15 n = 16 
a: 14 : 86; b: 29 : 71 b: n = 26  
 
 
Figure 3-17. a) OD (600 nm) as a function of time in the absence and presence 
of different amounts of Polymer 1a, b) %Ag as a function of Polymer 1a 
concentration and time. 
 
Figure 3-18 a) OD (600 nm) as a function of time in the absence and presence 
of different amounts of PVA, b) %Ag as a function of PVA concentration and 
time 
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3.2.6.2 Microscopy 
Dense ÔmatsÕ of polymer-cell aggregates were apparent in the presence of all 
the tested polymers. Polymers clustered of bacterial cells more significantly 
than the blank controls, as shown in images (Figure 3-19).  
Blank 
1a 
1b 
2a 
2b 
3 
 
Figure 3-19. Representative examples of the V. harveyi-polymer aggregates in 
AB media, as seen by Optical Microscopy, scale bars = 10 µm 
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All the above experimental results indicated that, as expected, the cationic 
polymers (polymer 1a and 1b) sequestered the negatively charged V. harveyi, 
with the formation of dense ÔmatsÕ of polymer-cell aggregates (Figure 3-19). 
In addition, since V. harveyi has been shown to bind to glucose,
[26]
 the fact that 
polymer 3 induced bacterial aggregation was also anticipated (Figure 3-15, 3-
16 and 3-19). The negatively-charged polymers (polymer 2a and 2b) also 
formed dense polymer-cell aggregates (Figure 3-19), a less predictable 
outcome, attributed to the inherent adhesive properties of L-DOPA-derived 
catechols.
[27]
  
 
3.2.7 Bioluminescence assays 
3.2.7.1 MM32 assay 
Bioluminescence assays were carried out with V. harveyi bacteria - MM32 
mutant (LuxN
-
 and LuxS
-
), in which no DPD molecule is produced by the 
bacterial cells themselves due to the lack of DPD biosynthesis protein LuxS. In 
this case, the concentration of DPD in solution would be constant all through 
the experiment, by externally adding DPD into the assay media, which 
simplified cellsÕ feedback loop with polymer materials. On the other hand, as 
described in the first chapter, the QS controlled behaviors, for example 
bioluminescence, are coordinated with different types of AI systems (i.e. AI-1 
and AI-2). MM32 mutant without LuxN protein (responsible for AI-1 
production) would only response to AI-2 signals (the product of reaction 
between exogenous added DPD and boric acid in assay media) in the solution 
to produce light. In another word, in this assay condition light production was 
only under control of AI-2 QS system. V. harveyi MM32 assays were 
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performed under a range of conditions (protocol 1-4) adapted from prior 
publications.
[18-19]
 Actually, there were several factors that might be 
significantly related to the intensity of light output with time. For example, 
boron concentration was one of the most essential issues that directly affect the 
AI-2 concentration available for bacterial QS. In addition, as described, in each 
individual experimental unit (well) only 200 µL mixture solution was loaded, 
so that evaporation at the 30 ¡C incubation temperature would significantly 
change its in-total volume, and therefore the concentration of each component, 
and even the growth of bacteria. Moreover, the growing state of the bacteria in 
different overnight cultures was not possible to be controlled.  
V. harveyi MM32 was grown on LB agar plate containing kanamycin (50 
µg/ml) and chloramphenicol (10 µg/ml), which were antibiotics for most of the 
other bacteria except of the Vibrio species, thus excluded any impact from 
other bacterial species. Bacteria were then precultured in 2 mL LB media with 
aeration at 30 ¼C overnight to reach a high OD in nutrient-rich media. AB 
medium, in which V. harveyi can produce light, was inoculated with this 
preculture (5000:1) and DPD was added externally to a final concentration of 
22 µM. 180 µL of the inoculated medium were placed in each of the wells of a 
96 well plate and combined with 20 µL of the samples to be analyzed 
(triplicate for each polymer). This way, the concentration of DPD in each of 
the wells was 20 µM. This optimal DPD concentration was determined by 
measuring the effect of DPD concentration in light production in the absence 
of polymer samples. As shown in Figure 4-20, the maximum bioluminescence 
changed significantly as a function of DPD concentrations when it was around 
20 µM following protocol 1. Thus, the bioluminescence was believed to be 
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highly sensitive to the change of DPD concentration around this concentration 
range (20 µM), which gave the possibility to understand better the effect of 
polymer on bacterial QS network with more reliable readout data 
(bioluminescence).  
 
Figure 3-20. Effect of DPD concentration in light production under the 
condition of protocol 1  
 
The same experiments were performed again for each new batch of 
commercial DPD and/or if a different protocol was followed, e.g. protocol 4. 
This time, the effect of different concentrations of boron was also taken into 
account. Although the maximum bioluminescence varied (Figure 3-21) which 
might be attributed to the independent overnight cultures (at different growing 
state, hard to know), the intrinsic variations in response of instrumentation, the 
difference of the protocol, DPD batch and/or the boron concentrations, the 
optimal final concentration of DPD in assay media was fixed to 20 µM. For the 
same reason as described above, the readout (bioluminescence) data were 
changed significantly on changing DPD concentration at around 20 µM. And 
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also, to keep DPD exogenous concentration the same allowed comparability as 
much as possible. s 
 
Figure 3-21. Effect of DPD concentration in light production under the 
condition of protocol 4, but in the presence of 0.4 mM (green) and 1 mM 
(blue) of boron prepared in boron-depleted media (no extra boron in the 
solution) 
 
For MM32 assay following protocol 1, in order to get dose response profiles 
for the different analytes, each compound was tested at least for 5 different 
concentrations. Light production and optical density (600 nm) were recorded at 
30 ¼C every 30 minutes for at least 6 hours in a 96-well plate. The experiments 
were carried out in triplicate and the plotted curves are derived from the mean 
value. The normalized bioluminescence was calculated by dividing the mean 
light output by the mean optical density at each time point. Significant 
differences in optical density (OD) between those cultures in the presence and 
absence of polymers were observed with increasing time (after about 8 h), for 
the impact from solution evaporation cannot be ignored at this stage, so that 
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every component in the solution was concentrated, which interfered with cell 
growth reflected by the dramatically increase of OD (more light 
transmission/reflection from cells was recorded). In this experiment, 
bioluminescence and OD were taken in the mean time by using Tecan 
instrument. Different from the aggregation assay carried out with the UV 
spectrometer, 96-well plate was used to locate samples instead of cuvet, and 
thus the light provided by Tecan went from the bottom of the wells to the top 
(not from the front to the back window of cuvets which only tested the particle 
in suspension) to record the OD of particles/cells in both suspension and 
precipitation, giving information of the cell growth but not its sequestration 
rate. The analysis of bioluminescence vs diol concentration was restricted to 
the 4-10 h timeframe, where almost no differences in OD were observed for 
most of the polymers and conditions analyzed. 
Having established binding of bacteria and boric acids by polymers 1-3, and 
their potential to reduce the concentration of AI-2 in solution, their effect on 
bacterial QS was investigated by means of bioluminescence. Unlike the 
expected dose-dependent suppression observed for conventional small 
molecule AI-2 quenchers,
[28]
 or polymers without the ability to bind 
bacteria,
[11b]
 such as PVA (Figure 3-18) the bioluminescence profiles reflected 
a more complex behaviour of V. harveyi in the presence of the dual-action 
polymers. Intriguingly, variations in time of onset, as well as magnitude, of 
light production were observed as the concentrations of different polymers in 
suspensions of bacteria varied (Figure 3-22 to 3-26).  
At the earlier time points (5h, Figure 3-22 to 3-26) all the polymers exhibited 
dose-dependent suppression of light production except the lower molar mass 
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anionic polymer 2a (for which the effects were small). However, at 
intermediate time periods (7h, Figure 3-22 to 3-26) increases in light 
production were observed in the presence of polymers 1a, 2a (and to a lesser 
extent 3) with bioluminescence only suppressed at higher polymer 
concentrations. Over more extended times (Figure 3-22 to 3-26) light 
production again was increased for low polymer concentrations and decreased 
at higher doses for all the polymers investigated here. These data suggest that 
the onset and duration of any quenching effects were strongly dependent on the 
cell density (cell growth cycle/time) as well as the affinity of the polymers 
towards the boron moiety and their ability to bind bacteria. Importantly, since 
QS itself partially depends on cell density
[29]
 and clustering
[30]
 it is likely that 
those polymers able to aggregate bacteria as well as remove DPD were 
interfering in the cell signalling pathways by both a Ôcell-bindingÕ and a ÔQS-
quenchingÕ mechanism. Since each of these processes could be in feedback, an 
apparent ÔoscillationÕ in light production could be inferred. In another word, 
the increase of polymer concentration would not always decrease the light 
output (sometimes enhance it), which resulted from both cell growth cycle and 
polymer affinity for both cells and QS signals. However, for the ÔcontrolÕ 
polymer PVA (Figure 3-27) with no cell sequestration function, there was no 
ÔoscillationÕ in bioluminescence correlated to the different polymer 
concentrations. Instead, the light production was suppressed in proportion to 
the polymer concentrations. These data of experiments were in accord with the 
Ôsingle functionÕ (QS quenching, but no cell sequestration) assumption.  PVA 
incorporates 1,3-propanediol units in its polymer backbone. The affinity for 2-
methyl-1,3-propanediol for PBA and boric acid was assessed using the AR-S 
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assay (Figure 2-8) and it was shown to be smaller than the catechol 
derivatives. Therefore, PVA was expected to bind boric acid with a decreased 
affinity when compared with the polymers investigated during this research. 
On the other hand, PVA did not induce extra cell aggregation (Figure 3-18), 
which means no dual function (no light oscillation) but only ÔQS signal 
quenchingÕ (more polymer more quenching) should be observed in MM32 
assay (Figure 3-27).  
Two experimental repeats were performed independently for each of the 
polymers analysed (Figure 3-28). Despite the difference between the two 
batches of cells causing slight differences of the bioluminescence reading and 
OD, the overall trends at each testing time point were quite similar. This gave 
the strong evidence that polymers interfering with the bacterial coordination 
network based on the assumption of Ôdual functionÕ theory were true and the 
experimental results were reproducible.  
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Figure 3-22. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Polymer 1a. 
Bottom: Effect of diol concentration in light production. (protocol 1) 
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Figure 3-23. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Polymer 1b. 
Right: Effect of diol concentration in light production. (protocol 1) 
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Figure 3-24. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Polymer 2a. 
Bottom: Effect of diol concentration in light production. (protocol 1) 
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Figure 3-25. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Polymer 2b. 
Bottom: Effect of diol concentration in light production. (protocol 1) 
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Figure 3-26. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Polymer 3. 
Bottom: Effect of diol concentration in light production. (protocol 1) 
  154
 
Figure 3-27. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Polymer PVA. 
Bottom: Effect of diol concentration in light production. (protocol 1) 
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Figure 3-28. Similar results of bioluminescence MM32 assay in the presence of 
polymer 1a and 2a from two independent repeats. (protocol 1) 
 
In addition, experiments were carried out with the same overnight culture of V. 
Harvey MM32 and Polymer 1a,b and Polymer 2a,b, which show similar water 
solubility and boron affinity, but whose main difference was their ability to 
cluster bacteria. In these experiments the concentration of boron was ﬁxed (0.4 
mM) in order to saturate AI-2 production and the addition of polymers was 
delayed 4 h, approximately the time of onset of light production for the 
previous experiments, in order to synchronize bacterial response prior to 
polymer addition. This way, not only the efﬁciency of the polymers could be 
properly compared but also different experimental conditions could be tested in 
order to see if they had an effect in the dual activity of the polymers (Figures 
3-29 to 3-33). In these cases, the same dual behavior (bioluminescence 
inhibition vs enhancement) was observed in additional assays at applied 
polymer concentrations as those reported before, but responses in the presence 
of polymers were significantly enhanced. Such enhancement was attributed to 
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the 0.4 mM boron externally added to the media (compared to protocol 1 in 
which the only boron source is the small amount that exists in water and media 
salts) that amplified the response of QS. This is because DPD molecules could 
react with boron to form active signal (AI-2) more effectively with higher 
boron concentration (fixed the concentration of DPD and other salts) and thus 
induced more lights (This has been proved by later work performed by Cheng 
Sui in my PhD group, data not shown).  On the other hand, polymer 1a and 1b 
were tested together by using the same overnight culture, while polymer 2a and 
2b were examined together with another batch of overnight culture. Thus, the 
much bigger enhancement of light in the presence of polymer 1a and 1b after 7 
h (Figure 3-29 and 3-30) than that with addition of polymer 2a and 2b (Figure 
3-31 and 3-32) were resulted from the difference between the two cultures. 
Here, the relative bioluminescence as a function of polymer-diol concentration 
at 3.5 h, 5 h and 7 h time points were presented together (Figure 3-33) to give a 
better comparation. Similar to the results of protocol 1, ÔoscillationÕ of light 
output with varied polymer-diol concentration could be observed due to the 
ÔdualÕ function competitively existence in the system, expect of polymer 2a, in 
the presence of which such phenomenon was not that significant. This is 
anticipated that polymer 2a gave comparable binding affinity for boron/QS 
signal to the other three polymers but lowest affinity to binding cells and thus 
the effect of QS quenching was much higher than cell sequestration (no 
enhancement for the first 7 h). However, the enhancement of bioluminescence 
was observed at later time point even for polymer 2a (Figure 3-31, left, at 9-10 
h), which reconfirmed its dual functionality. It was notable that the reduction 
and enhancement of light production appeared at different time point and also 
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gave varied value when different protocols and/or overnight cultures were used, 
but the overall trends were always the same.  
 
Figure 3-29. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 1a (protocol 2) 
 
Figure 3-30. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 1b (protocol 2) 
 
Figure 3-31. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 2a (protocol 2) 
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Figure 3-32. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 2b (protocol 2) 
 
 
Figure 3-33. Effect of diol concentration in light production, in the absence and 
presence of Polymers 1 and 2 (protocol 2) 
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These results suggested that in these systems reversible borate-diol binding 
reactions compete with irreversible bacteria-polymer clustering as well as 
bacteria-QS binding interactions. While the detailed mechanisms by which 
these interactions were occurring are still not fully clear, support for a 
feedback-competition model was obtained from experiments with PVA, which 
did not bind to bacteria, but was able to sequester borate with low affinity, 
giving rise to simpler dose-dependent QS quenching (Figure 3-27) but with no 
cell sequestration or cell-growth dependent binding. By contrast, the dual-
action polymers 1-3, having three different functional group types (cationic, 
saccharide and catechol), each of which varied in total aggregation efficacy, 
were able to sequester V. harveyi through adhesion and interference with their 
QS network. Of crucial importance was that this range of polymers was able to 
maintain bacterial capture and suppression of QS signalling, but without 
damaging cell viability
[31]
 (as judged by continuing growth in optical density 
measurements) (Figure 3-22 to 3-27, 3-29 to 3-32).  
In order to minimize any error coming from the protocol, another approach 
aimed to achieve constant volumes of bacterial media of each well in the 96-
microplate was applied. To explain the difference, in protocol 3 samples 
composed of polymers, bacteria and media placed in each wells and sealed 
with aluminum plate cover were incubated in a 30 ¡C incubator all through the 
assay, (except 10 min/2 h testing time in room temperature) while in the 
protocol 1 and 2, a 30 ¡C Tecan plate reader automatically reads light 
production and optical density every 30 min without cover to prevent sample 
media evaporation.  
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According to the data presented (Figure 3-34 to 3-37), the linear polymers 
decreased the light production in a dose-dependent way in all cases at earlier 
time points. However, compared to the results from the previous protocol, the 
maximum output of light production moved from 9 h to 11 h, and even after 12 
h there was no sign to show a reduction of light production.  These results were 
anticipated. The new method to some extent decreased the media evaporation 
rate. In this case, the change of OD and concentration of the contents (e.g. AI-2 
molecules, DPD and free boron) correlated to media volume, but was slower. 
However, the overall trend of each polymer addition assay was in accord with 
what was obtained before. The ÔoscillationÕ of light output with different 
polymer-diol concentrations, which was believed to be the feature in the 
presence of dual function polymers, could be observed (Figure 3-38). The 
results suggested two basic mechanisms operate in tandem in terms of 
polymers inhibiting light production based initially on boron-diol binding, but 
also enhancing light production as the polymer induced bacteria aggregation 
occurs. This conclusion was verified again when the assay data of control 
polymer PVA was compared to those of the other proposed diol-functional 
polymers. PVA lacks the ability to induce bacterial aggregation and thus could 
change the bacterial communication via only one mechanism (QS quenching). 
It should be noted that an issue for the bioassays is the variation of factors 
arising from the cell environment that are difficult to be fixed exactly the same 
for each assay. For example, the end-point assay and time-course assay were 
performed with the same bacterial overnight culture, 96-well plate, incubator 
and plate-reader, but results were on occasions different. Therefore, it is worth 
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focusing on the overall trend of each assay result rather than specific individual 
values.  
 
Figure 3-34. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 1a (protocol 3) 
 
Figure 3-35. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 1b (protocol 3) 
 
Figure 3-36. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 2a (protocol 3) 
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Figure 3-37. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 2b (protocol 3) 
 
 
Figure 3-38. Effect of diol concentration in light production, in the absence and 
presence of Polymers 1 and 2 (protocol 3) 
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To address some of the issues above, future bioluminescence assays were 
considered to compromise with protocols 1, 2 and 3 (Figure 3-39 to 3-41). In 
this case, sample loaded well-plates are incubated in the 30 ¡C incubator for 
the first 4 h (the light onset time point) and then kept in the plate reader to 
automatically record the intensity of bioluminescence and cell optical density 
every 30 min (protocol 4). The resutls showed the same ÔoscillationÕ of 
bioluminescence in the presence of different concentrations of polymer 1a, 1b, 
2a and 2b, which demonstrated again the dual function as described above 
(Figure 3-42).  
 
Figure 3-39. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 1b. (protocol 4) 
 
 
Figure 3-40 Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer 2b. (protocol 4) 
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Figure 3-41 Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Polymer PVA. (protocol 
4) 
 
Figure 3-42. Effect of diol concentration in light production, in the absence and 
presence of Polymers 1b, 2b and PVA (protocol 4) 
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3.2.7.2 BB170 assay 
Bioluminescence assay were also performed with V. harveyi bacteria - BB170 
mutant (LuxN
-
), in the presence and absence of linear polymers. Unlike V. 
harveyi MM32 mutant (LuxN
-
 and LuxS
-
), the BB170 strain is able to produce 
its own AI-2 precursor - DPD molecules, as it possesses LuxS protein 
responsible for DPD biosynthesis, while similar to MM32 that no other signal 
molecule (AI-1) generated by BB170 due to the lack of protein LuxN 
responsible for AI-1 signal molecule biosynthesis. In this case, the light 
production was only under control of AI-2 QS system. The whole assay 
procedure was the same as described in protocol 1 for MM32 assay and no 
modification to prevent evaporation for this initial stage, but without external 
addition of DPD. As mentioned, MM32 strain was selected as the main 
bacterial model was because it is a V. harveyi mutant which lacks LuxS protein 
and therefore cannot produce DPD by its own. By externally adding DPD 
molecule into the assay media, its overall concentration should be constant all 
through the experiment, which simplifies the bacteria QS feedback system. On 
the other hand, for BB170 the concentration of QS signals increase as the 
number of bacteria in a local population increase. When reaching a threshold 
concentration, the signaling molecules (AI-2) activate specific receptors to 
regulate QS-dependent gene expression.
[29, 32]
 Herein, the bioluminescence 
outputs for BB170 strain in the presence of investigated polymers are 
anticipated to be more complicated than those for MM32 mutant.  
Similarly, variations in time of onset, as well as magnitude of light production 
were observed as the concentrations of different polymers in suspensions of 
bacteria varied (Figure 3-43 to 3-46). Intriguingly however, unlike MM32 
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assay for which all the polymers exhibited dose-dependent suppression of light 
production (except polymer 2a, see 'MM32 dataÕ) at earlier time points (5h, 
Figure 3-22 to 3-27), the assay performed with BB170 mutant showed dose-
dependent enhancement of light output all through the assay (Figure 3-43 to 3-
46). Apparently, the light onset of BB170 was earlier (around 2h) than that of 
MM32 strain (around 4h), so more attention was paid on earlier time points 
(2h, 4h, 6h) for the effect of diol concentration on light output (Figure 3-43 to 
3-46, bottom). At early time periods (2h, Figure 3-43 to 3-46, bottom) 
increases in light production were observed in the presence of polymers 1a, 1b, 
2c and 3 without bioluminescence suppression at any time points, while over 
time (4h and 6h, Figure 3-43 to 3-46, bottom) the same dose-dependent trends 
but varied rates of light enhancement were observed. Interestingly, the 
ÔoscillationÕ of the light with different polymer concentrations could be 
observed again. 
These initial results of BB170 assay suggested that the onset and duration of 
polymer effects were dependent on the bacterial mutant as well as their cell 
growth stage. Since binding of bacteria (MM32) and boronic acids by 
polymers 1-3, and their potential to reduce the concentration of AI-2 in 
solution have already been demonstrated (AR-S assay and bacterial attachment 
assay), it was assumed that polymers retained their dual-action on QS and 
bacterial sequestration for BB170 strain (light ÔoscillationÕ responsed to 
different polymer concentration). However, to identify its feedback 
mechanism, more experiments are needed such as polymer sequestration assay 
with BB170 cells, repeated bioluminescence assays with modified protocols 
and investigation of new in-vitro assays.  
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Figure 3-43. Top: Light production curves and OD (600 nm), as a function of 
time for V. harveyi MM32 in the absence and presence of Polymer 1a. Bottom: 
Effect of diol concentration in light production. 
 
Figure 3-44. Top: Light production curves and OD (600 nm), as a function of 
time for V. harveyi MM32 in the absence and presence of Polymer 1b. Bottom: 
Effect of diol concentration in light production.  
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Figure 3-45. Top: Light production curves and OD (600 nm), as a function of 
time for V. harveyi MM32 in the absence and presence of Polymer 2c (DP 89). 
Bottom: Effect of diol concentration in light production. (Polymer 2c was used 
instead of polymer 2a and 2b (limited amount).)  
 
Figure 3-46. Top: Light production curves and OD (600 nm), as a function of 
time for V. harveyi MM32 in the absence and presence of Polymer 3. Bottom: 
Effect of diol concentration in light production. 
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3.3 Conclusions 
In this chapter, a series of polymers were successfully synthesized via RAFT 
polymerization process and characterized by 
1
H-NMR, GPC (see Appendix) 
and DLS analysis. The binding abilities of the reported polymers with 
boric/boronic acid were established by the AR-S assay and confirmed by 
11
B-
NMR spectra. In all cases, polymers with multivalent effects gave higher 
affinities to boric and boronic acids than their corresponding small molecule 
analogous. In order to test cell sequestration of the polymers, bacterial 
attachment assays were performed in both AB-media and PBS buffer at pH 
7.4. In this case, all the three types of investigated polymers were demonstrated 
to induce bacterial aggregation. All the above in-vitro experimental results 
suggested that polymers made in this chapter had dual function to the AI-2 
controlled bacterial communication network.  
In this case, the three types of polymers and ÔcontrolÕ polymer PVA were 
employed in a complex biological environment. The data showed the polymers 
had dual-function in binding and deactivating population responses in V. 
harveyi. Although MM32 assays were performed in different conditions (batch 
of cells, protocols and batch of DPD), the trends of light output in the presence 
of each individual polymer were constant all the experiments. Significantly this 
range of polymers was able to maintain bacterial capture and suppression of 
QS signaling without damaging the cells as judged by continuing growth in 
optical density measurements. 
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Chapter 4. Preparation and Characterization of Polymeric 
Vesicles/Polymersomes: Biological Application Studies 
4. Introduction  
Having established a basic platform for understanding the principles of 
polymer-cell and polymer-signal molecule/boron interactions (Chapter 2 and 
3) in cell-cell communication process as well as in the bacterial-colony 
invasion network, the research in this chapter extends towards a more 
meaningful test between real cells and artificial protocells. 
As noted earlier, in this project the research was mainly focused on three key 
hypotheses underlying the concepts of protocells. 
1. Synthesis of artificial materials that interact with natural networks; 
2. Interference of Quorum Sense (QS) signaling and sequestration of cells; 
3. Establishment and development of artificial-natural signal feedback loops. 
The first two aspects have been addressed by developing diol-functional linear 
polymers capable of interfering bacterial chemical communication pathways as 
well as binding cells into clusters (Chapter 3).  However, the linear polymers 
have a limited ability to establish communication cycles between real cells and 
artificial materials as they cannot encapsulate and release signals. Herein, 
polymersomes self-assembled from amphiphilic block copolymers with a 
liposome-like membrane and an aqueous compartment are investigated. The 
concept is to contain a series of small functional molecules, such as QS 
mediator - DPD into the aqueous compartment of the polymersomes and then 
to release the signals in a controlled manner by tuning the chemical 
composition and architecture of block copolymers. In this chapter, 
polymersomes will be designed to release, detect and respond to signal 
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molecules, as an interim step towards establishing communication loops with 
the real bacterial cells. These polymersomes might in future function as 
protocells if they could incorporate a simple metabolism.
[1]
  
Polymersomes are usually self-assembled from three types of amphiphilic 
block copolymers: regular block copolymers - coil to coil, block copolymers 
with rigid blocks - rod to coil and rod to rod, and block copolymers with 
intermolecular interactions such as charge interactions, ligand binding, H-
bonds, dipolar interactions, etc.
[2]
 There are two commonly used approaches 
for preparing polymersomes: 1) film rehydration, and 2) solvent-exchange 
techniques. In both methods, a good solvent for both hydrophilic and 
hydrophobic components has to be properly selected, such as tetrahydrofuran 
(THF), ethanol, methanol or even mixture solvents, to completely dissolve the 
amphiphilic copolymers. Polymersomes are subsequently prepared through 
solvent evaporation to form a thin film, which is then rehydrated in the 
aqueous phase in the Ôfilm rehydrationÕ approach. Alternatively, the organic 
phase loaded with copolymer can be added to aqueous media or vice versa and 
then the organic solvent either evaporates or diffuses into the aqueous phase, 
leaving the polymersomes.  
Typically, the size and shape of the aggregates are determined by chemical 
constitution, the length of each individual block, the properties of the solvent, 
the environmental conditions of the solution (e.g. pH, temperature, ions and 
concentration), the volume ratio of organic phase and aqueous phase, the 
solvent removing rate and also the preparation method.
[3]
 For typical polymer 
materials the effects of solvents and process variables are key parameters in 
formulation development. A recent paper reported the preparation of 
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doxorubicin-loaded nanopolymersomes and investigation of various solvents 
and process variables as a function of size and drug loading during the whole 
preparation process.
[4]
 The polymersome preparation method adopted in this 
study was based on nanoprecipitation and Ôsolvent-exchangeÕ techniques and 
has been recognized as a valid and efficient approach toward preparing 
polymersomes.
[5]
 After polymersome formation, the solvent residue or free 
drug if applicable was removed by dialysis against aqueous solution. A number 
of variables can be optimized in order to achieve targeted size and dispersity of 
nanopolymersomes in this process, which was demonstrated in this report that 
many experimental parameters including ratio and composition of organic and 
aqueous phase, order of addition of phases, copolymer concentration and 
external energy input can be important factors.  
An important part of the design and preparation process is characterization of 
polymersomes using particle analysis techniques. The most commonly applied 
technique to determine particle size and distribution in suspension or solution 
is Dynamic Light Scattering (DLS) also known as Photon Correlation 
Spectroscopy.
[6]
 Another important characteristic of polymersomes is the 
surface electrical charge in colloidal suspension or emulsion, which is usually 
measured by DLS and recorded as zeta potential.
[7]
 Some polymersomes tend 
to ionize to form a charged-film on particle surfaces, while others may gain 
charges by adsorbing ions from their surroundings. In either case, the overall 
condition of the solution is always neutral since the numbers of counter ions 
are evenly balanced. Such property of polymersomes is important, as it reflects 
several properties of the media suspension or emulsion. Microscopy can also 
be used to characterize polymersomes in terms of size, size distribution, 
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morphology and homogeneity.
[8]
 For example, optical microscopy is suitable to 
assess particles with diameter greater than 1 µm, while Transmission Electron 
Microscopy (TEM) and Scanning Electron Microscopy (SEM) are good 
alternatives to record the nano-sized particles (> 5 nm). Particularly, Confocal 
Laser Scanning Microscopy (CLSM), a fluorescence microscopy, allows to 
record images of large polymersomes (> 1 µm) with fluorescence either from 
its own chemical structure or from labeling fluorochromes.
[9]
 For surface 
analysis, Atomic Force Microscopy (AFM) measures surface morphology by 
testing the change in surface height with a cantilever tip on an atomic scale.
[10]
 
Surface roughness values calculated from AFM data are an important 
parameter in several biological applications, for such property may be related 
to cell adhesion.
[11]
  
This chapter will mainly describe the synthesis of amphiphilic block 
copolymers and the preparation of polymersomes, while the effect of 
functional polymersomes for QS network and bacterial invasion system in a 
specific strain compared to their corresponding linear polymers investigated 
early in this study will also be discussed. Also, the encapsulation of DPD 
molecules in the aqueous compartment of polymersomes and the release of 
these signal molecules will be demonstrated as the first step toward 
constructing synthetic-natural feedback loops. 
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4.1 Experiments 
4.1.1 Synthesis of amphiphilic block copolymers 
4.1.1.1 Synthesis of monomers  
4.1.1.1.1 N-(2-ethylhexyl) methacrylamide (2-EHMAm)
[12]
 
NH2
+
O Cl
O NHNaOH
H2O/Acetone
  0oC r.t.
N-(2-ethylhexyl)methacrylamide2-ethylhexan-1-amine methacryloyl chloride  
2-Ethylhexan-1-amine (5.0 g, 38 mmol) was dissolved in 57 mL acetone and 
57 mL sodium hydroxide solution and cooled in an ice bath. Methylacryloyl 
chloride (7.4 mL, 76 mmol) was added dropwise over 30 mins, and the 
reaction mixture was stirred at 0 ¡C in the ice bath overnight. Then, sodium 
chloride solid was added to saturate the mixture. The product was extracted 
with ethyl acetate three times and then washed with sodium chloride solution 
once. The extract was concentrated on a rotary evaporator (~ 30 ¡C) and the 
residue was purified by flash chromatography using a mixed eluent of hexane 
and ethyl acetate (3:1 ~ 7:3 v/v). After the solvent was removed, the title 
compound was recovered (5.6 g, 76%) and stored in the refrigerator. 
1
H-NMR 
(CDCl3, 400 MHz) δ (ppm) 5.61 (s, 1H, C=CH, trans), 5.25 (s, 1H, C=CH, cis), 
3.30-3.17 (m, 2H, N-CH2), 1.99 (m, 1H, CH), 1.92 (s, 3H, CCH3), 1.52-1.36 (m, 
2H, CHCH2CH3), 1.37-1.15 (m, 6H, CH2CH2CH2), 0.99-0.80 (m, 6H, 
CH2CH3). 
13
C-DEPT (CD3Cl, 400 MHz) δ (ppm) 118.84 (=CH2), 42.54 
(NHCH2), 39.34 (CH), 31.04 (CHCH2CH2), 28.85 (CHCH2CH2), 24.30 
(CHCH2CH3), 22.96 (CH2CH2CH3), 18.71 (CCH3), 14.00 (CH2CH2CH3)), 
10.84 (CHCH2CH3). IR (KBr) ν (cm
-1
) 3318 (N-H), 3089 (=C-H), 2958, 2926, 
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2872 and 2859 (-C-H), 1655 (Amide C=O), 1618 and 1538 (N-H), ESI-MS: 
m/z 198.18 (MH
+
, 100%), 197.28 (M, 1%). 
 
4.1.1.1.2 N-(2-ethylhexyl) acrylamide (2-EHAm)
[12]
 
NH2
+
O Cl
O NH
NaOH
H2O/Acetone
  0oC r.t.
N-(2-ethylhexyl)acrylamide2-ethylhexan-1-amine acryloyl chloride  
2-Ethylhexan-1-amine (5.0 g, 38 mmol) was dissolved in 57 mL acetone and 
57 mL sodium hydroxide solution and cooled in an ice bath. Acryloyl chloride 
(7.4 mL, 76 mmol) was added dropwise over 30 min, and the reaction mixture 
was stirred at 0 ¡C in the ice bath overnight. Then, sodium chloride solid was 
added to saturate the mixture. The product was extracted with ethyl acetate 
three times and then washed with sodium chloride solution once. The extract 
was concentrated on a rotary evaporator (~ 30 ¡C) and the residue was purified 
by a flash chromatography using a mixed eluent of hexane and ethyl acetate 
(1:4 ~ 3:7 v/v). After the solvent was removed, the title compound was 
recovered (2.4 g, 34%) and stored in the refrigerator. 
1
H-NMR (CDCl3, 400 
MHz): δ (ppm) 6.31-6.21 (m, 1H, CHC=O), 6.16-6.03 (m, 1H, C=CH, trans), 
5.69-5.51 (m, 1H, C=CH, cis), 3.27 (m, 2H, N-CH2), 2.62 (m, 1H, CH), 1.55-
1.36 (m, 2H, CHCH2CH3), 1.37-1.20 (m, 6H, CH2CH2CH2), 1.00-0.77 (m, 6H, 
CH2CH3). 
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4.1.1.1.3 4-acrylamidobutanoic acid (4-AmBA)
[12]
 
+
HN O
NH2
4-acrylamidobutanoic acid4-aminobutanoic acid
O Cl
acryloyl chloride
NaOH
H2O
0 oC r.t.
O
OH
O
OH
 
4-Aminobutanoic acid (4-ABA) (10 g, 96 mmol) was dissolved in 191 mL 
sodium hydroxide solution (2M) and cooled in an ice bath. Acryloyl chloride 
(16 mL, 191 mmol) was added dropwise over 30 min, and the reaction mixture 
was stirred at 0 ¡C in the ice bath overnight. Then, chlorine hydride (2M) was 
added to adjust the pH to 1.0. The solution was saturated with sodium chloride 
solid. The product was extracted with ethyl acetate three times and then dried 
over magnesium sulfate. The filtrate was concentrated on a rotary evaporator 
(~ 30 ¡C) and the residue was diluted with ethyl acetate again and cooled in ice 
bath. The solid was collected through filtering and washed with cold diethyl 
ether three times. The resultant crystals (6.8 g, 45%) were kept in desiccator to 
remove the residue solvent. 
1
H-NMR (D2O, 400 MHz): δ (ppm) 6.28-5.96 (m, 
2H, CH2=CH, trans), 5.70-5.62 (m, 1H, CH2=CH, cis), 3.31-3.13 (m, 2H, N-
CH2), 2.42-2.24 (m, 2H, CH2COOH), 1.87-1.67 (m, 2H, CH2CH2CH2). 
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4.1.1.2 Synthesis of amphiphilic di-block copolymers  
General protocol for RAFT polymerization:
[13]
  
Polymerizations were conducted in round bottom flasks sealed with a rubber 
septum and parafilm. An NMR spectrum was recorded at the beginning of the 
experiment. The polymerization solutions were degassed using argon for at 
least 10 min and transferred to an oil bath preheated to 70 ¡C. After reaction, 
the solution was quenched by cooling in ice-water and another NMR spectrum 
was recorded to enable calculation of degree of conversion. For the removal of 
the CTA, the reaction was carried out at 70 ¼C, and the absence of CTA was 
confirmed by UV spectroscopy. 
 
4.1.1.2.1 p(L-DMAm)-b-p(2-EHAm): poly(3,4-dihydroxy-L-phenylalanine 
methacrylamide)-block-poly[N-(2-Ethylhexyl) acrylamide] 
+
N
CN
N
CN
COOHHOOC
DMSO
70 ¼C
HN O
HN O
S
S
n
S
OH
OH
O
HO
OH
HO
HN O
n
OH
O
HO
OH
HO
S
O NH
S
OH
Sm
O O
N
CN
N
CN
COOHHOOC
DMSO
70 ¼C
HN O
n
OH
O
HO
OH
HO
O NH
COOH
m
O CN
p(L-DMAm)-Macro CTA
p(L-DMAm)-b-p(2-EHAm)
2-EHAm
polymer 2-Macro CTA
 
In a typical experiment, 2-EHAm (436 mg, 2.4 mmol, 1.0 M) in DMSO (2.4 
mL), p(L-DMAm)-macro CTA (polymer 2-macro CTA) (100 mg, 0.024 mmol, 
0.12 M) in DMSO (0.20 mL) and V-501 (1.3 mg, 0.0050 mmol, 0.060 M) in 
DMSO (0.080 mL) were prepared separately and then mixed together (to make 
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a final 0.90 M concentration of 2-EHAm). The polymerization was carried out 
overnight. The polymer product was purified by dialysis against water and 
recovered as a white powder (0.36 g, 67%) after freeze-drying from water 
(dark, 2 days). In order to remove the CTA, the polymer (339 mg, 0.019 mmol, 
0.0050 M) and V-501 (152 mg, 0.54 mmol, 0.15 M) were dissolved in DMSO 
(3.6 mL) (to make a final ratio 1:30 of polymer to initiator). This mixture was 
degassed for 15 min and allowed to react at 70 ¼C overnight. The title 
compound p(L-DMAm)-b-p(2-EHAm) was purified by dialysis against water 
and recovered as a white powder (0.27 g, 80 %) after freeze-drying from water 
(dark, 2 days) 
1
H-NMR (DMSO, 400 MHz) δ (ppm) 12.45 (br, 1H, COOH), 
8.71 (br, >2H, NH), 7.22-6.04 (m, 3H, Ar-H), 4.54-3.88 (m, 1H, N-CH), 3.13-
2.70 (m, >5H, CH-CH2-L-DMAm + N-CH2-CH-EHAm), 2.33-1.87 (m, 3H, 
CH3-MAm), 1.41-1.06 (m, >8H, CH2CH2CH2 + CHCH2CH3), 1.04-0.57 (m, 
6H, CH2CH3), 1.84-0.00 (br, >2H, CH2-MAm/Am backbone).  
 
4.1.1.2.2 p(L-DMAm)-b-p(PAm): poly(3,4-dihydroxy-L-phenylalanine 
methacrylamide)-block-poly(N-phenylacrylamide) 
+
N
CN
N
CN
COOHHOOC
DMSO
70 ¼C
HN O
HN O
S
S
n
S
OH
OH
O
HO
OH
HO
HN O
n
OH
O
HO
OH
HO
S
O NH
S
OH
Sm
O O
N
CN
N
CN
DMSO
70 ¼C
HN O
n
OH
O
HO
OH
HO
O NH
m
O CN
PAm p(L-DMAm)-Macro CTA
p(L-DMAm)-b-p(PAm)
polymer 2-Macro CTA
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In a typical experiment, PAm (440 mg, 3.0 mmol, 1.0 M) in DMSO (3.0 mL), 
p(L-DMAm)-macro CTA (polymer 2-macro CTA) (100 mg, 0.030 mmol, 0.12 
M) in DMSO (0.25 mL) and V-501 (1.7 mg, 0.0060 mmol, 0.060 M) in DMSO 
(0.10 mL) were prepared separately and then mixed together (to make a final 
0.90 M concentration of PAm). The polymerization was carried out for 90 min. 
The polymer product was purified by dialysis against water and recovered as a 
white powder (0.39 g, 72%) after freeze-drying from water (dark, 2 days). In 
order to remove the CTA, the polymer (390 mg, 0.023 mmol, 0.010 M) and 
AIBN (75 mg, 0.46 mmol, 0.15 M) were dissolved in DMSO (3.0 mL) (to 
make a final ratio 1:20 of polymer to initiator). This mixture was degassed for 
15 min and allowed to react at 70 ¼C for 3 h. The title compound p(L-DMAm)-
b-p(PAm) was purified by dialysis against water and recovered as a white 
powder (0.30 g, 76%) after freeze-drying from water (dark, 2 days) 
1
H-NMR 
(DMSO, 400 MHz) δ (ppm) 12.46 (br, 1H, COOH), 8.68 (br, >2H, NH), 7.87-
6.37 (m, >8H, Ar-H), 4.56-3.88 (m, 1H, N-CH), 2.47-2.08 (m, >5H, CH-CH2 + 
CH3-MAm), 2.08-0.00 (br, >4H, CH2-MAm/Am backbone).  
 
4.1.1.2.3 p(4-AmBA)-b-p(PAm): poly(4-acrylamidobutanoic acid)-block-
poly(N-phenylacrylamide) 
+ H2O/EtOH
70 ¼C
HN O
OH
O
S S
OH
O
S
HOOC N
CN
N COOH
CN
S
NHO
O
OH
HO
O
S
S
n
4-AmBA RAFT agent p(4-AmBA)  
In a typical experiment, 4-AmBA (500 mg, 3.2 mmol, 0.88 M) in H2O (3.6 
mL), RAFT agent (20 mg, 0.091 mmol, 0.24 M) in ethanol (0.38 mL) and V-
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501 (2.6 mg, 0.0090 mmol, 0.030 M) in ethanol (0.27 mL) were prepared 
separately and then mixed together (to make a final 0.75 M concentration of 4-
AmBA). The polymerization was carried out for 60 min. The compound p(4-
AmBA) was purified by dialysis against water and recovered as a white 
powder (464 g, 85%) after freeze-drying from water (dark, 2 days). 
1
H-NMR 
(DMSO, 400 MHz) δ (ppm) 12.06 (br, 1H, COOH), 8.04 (br, 1H, NH), 3.82-
2.73 (m, 2H, N-CH2), 2.17 (br, 2H, CH2COOH), 1.92 (br, 2H, CH2CH2CH2), 
1.69-0.85 (br, 2H, CH2-Am backbone).  
+
N
CN
N
CN
COOHHOOC
DMSO
70 ¼C
HN O
HN O
S
S
n
S
HO
HN O
n
OH
HO
S
O NH
S
Sm
O O
N
CN
N
CN
DMSO
70 ¼C
HN O
n
OH
HO
O NH
m
O CN
PAm p(4AmBA)-Macro RAFT agent
p(4AmBA)-b-p(PAm)
OH
O O
O
 
In a typical experiment, PAm (330 mg, 2.2 mmol, 0.50 M) and p(4-AmBA)-
macro CTA (100 mg, 0.022 mmol, 0.0050 M) in DMSO (4.5 mL), and V-501 
(1.6 mg, 0.0060 mmol, 0.060 M) in DMSO (0.094 mL) were prepared 
separately and then mixed together (to make a final 0.49 M concentration of 
PAm). The polymerization was carried out for 5 h. The polymer product was 
purified by diluted in THF and precipitated into hexane as a white powder 
(0.25 g, 90%) after desiccated (dark, 2 days). In order to remove the CTA, the 
polymer (251 mg, 0.014 mmol, 0.0050 M) and AIBN (47 mg, 0.28 mmol, 
0.094 M) were dissolved in DMSO (3.0 mL) (to make a final ratio 1:20 of 
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polymer to initiator). This mixture was degassed for 15 min and allowed to 
react at 70 ¼C for 5 h. The title compound p(4-AmBA)-b-p(PAm) was purified 
by purified by diluted in THF and precipitated into hexane as a white powder 
(0.20 g, 78%) after desiccated (dark, 2 days). 
1
H-NMR (DMSO, 400 MHz) δ 
(ppm) 12.06 (br, 1H, COOH), 9.65 (br, >2H, NH), 7.70-6.68 (m, 5H, Ar-H), 
3.73-2.88 (m, 2H, N-CH2), 2.21 (br, 2H, CH2COOH), 1.76 (br, 2H, 
CH2CH2CH2), 2.03-0.73 (br, >4H, CH2-Am backbone).  
 
4.1.1.2.4 p(DMAm-c-DMAPMAm)-b-p(PAm): poly{N-(3,4-dihydroxy-
phenethyl)methacrylamide-co-N-[3-(dimethylamino)propyl] 
methacrylamide}-block-poly(N-phenylacrylamide) 
+
N
CN
N
CN
COOHHOOC
DMSO
70 ¼C
HN O HN O
HO
OH
HO
O
N
CN
N
CN
DMSO
70 ¼C
PAm p(DMAm-c-DMAPMAm)-Macro CTA
       14     :     86
p(DMAm-c -DMAPMAm)-b-p(PAm)
       14     :     86
S
OHN
N
S
OH
S
HN O
HO
OH
HO
O
OHN
N
S
NHO
n
S
OH
S
HN O
HO
OH
HO
O
OHN
N
NHO
CN
n
polymer 1a-Macro CTA
 
In a typical experiment, PAm (526 mg, 3.6 mmol, 0.93 M) in DMSO (3.8 mL), 
p(DMAm-c-DMAPMAm)-macro CTA (polymer 1a-macro CTA) (150 mg, 
0.011 mmol, 0.12 M) in DMSO (0.090 mL) and V-501 (0.61 mg, 0.0020 mmol, 
0.060 M) in DMSO (0.036 mL) were prepared separately and then mixed 
together (to make a final 0.90 M concentration of PAm). The polymerization 
was carried out for 4 h. The polymer product was purified by dialysis against 
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water and recovered as a light brown powder (0.34 g, 50%) after freeze-drying 
from water (dark, 2 days). In order to remove the CTA, the polymer (341 mg, 
0.0070 mmol, 0.0035 M) and AIBN (23 mg, 0.14 mmol, 0.070 M) were 
dissolved in DMSO (2.0 mL) (to make a final ratio 1:20 of polymer to initiator). 
This mixture was degassed for 15 min and allowed to react at 70 ¼C for 3 h. 
The title compound p(DMAm-c-DMAPMAm)-b-p(PAm) was purified by 
dialysis against water and recovered as a light brown powder (0.28 g, 81%) 
after freeze-drying from water (dark, 2 days) 
1
H-NMR (D2O, 400 MHz) δ 
(ppm) 9.65 (br, >3H, NH), 7.84-6.59 (m, >8H, Ar-H), 3.13-2.82 (m, 2H, CH2-
N-DMAm), 2.72-2.48 (m, 4H, CH2-N-DMAPMAm), 2.47-2.03 (m, >8H, N-
CH2-CH2-DMAm + CH3-DMAP), 2.00-1.35 (m, >5H, CH3-MAm + HN-CH2-
CH2-DMAPMAm), 1.10-0.59 (m, 2H, CH2-MAm backbone). 
 
4.1.2 Preparation of vesicles 
General procedure to prepare vesicles:
[14]
 
Amphiphilic diblock copolymer (5.0 mg) was completely dissolved in a 
volatile organic solvent (e.g. THF, Methanol or mixture, 1mL). The aqueous 
phase (1.0 mL, 10 mM HEPES, 10 mM NaCl and 50 mM dye, pH 7.4) was 
placed in a narrow neck flask (25 mL) with continuous stirring. Organic phase 
and polymer samples were added dropwise into the aqueous solution. The top 
of the flask was covered with clean tissues, and the mixture was stirred over 
night at room temperature to allow evaporation of all the organic solvent. 
To remove the free dye and purify the vesicles, two approaches were applied. 
The simpler way was to dialyze the crude vesicle solution with 1000 MW 
dialysis membrane against osmotic buffer (5000 mL, 10 mM HEPES, 100 mM 
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NaCl) for 2 days with twice osmotic buffer change. For those polymers with 
improved permeability (see details in 4.2.3), the crude sample was purified 
through a Sephadex G-50 (Dry bead diameter 20-80 µm, bed volume 9-11 
mL/g) column. The pure vesicle solution was collected for the following tests. 
 
4.1.3 Measurement of membrane permeability using 5(6)-
carboxyfluorescein 
5-Carboxyfluorescein loaded polymeric vesicles were prepared as described 
above. The fluorescence emission spectra from 500 to 600 nm, λex 470 nm, 
were recorded with slit widths 10 nm excitation 5 nm emission. The original 
vesicle solution (100 µL) was mixed with osmotic buffer (2.0 mL) pH 7.4 and 
pH 12 separately, and the fluorescence spectra recorded with the parameters as 
above. The above solution (1.0 mL) were then taken out and solubilized with 
10% Triton-X-100 (20 µL) and after 30 min the fluorescence was recorded. If 
this initial assay worked, kinetics would be carried out as described below.  
Kinetics of fresh diluted vesicle solutions were recorded with λex 470 nm, λem 
517 nm, slit widths 10 nm excitation 5 nm emission for 2 h at pH 7.4 and pH 
12, separately. The diluted vesicle solutions (1.0 mL) were then solubilized 
with 10% Triton-X-100 (20 µL), and the fluorescence was recorded as above 
for another 2 h.   
 
4.1.4 Measurement of membrane permeability to pH using pyranine 
Pyranine loaded polymeric vesicles were prepared as described above. The 
fluorescence emission spectra from 480 to 600 nm, λex 460 nm, were recorded 
with slit widths 10 nm excitation 5 nm emission. The original vesicle solution 
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(100 µL) was mixed with osmotic buffer (2.0 mL) pH 7.4 and pH 12 separately, 
and the fluorescence spectra recorded with the parameters as above. The above 
solution (1.0 mL) was removed and treated with 10% Triton-X-100 (20 µL) 
and after 30 min the fluorescence was recorded. For permeable vesicles, 
kinetics was carried out as described below. 
Kinetics of release from fresh diluted vesicle solutions were recorded with λex 
460 nm, λem 510 nm, slit widths 10 nm excitation 5 nm emission for 2 h at pH 
7.4 and pH 12, separately. The diluted vesicle solutions (1.0 mL) were then 
solubilized with 10% Triton-X-100 (20 µL), and the fluorescence was recorded 
as above for another 2 h.   
 
4.1.5 Bacterial aggregation assay 
The bacterial aggregation assay by using UV spectrometer followed a similar 
protocol as described in Chapter 3. Briefly, 285 µL of the overnight culture, 
diluted with AB media to reach an optical density of approximately 1.0, were 
placed in a UV cuvette and combined with 15 µL of original vesicle samples to 
be analyzed. The final concentration of vesicles was 0.25 mg/mL. Optical 
density (600 nm) was recorded at 30 ¡C every 30 seconds for 60 min.  
 
4.1.6 Bioluminescence assay with MM32 strain 
MM32 assays were carried out with protocol 2, 3 and 4 in Chapter 3. V. 
harveyi MM32 grown on LB agar plate containing kanamycin (50 µg/mL) and 
chloramphenicol (10 µg/mL) was used to inoculate 2 mL LB from a fresh plate. 
The bacteria were then grown with aeration at 30 ¼C overnight. AB medium 
was then inoculated with this preculture (5000:1) and DPD was added to a final 
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concentration of 22 µM. 180 µL of the inoculated medium were placed in each 
of the wells of a 96 well plate and combined with 20 µL of the samples to be 
analyzed. The vesicle samples were prepared one day before the assay, and 
purified through Sephadex G-50 column just before the assay. The effect of 
different protocol on assay results was also investigated. 
 
4.1.7 DPD release studies 
Amphiphilic diblock copolymer (5.0 mg) was completely dissolved in a 
volatile organic solvent (e.g. THF, Methanol or mixture, 1.0 mL). DPD 
solution (3.7 mM, 1.0 mL) was placed in a narrow neck flask (25 mL) with 
continuous stirring. Organic phase loaded with copolymer samples was added 
dropwise into DPD aqueous solution. The top of flask was covered with clean 
tissues. The mixture was kept stirring over night in cold room to remove all the 
organic solvent. 
To remove the free DPD molecules and purify the vesicles, the crude sample 
was purified through a PD-10 column twice. The pure sample of DPD-loaded 
vesicles was collected for MM32 assay.  
The MM32 assay was carried out with protocol 4 in Chapter 3. Additionally, 
three types of assays were devised: 1) Different diol-concentrations of vesicles 
were added into media with DPD (0.10 µM); 2) Different diol-concentrations 
of DPD loaded vesicles were added into media with DPD (0.10 µM); 3) 
Different diol-concentrations of DPD loaded vesicles were added into media 
without DPD. 
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4.2 Results and discussions 
4.2.1 Monomers 
The preparation of amphiphilic block copolymers commenced with monomer 
synthesis. N-(2-ethylhexyl) methacrylamide (2-EHMAm) and N-
phenylmethacrylamide (PMAm) were initially selected as hydrophobic 
monomers, due to the assumption that the difference of the monomer structures 
could lead to different membrane permeability of polymeric vesicles self-
assembled from their corresponding amphiphilic copolymers. Additionally, 
methacrylamide monomers were of preference rather than acrylamides, for the 
macro-CTA hydrophilic polymers (Polymer 1 and Polymer 2 prepared in 
Chapter 3) are all methacrylamides and the methyl groups on polymer 
backbone might have an effect on polymeric vesicle formation. Specifically, 
the bilayer of polymeric vesicles should be looser due to the presence of the 
methyl group on the backbone and less dense bilayer packing, and therefore 
would give the possibility to establish channels linking the inner and outer 
environment.  
2-EHMAm was synthesized by using similar conditions according to the 
reference
[12]
 with modification. The 1:1 ratio reaction was carried out in 
sodium hydroxide (2 M) and acetone (1 : 1, v/v) mixture solution using 1 : 2 : 3 
molar ratio of 2-EHA to acryloyl chloride to sodium hydroxide at 0 ¡C. The 
mechanism of this acylation reaction to 2-ethylhexan-1-amine or aminolysis 
reaction to acryloyl chloride is shown in Figure 4-1.  
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+
ClO O N
H
H
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-
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+ H2O
NaOH
+ NaCl
 
Figure 4-1. Scheme of the mechanism of synthesis of 2-EHMAm monomer 
 
The crude product was obtained by saturating the overnight reaction mixture 
with sodium chloride solid and extracted with ethyl acetate three times. 
Emulsification was observed during extraction, and therefore the extract was 
settled after a while and then washed with sodium chloride solution once. Flash 
chromatography was performed to purify the target monomer. Since the 
synthesis of 2-EHMAm has not been published before, its full characterization 
was carried out by 
1
H-NMR (Figure 4-2), 
13
C DEPT-NMR (Figure 4-3), FT-
IR and mass spectrum (see Appendix). 
 
Figure 4-2 
1
H-NMR spectra of 2-EHMAm in d-chloroform 
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Figure 4-3 
13
C DEPT-NMR spectra of 2-EHMAm in d-chloroform 
 
Monomer 2-EHMAm was then used for RAFT polymerization to grow 
hydrophobic blocks from macro-CTA p(L-DMAm). However, with the 
conditions employed, the diblock copolymer was never successfully made (see 
details in 4.2.2.1 about preparation of copolymers). In this case, 2-EHAm as an 
acrylamide monomer was considered to be an alternative and synthesized by 
using the same protocol. Also, in order to keep the structural coherence, N-
phenylacrylamide provided by my colleague Francisco Fernandez-Trillo was 
used instead of its corresponding methacrylamide monomer in the subsequent 
polymerization studies. 
In this section, as the control of the hydrophilic polymers investigated in 
Chapter 3, monomer 4-AmBA was also synthesized using a reported 
method
[12]
 and was employed to form hydrophilic blocks in amphiphilic 
copolymers and finally applied in the bioassays. The product yield (45%) was 
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not as high as reported (> 70%)
[1]
 maybe because of the inevitable loss during 
purification.  
 
4.2.2 Amphiphilic block copolymers 
4.2.2.1 Synthesis of p(L-DMAm)-b-p(2-EHAm) 
The first amphiphilic block copolymer polymerized in this study was p(L-
DMAm)-b-p(2-EHMAm) following the general RAFT polymerization protocol. 
In this case, p(L-DMAm) prepared in Chapter 3 with active trithiocarbonates 
was used as a water-soluble macro-CTA or macro-RAFT agent. To produce 
the target copolymers, a series of experimental conditions were tried. Even 
though several batches of p(L-DMAm)-CTA were synthesized to achieve 
active macro-CTA for 2-EHMAm polymerization, no subsequent copolymers 
formed. On the other hand, the amphiphilic copolymer composed of L-DMAm 
and 2-EHAm (instead of EHMAm) was successfully made. P(L-DMAm)-b-
p(2-EHAm) with a series of monomer ratios was prepared initially in order to 
confer different potency to both QS quenching and cell sequestrating, while at 
the same time maintain the desired morphological property in aqueous media.  
As described in Chapter 1 (1.2.1), the morphologies of nanoparticles self-
assembled from amphiphilic block copolymers are theoretically a result of the 
inherent molecular curvature.
[15]
 In Eq. 1, ÔγÕ represents the volume of the 
hydrophobic chains, ÔaÕ is the optimal area of the head group, and ÔlÕ means the 
length of the hydrophobic tail. Only when the value of Ôpacking parameterÕ of 
a presented molecule is between 1/2 and 1, will a polymeric vesicle be the 
predominant morphology existing in solution. 
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Equation 1 
p =
!
" # l
 
 
Although in the theoretical Ôpacking parameterÕ equation, only the parameters 
of hydrophobic chains have been involved, a series of factors were found to be 
important for the size and shape of the aggregates empirically.
[3a]
 Besides the 
environmental conditions, the key to a successfully prepared vesicle is its 
chemical constitution and length of each individual block. In order to 
synthesize p(L-DMAm)-b-p(2-EHAm) with different compositions, 
polymerization was initially performed by using the same p(L-DMAm) macro-
CTA (the same degree) mixed together with 2-EHAm monomer as well as 
initiator in selected solvent in one pot, but the reacting mixture was taken out 
and therefore terminated at different reaction time points (8h 32 min for C1a 
and 20h 38min for C1b) (Table 4-1).  In this case, the copolymers with 
different p(2-EHAm) degrees were produced. On the other hand, the kinetic 
experiment for this reaction has been carried out as usual, so that the 
copolymer products with other different compositions (data not shown) were 
also collected. Based on the experimental experience of the preliminary studies, 
amphiphilic copolymers with relatively long hydrophilic chains may tend to 
form micelles rather than vesicles in aqueous solution. Therefore, p(L-
DMAm)-CTA was then made with low molecular weight 4204 g/mol (for C1c) 
and 3241 g/mol (for C1d), respectively. The feed of 2-EHAm was still 100:1 
ratio to macro-CTA, and thus keeping the hydrophobic chain the same, 
theoretically. Even though all the conditions were the same such as solvent, 
initiator stock solution, oil bath (temperature) and reaction duration, the lengths 
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of p(2-EHAm) block were still different at the end, maybe resulting from the 
macro-CTA and/or degassing operation (Table 4-1).  
A correlation between the particle morphology in water and the monomer feed 
as well as the weight percentage of hydrophilic block was recorded (Table 4-1). 
Copolymers of p(L-DMAm)-b-p(2-EHAm) with higher than 30% hydrophilic 
weight percentage showed broad particle-size dispersity in water as shown by 
DLS (Figure 4-4, a and b), while the same copolymer, but with L-DMAm 
weight percentage of around 20% gave narrow dispersities and also good 
correlation profiles by DLS (Figure 4-4, c and d). In this case, the 
hydrodynamic diameter of copolymer C1c and C1d were ~ 60 nm and 50 nm 
respectively based on the DLS data (Table 4-4). It was expected that particle 
sizes of these two copolymers would not differ much owing to the similar 
compositions. Additionally, all these four copolymers were negatively charged 
according to zeta-potential data, which was also anticipated, for the carboxyl 
group in p(L-DMAm) was expected to be ionized in neutral aqueous media 
(Table 4-1).  
Table 4-1 
Copolymer 
n:m
a
 
Mhydrophilic
b
 Mhydrophobic
c
 
Whydrophilic % 
(w/w) 
Diameter 
(nm) 
Zeta-
Potential 
(mV) 
C1a Ð 27 : 64 7043.18 11734.23 37.4% - -29.1 
C1b Ð 27 : 66 7043.18 12161.29 36.6% - -29.1 
C1c Ð 16 : 73 4204.28 13402.16 23.9% 59.7 -34.7 
C1d Ð 12 : 84 3241.48 15475.17 17.3% 49.8 -38.3 
a) n/m molar ratio of L-DMAm/2-EHAm. b) p(L-DMAm) hydrophilic block molecular weight 
calculated from 
1
H-NMR. c) p(2-EHAm) hydrophobic block molecular weight calculated from 
1
H-NMR.  
 
  194
 
Figure 4-4. DLS data for a) C1a, b) C1b, c) C1c, d) C1d in double-distilled 
water (2.5 mg/mL) 
  
The non-aggregating vesicles assembled from copolymer C1d were 
investigated by cryogenic (cryo) (Figure 4-5, a) technique. The sample of 
cryo-TEM was prepared through suspending copolymers in dilute solution 
(0.25 mg/mL) and subsequently hydrating and vitrifying. Such preparative 
procedure caused particlesÕ shrinking on occasions because of the inevitable 
dehydration of particles. According to the images (Figure 4-5, a and b), the 
average diameters of cryo-particles were mostly smaller than 60 nm, while 
those of stain-particles were always around 100 nm. Also the imaging of cryo-
TEM always recorded ice coexisting with particles, which made it difficult to 
tell the particles apart. Considering all these drawbacks of cryo-TEM in this 
study, standard TEM techniques with staining finally employed instead, which 
gave more reliable particle-size evaluation and also clearer membrane 
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boundaries. The transparent particles overlapping with each other were 
observed in these imagines (Figure 4-5, b and c), which could demonstrate the 
formation of vesicles, as if the round particles were spherical micelles instead, 
their cores would have been solid and opaque rather than transparent. 
 
 
Figure 4-5. Transmission Electron Micrograph (TEM) imaging of the 
copolymer a) C1d (cryo) b) C1d (stain) c) and d) C1c (stain) (0.25 mg/mL in 
H2O) 
 
In summary, the data from DLS and TEM characterizations revealed that 
aqueous suspensions of copolymer p(L-DMAm)-b-p(2-EHAm) with different 
composition probably formed mixed species of spherical micelles and vesicles 
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since more than two average sizes of particle groups were observed. With 
decreased hydrophilic weight percentage, copolymers formed vesicle-like 
morphology and relatively narrow dispersities. Therefore, copolymers with 
hydrophilic weight percentage around 20% were of more interest for 
subsequent study. 
Alizarin Red S (AR-S) competitive binding assays were also carried out with 
copolymer C1c (Figure 4-6) to establish binding affinities for copolymers to 
phenylboronic acid (PBA). Again, as already discussed (Chapter 3, 3.2.4), 
polymer analysis was limited by the lack of binding saturation in some of the 
cases, which was more significant with amphiphilic block copolymers with 
hydrophobic blocks. In this case, problems in the assay still existed such as low 
amount of material and/or low affinity, presence of new bands at 520 nm 
attributed to catechol structures when increasing the polymer concentrations. 
Therefore, no further AR-S assays were carried out.  
 
Figure 4-6. Alizarin Red S competitive binding assay was performed with 
copolymer C1c, but dose-dependent fluorescence quenching was not observed. 
New band of catechol structure at 520 nm appeared and was increased with the 
addition of copolymer C1c, which prevented its further analysis.  
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4.2.2.2 Synthesis of p(L-DMAm)-b-p(PAm) 
The membrane properties of polymersomes investigated here were adjusted by 
tuning hydrophobic structures. Another hydrophobic monomer PAm was 
therefore selected with the expectation of giving distinct permeability for 
polymersomes compared to those self-assembled from p(L-DMAm)-p(2-
EHAm). In this context, p(L-DMAm)-b-p(PAm) - copolymer C2 was 
synthesized following the same reaction conditions as p(L-DMAm)-b-p(2-
EHAm). Specifically, p(L-DMAm)-CTA used was around 3200 g/mol 
molecular weight (target degree of polymerization 20), while the target degree 
of polymerization of PAm was 100. Notably, the kinetic experiment indicated 
that this polymerization was very fast, so that the monomer conversion reached 
94 % after only 90 min.  
HN O
*
13
OH
O
HO
OH
*
O NH
93
 
p(L-DMAm)13-b-p(PAm)93 
 
4.2.2.3 Synthesis of p(4-AmBA)-b-p(PAm) 
P(4-AmBA)-b-p(PAm) - copolymer C3 was synthesized via similar 
polymerization procedures described above. In this copolymer structure, p(L-
DMAm) hydrophilic block was replaced with p(4-AmBA), while p(PAm) 
remained  as hydrophobic chain. As discussed in Chapter 2, a series of 
functional groups had been demonstrated to give various binding affinities to 
boron other than catechols. Therefore, copolymers p(4-AmBA)-b-p(PAm) 
composed of hydrophilic chains with carboxyl acid pendent functionalities 
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showing low affinities to boron were prepared to be ÔcontrolÕ materials for p(L-
DMAm)-b-p(PAm).  
HN O
*
27
OH
*
O NH
90
O
 
p(4-AmBA)27-b-p(PAm)90 
 
4.2.2.4 Synthesis of p(DMAm-c-DMAPMAm)-b-p(PAm) 
Having prepared copolymer vesicles with p(L-DMAm) (4.2.3 and 4.2.4), 
vesicles were formulated from p(DMAm-c-DMAPMAm) (polymer 1) - 
another potent linear polymer targeting biological applications investigated in 
Chapter 3. A series of vesicles with variety of potency was therefore ready 
prior to subsequent bioassays. 
First of all, the polymerization conditions to prepare p(DMAm-c-
DMAPMAm)-CTA were modified in order to keep the CTA group active for 
the second block synthesis. For the alkaline conditions are known to readily 
quench CTA, the reaction was performed in t-BuOH and acetate buffer mixed 
solvent at pH 5.5. Again, the second p(PAm) blocks were successfully 
connected  to p(DMAm-c-DMAPMAm) with general conditions and 
characterized by 
1
H-NMR (Copolymer C4). However, the study of this product 
was at very early stage. The p(DMAm-c-DMAPMAm) composition was 
followed the previous monomer ratio (theoretical degree of polymerization 20 : 
80, and final value was 14 and 86, respectively). The degree of polymerization 
of p(PAm) block was initially targeted to 330 and the final value was 237. The 
copolymers with such composition gave poor water solubility and thus were 
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difficult to form vesicles. To find out appropriate monomer compositions for 
this copolymer as well as its vesicle preparation conditions considerable extra 
work in future is need. 
HN O
*
HO
OH
OHN
N
*
NHO
237
 
p(DMAm14-c-DMAPMAm86)-b-p(PAm)237 
 
4.2.3 Preparation of vesicles 
The vesicle preparation method ultimately adopted here was the Ôsolvent-
exchangeÕ technique. Although at the initial study stage the Ôfilm rehydrationÕ 
technique was also considered, after several attempts it was found to be 
difficult in practice, at least for copolymers (C1 and C2) investigated in this 
study.  Therefore, more efforts focused on preparative conditions optimized the 
Ôsolvent-exchangeÕ method. As introduced at the beginning of this chapter, it is 
key for a successful vesicle preparation to select a good volatile organic 
solvent for both hydrophilic and hydrophobic blocks of copolymers. It is easy 
to understand that the organic solvent should be good to both components, so 
that even and uniform nanoparticles are easily formed via dropping expanded 
copolymer chains into an aqueous phase. The organic solvents are also 
necessarily volatile and thus finally completely removed under stirring in fume 
hood overnight. Thus, the nanoparticles are eventually obtained in pure 
aqueous media. The volume ratio of 3 : 2 of THF to Methanol was found to be 
the best choice meeting the above requirements, and no single pure solvent 
could provide such good solubility for p(L-DMAm)-b-p(2-EHAm) and p(L-
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DMAm)-b-p(PAm). The concentration of copolymers in organic solvents was 
adjusted from 10.0 mg/mL to 5.0 mg/mL, for the vesicles prepared from lower 
concentration solutions had more uniform morphology and more narrow 
dispersities (checked with DLS). The contents of vesicle buffer or aqueous 
phase employed were derived from those reported in the literature
[14]
 and 
proved to be effective for making polymersomes. Ionic concentration and pH 
were therefore kept the same throughout the experiments. All the other factors 
such as temperature (room temperature), stirring rate and ratio for the two 
phases (1 : 1) were fixed for all the experiments.  
A commonly used method to purify vesicles is dialysis against osmotic buffer. 
This method was also initially adopted for this study. However, leakage of the 
loaded dye was significant, which was likely due to the concentration gradient 
of ions between the inner and outer environments of the vesicles. Subsequently, 
a size-exclusion column was employed instead. This was advantageous for 
maintaining the dye inside and minimizing its leakage. 
Vesicle morphologies were again recorded with TEM imaging. In order to 
evaluate particle size distribution fully, statistical analysis was used (Table 4-2). 
The diameters of at least 200 particles were randomly measured manually from 
the TEM images. The particle size was found to cluster into four groups. The 
results were also reported in histograms in order to show the particle size 
distribution (Figure 4-7). At this stage, the dispersities of preparative particles 
were still broad, and spherical micelles as well as polymeric vesicles probably 
coexisted in the mixture.  
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Table 4-2 
Diameter 
Vesicle 
0-50 nm 51-99 nm 100-150 nm > 151 nm Average 
1a
a
 41.1 ± 9.1 74.5 ± 13.2 123.0 ± 15.1 171.4 ± 17.9 96 ± 39.2 
1b
b
 40.7 ± 10.5 73.8 ± 12.7 123.3 ± 15.1 177.3 ± 23.6 105 ± 44.0 
2
c
 34.8 ± 8.3 67.2 ± 11.2 122.2 ± 8.1 208.3 ± 9.6 48 ± 34.3 
a) Vesicle 1a made from copolymer C1d (12/84 molar ratio of L-DMAm/2-EHAm). b) Vesicle 
1b made from copolymer C1c (16/73 molar ratio of L-DMAm/2-EHAm). c) Vesicle 2 made 
from copolymer C2 (13/93 molar ratio of L-DMAm/PAm).  
 
 
Figure 4-7. Histograms of diameter distribution of Vesicle 1a, 1b and 2 
analyzed from TEM images 
 
More techniques were attempted in order to better characterize vesicles and at 
the same time to compare particle size obtained from different techniques 
(Table 4-3). The AFM imaging was found not to be a suitable technique to 
characterize L-DOPA containing polymers, for DOPA-derivatives were found 
to adhere to AFM cantilevers as reported previously.
[16]
 However, other 
techniques indicated that the particles encapsulated hydrophilic fluorescent dye. 
Hence, the study moved to fluorescent dye encapsulation and release 
experiments.  
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Table 4-3 
Vesicle 
Mean diameter (nm) Zeta-potential 
(mV) DLS TEM AFM 
1a 27 ± 8.9 96 ± 39.2 - -38.8 ± 0.9 
1b 56 ± 13.7 105 ± 44.0 - -31.7 ± 1.5 
2 36 ± 10.6 48 ± 34.3 31 ± 9.6 -36.8 ± 1.6 
a) Vesicle 1a made from copolymer C1d (12/84 molar ratio of L-DMAm/2-EHAm). b) Vesicle 
1b made from copolymer C1c (16/73 molar ratio of L-DMAm/2-EHAm). c) Vesicle 2 made 
from copolymer C2 (13/93 molar ratio of L-DMAm/PAm).  
 
4.2.4 Membrane permeability 
Fluorescent dye 5(6)-carboxyfluorescein was used as a reporter for testing 
membrane permeability. The concentrations of the dye internally trapped 
within vesicles were planned to be high enough to quench fluorescence.
[17]
 
After addition of Triton-X-100, the vesicles should burst and subsequently 
release dye into the bulk solution. Based on this strategy, both encapsulation 
capability and membrane permeability of resulted vesicles are examined in one 
experiment.  
5(6)-Carboxyfluorescein was completely dissolved in vesicle-preparing buffer 
at pH 7.4 at an initial concentration of 50.0 mM and then encapsulated into 
vesicles following the vesicle preparation procedure. The free dye was 
removed by Sephadex G-50 column. Figure 4-8 (left) shows the results of this 
assay for Vesicle 02 self-assembled from copolymer p(L-DMAm)13-b-
p(PAm)93. The blue solid line represents sample in pH 7.4 buffer and the 
dashed line represents the same sample after addition of Triton. As expected, 
fluorescence increased when vesicles were burst and 5(6)-carboxyfluorescein 
was released into the bulk solution. The profile for samples in pH 12 is shown 
as a green solid line, while the profile following vesicle burst is shown as a 
green dashed line. It is necessary to note that the original 5(6)-
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carboxyfluorescein concentration could not be measured directly, as it was 
above the sensitive range of the spectrometer. The original sample solutions 
(pH 7.4 in vesicle-preparing buffer) were therefore always diluted to reach a 
measurable fluorescence ranges. When dilution in the same fold was performed 
with different pH buffer, the fluorescence changed (between blue and green 
profiles) (Figure 4-8). This might be attributed to the sensitivity of the 
permeable membrane to the change of buffer pH. The detailed progress was 
recorded in the kinetic profiles (Figure 4-8, right). The fluorescence increase 
occurred within the initial 30 min after the pH of the original sample solution 
(pH 7.4) was adjusted to 12 (Figure 4-8, right, green profile). On the other 
hand, the pH sensitive range of 5(6)-carboxyfluorescein is from neutral to 
acidic conditions
[18]
, and thus the fluorescence change before and after addition 
of Triton only resulted from the dye concentration increase in bulk solution 
(Figure 4-8, right). 
Vesicle 1 prepared from p(L-DMAm)-b-p(2-EHAm) was less effective for 
entrapping 5(6)-carboxyfluorescein, either because it has a softer membrane 
and more possibilities to leak, or because it may have been the case that 5(6)-
carboxyfluorescein was not a suitable dye to be encapsulated in Vesicle 1. 
Hence, pyranine as a fluorescent pH indicator was used for further studies.  
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Figure 4-8. Fluorescence spectra of 5(6)-carboxyfluorescein encapsulated in 
Vesicle 2 at pH 7.4 and pH 12 (left), and kinetic experiments (right), before 
and after addition of Triton X-100  
 
4.2.5 Membrane permeability with varying pH 
According to the results showed in Figure 4-9 (top), replacing 5(6)-
carboxyfluorescein with pyranine as the fluorescence reporter did not 
significantly affect the qualitative results except the dye fluorescence emission 
length shifted to 510 nm. Kinetic experiment gave the possibility to compare 
the difference in fluorescence before and after vesicle burst under two pH-
conditions. The change in fluorescence at pH 12 was remarkable compared to 
that at pH 7.4 owing to the pH-sensitive properties of pyranine as well as the 
increased dye concentration in the bulk solution following burst of the vesicle 
structure. Initially, the pH within vesicles was 7.4, but on vesicle burst the 
pyranine was exposed to the pH 12 external environment.  
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Figure 4-9. Fluorescence spectra of pyranine encapsulated in Vesicle 2 at pH 
7.4 and pH 12 (left), and kinetic experiments (right), before and after addition 
of Triton X-100 
 
The assay performed with Vesicle 1a (12/84 molar ratio of L-DMAm/2-EHAm) 
indicated via pyranine fluorescence that encapsulation and release were 
successful (Figure 4-10). Again, the whole experimental duration was 
separated into two stages by the time point at which Triton was externally 
added. The resulting fluorescence profiles were similar as discussed for Vesicle 
2. However, there were some features observed for vesicle 1a compared to 
Vesicle 2. After diluting original sample solution, the fluorescence fluctuated 
in both pH conditions before the addition of triton. Also, after adding Triton 
the fluorescence increased fast initially but subsequently plateaued. This may 
have been due to the p(2-EHAm) block changing the properties of the vesicle 
membrane.  
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Figure 4-10. Fluorescence spectra of kinetic experiments of pyranine 
encapsulated in Vesicle 1a at pH 7.4 and pH 12, before and after vesicle burst 
 
4.2.6 Bacterial aggregation assay 
The principles of the bacterial aggregation assays were described before. This 
assay was performed again with Vesicle 1a and Vesicle 2 as well as Polymer 
2d - p(L-DMAm)12 as representative for linear polymers. This is because it was 
demonstrated that all the three types of polymers investigated in Chapter 3 
enhanced bacterial aggregation significantly in bacterial media (Figure 3-16). 
Also, the hydrophilic blocks of Vesicle 1 and 2 were p(L-DMAm) as also the 
component for Polymer 2d. The bacterial adhesion assay was performed by 
using the same bacterial culture as well as the same conditions to obtain 
comparative data to properly understand the potential capability of the vesicles 
to effect bacterial sequestration. Interestingly, the results (Figure 4-11) 
indicated that there was no significant difference of OD with (blue and green) 
and without vesicles (ÔcontrolÕ, black), but a fast decrease of bacterial OD 
could be observed in the presence of linear polymers (red). It is likely that 
some of the cell-binding hydrophilic functionality on the polymers would be 
trapped inside the particles if they were self-assembled into vesicles. This loss 
in binding ability may have caused the vesicles to be less effective sequestrants 
than the linear polymers. Alternative explanation was that, compared to linear 
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polymers, the contact area of vesicles and bacterial cells, both of which were 
ball-like round shape, allowed the formation of free spaces and therefore the 
inaccessibility of some binding sites of bacteria to polymersome-bound ligands.  
 
Figure 4-11. OD (600 nm) as a function of time in the absence and presence of 
polymers, only linear polymer (red) showed significant difference from the 
ÔcontrolÕ (black); b) %Ag as a function of time.  
 
4.2.7 MM32 assay 
In order to understand better the interaction mechanisms between investigated 
vesicles and bacterial cells, the bioluminescence assay was considered as the 
best candidate assay. This was because as already discussed in Chapter 3 the 
action of investigated synthetic polymers to bacterial QS network was well 
characterized. For the bacterial MM32 assay with Vesicle 1a, in order to get 
sufficient comparison profiles to linear polymers, each protocol (protocol 2-4) 
was employed at least once. Light production and optical density (600 nm) 
were recorded at 30 ¡C every 30 minutes for at least 6 hours in a 96-well plate, 
and each experiment was carried out in triplicate and the plotted curves were 
derived from the mean value (Figure 4-12). Again, the timeframe for the 
reported analysis was restricted to 4-10 h, for it was demonstrated that 
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significant differences in OD between those cultures in the presence and 
absence of polymers were observed with increasing time (after about 8h). 
Figure 4-12 showed one example of light production curves and OD (600 nm) 
as a function of time for V. harveyi MM32 in the absence and presence of 
Vesicle 1a following protocol 4. This result was compared with that reported 
in Figure 3-41 for Polymer 2b. It seems that when the diol concentration of 
Vesicle 1a reached 4.01×10
-4
 M, complete quenching of bioluminescence 
could already be observed, while in similar diol concentrations (3.6×10
-4
 M) 
Polymer 2b was not as potent in reducing light production. The behavior of the 
vesicles also differed from that of PVA (Figure 3-42), for Vesicle 1a not only 
had higher activity to decrease bioluminescence at earlier time points but also 
increased light production at intermediate time periods in a manner similar to 
the dual-action polymers described in Chapter 3. The block copolymers were 
able to aggregate bacteria as well as remove DPD, thus interfering in the cell 
signaling pathways by both a Ôcell-bindingÕ and a ÔQS-quenchingÕ mechanism. 
Again, both mechanisms should also be considered to understand interactions 
between vesicles and bacterial biological activities. It was demonstrated that 
vesicles did not aggregate bacterial cells to the same extent as analogue linear 
polymers. On the other hand, the diol-functionality present at vesicle surfaces 
could bind DPD molecules via the same functionality (p(L-DMAm)) as the 
linear polymers. Thus the vesicles might bind with similar affinity for boron as 
that of Polymer 2, but to a lower saturation limit because 50% of diols should 
be on the inner wall of the vesicles. Obviously, such change simplifies the 
result profile of MM32 assays if we compare the two figures (Figure 3-41 and 
Figure 4-12). For the binding activity of vesicles to boron species to be the 
  209
predominant effect, the dose-dependent reduction of bioluminescence was 
observed and only at low concentration of vesicles was an enhanced light 
production achieved. Also, the bacterial cells grew differently with a dose-
dependent profile (Figure 4-12, right). It should also be noted that vesicles in 
the sub-nm size range could also scatter light and interfere with OD readings.  
 
Figure 4-12. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of Vesicle 1a. (protocol 4) 
 
The results of repeat assays for MM32 with Vesicle 1a following different 
protocols and with a variety of diol-concentrations were compared in order to 
have sufficient data to determine the final assay conditions, from which similar 
overall trends at each testing time point could be observed (Figure 4-13). In 
this case, the following assays were carried out using protocol 4 and testing at 
least seven appropriate diol-concentrations for each vesicle (Figure 4-13, c), so 
that both the dose-dependent light reduction and the quenching trends were 
obtained in one experimental run. Obviously, the specific diol-concentration 
range for different vesicle types varied and pre-experiments were necessarily 
performed. 
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Figure 4-13. Effect of diol concentration in light production of Vesicle 1a a) 
with protocol 2, b) with protocol 4, c) 7 concentrations of vesicles with 
protocol 4, d) with protocol 3 and e) higher concentrations of vesicles with 
protocol 3  
 
Following the protocol 4 determined for this assay, Vesicle 1 was compared 
with Vesicle 2 (Figure 4-14). Similar results for both light production and OD 
(600 nm) as a function of time were observed for Vesicle 2 compared to those 
of Vesicle 1. However, if the effect of diol concentration on light production is 
considered at certain testing times, for example at 4 h which was believed to be 
the onset of light production, it can be seen that Vesicle 2 quenched the 
bioluminescence at a lower diol-concentration (0.09 mM) (Figure 4-14, 
bottom) than that of Vesicle 1a (0.4 mM) (Figure 4-13, c). Such MM32 results 
were in accord with those presented for the aggregation assay. Thus, according 
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to Figure 4-11, Vesicle 2 exhibited low binding affinity to bacterial cells 
compared to Vesicle 1a. As these polymers and the corresponding vesicles 
were believed to function in both  ÒQS-quenchingÓ and Òcell-bindingÓ modes 
of action, Vesicle 2 with lower potency of cell binding was therefore 
anticipated to show greater QS-quenching. However, subsequent assay results 
discussed below suggest that the formation of vesicles rather than the linear 
forms in some way acts, such that the vesicle form could quench the QS 
network more effectively.  
  212
 
Figure 4-14. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Vesicle 2. 
Bottom: Effect of diol concentration in light production. (protocol 4) 
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In order to understand the mechanism better, linear Polymer 4 p(4-AmBA)27 
was introduced in this assay, due to its expected lower boron-binding affinity 
provided by carboxyl groups compared to catechols. The results of MM32 
assay for Polymer 4 indicated that bioluminescence change as a function of 
time could be observed in the presence of analogous diol-concentrations of 
Polymer 4 (Figure 4-15). The trends of effect of diol concentration in light 
production were similar to those obtained with p(L-DMAm) homopolymers 
(Polymer 2) (Figure 3-25 and 3-26), which suggested that Polymer 4 also had 
dual-functionality though with low binding affinity for both boron and 
bacterial cells. Therefore, we assumed that if Vesicle 3 prepared from p(4-
AmBA)-b-p(PAm) was found to have a stronger ability to quench QS than its 
corresponding linear Polymer 4 or even catechol-pendent linear polymers 
(Polymer 1-3) in MM32 assays, it suggested that the morphology of vesicles 
enhanced their binding affinity for boron, and such an effect, together with 
their decreased binding affinity for cells, reduced light output significantly. In 
fact, the experimental results demonstrated this assumption was correct (Figure 
4-16 to Figure 4-17). The relative bioluminescence decreased approximately 
40% in the presence of Vesicle 3 (4-AmBA/PAm monomer ratio: 16 : 42, a 
and 27 : 90, b) with carboxyl acid concentration around 0.3 mM, while in the 
presence of Polymer 1b and 2b with similar diol-concentrations of 0.26 and 
0.36 mM it did not decrease to below 60% throughout the experiment (Figure 
3-43). This suggested that the formation of vesicles significantly enhanced 
polymerÕs binding affinity for boron and could quench bioluminescence of V. 
harveyi MM32 with relatively low concentrations compared to linear polymers 
investigated in Chapter 3. 
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Figure 4-15. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Polymer 4. 
Bottom: Effect of diol concentration in light production. (protocol 4) 
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Figure 4-16. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Vesicle 3a. 
Bottom: Effect of diol concentration in light production. (protocol 4) 
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Figure 4-17. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Vesicle 3b. 
Bottom: Effect of diol concentration in light production. (protocol 4) 
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Additionally commercial available lipid 1,2-dioleoyl-sn-glycero-3-phospho-
rac-(1-glycerol) sodium salt (DOPG) able to form Vesicle L1 was also of our 
interest due to the proposed effect of diol functionality on interfering with  
bacterial cell activities. As expected, the light output was completely quenched 
with diol concentration of 0.3 mM close to that of Vesicle 1a (Figure 4-18). 
However, Vesicle L2 self-assembled from 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) lacking of diol functionality but amine groups instead 
also gave comparative ability for quenching MM32 light production (Figure 4-
19). In this case, these assays performed with a linear amine-pendent polymer 
Polymer 5 - p(DMAPMAm)100 was selected as ÔcontrolÕ polymer (Figure 4-
20). The amine functionality was demonstrated to contribute to aggregate 
bacterial cells owing to its positively charge (Figure 3-18) at neutral pH and 
also have relatively low binding affinity for boron (Figure 3-8). The results of 
MM32 assay for Polymer 5 was in accord with the above results that no 
reduction of light production was observed throughout the testing time, for the 
Ôcell-bindingÕ effect was predominant rather than ÔQS-quenchingÕ. In 
conclusion, all the above assay results suggest that the formation of vesicles 
significantly changed the effect of dual-action of linear materials (polymers 
and lipids) on interacting with bacterial system via increasing their affinity to 
boron while at the same time decreasing their affinity to cells. 
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Figure 4-18. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Vesicle L1. 
Bottom: Effect of diol concentration in light production. (protocol 4) 
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Figure 4-19. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Vesicle L2. 
Bottom: Effect of diol concentration in light production. (protocol 4) 
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Figure 4-20. Light production curves and OD (600 nm), as a function of time for V. harveyi MM32 in the absence and presence of Polymer 5. 
Bottom: Effect of diol concentration in light production. (protocol 4) 
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4.2.8 DPD release assay 
For the second goal of this PhD project it was of interest to develop concepts in 
artificial cellularity and explore potential Ôcross talkÕ between bacterial cells 
and polymersomes. In particular, self-assembled copolymers with surface diol 
functionality were designed to bind QS signals but were also considered to be 
capable of encapsulating and releasing QS signal precursors or metabolites. 
Such polymersomes could in such a case exhibit partial biomimicry of QS 
communication systems, such as detecting and responding/binding to bacterial 
signal molecules as well as binding microbial cells. In order to function as 
artificial protocells with QS signaling networks, the polymersomes should 
ideally also have their own metabolism and be able to transfer the metabolic 
information between polymersomes and cells. However, before incorporating a 
Ômetabolic systemÕ, first it was necessary to investigate whether a known 
bacterial metabolic product could be encapsulated in the polymersomes. 
Therefore, the AI-2 precursor DPD was an obvious choice to be considered for 
inclusion into vesicle compartments and subsequent release. Although such a 
system is clearly an oversimplification of a protocell due to the lack of a true 
metabolism, it can nevertheless be considered that if the polymersomes could 
encapsulate and release their own signal precursor (DPD), and at the same time 
detect and respond to the active form of signal, ie. the product of DPD borate 
ester, AI-2, the first ÔwordsÕ in the cross-talk experiment between protocells 
(Chells) and bacterial cells might be achieved (Figure 4-21). 
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Figure 4-21. Scheme of mechanism of DPD loaded polymersomes interacting 
with real V. harveyi cells in the way of releasing DPD and reversibly binding 
AI-2 molecules in the media.  
 
Initial experiments concentrated on the encapsulation process for DPD into the 
vesicle compartments, for there were a number of difficulties in optimizing the 
preparative system. Commercially available DPD is stored as a water solution 
at a concentration of 3.7 mM to maintain its activity. To increase the amount of 
DPD in the vesicles was therefore a challenge, since the highest DPD 
concentration without solvent evaporation was thus limited to 3.7 mM, while 
the optimized copolymer concentration for preparing vesicles was 
demonstrated to be 5.0 mg/mL. In addition, the aqueous phase for preparing 
the best vesicles was composed of HEPES buffer and sodium chloride solution. 
To retain the same buffer composition, the commercial DPD solution and stock 
vesicle buffer were therefore mixed with the appropriate ratio to reach the 
same salt concentrations as that used for making blank vesicles, however this 
resulted in unacceptably low incorporation of DPD. Therefore, an alternative 
approach by using the commercial DPD solution as the aqueous phase instead 
of buffers was also attempted. Following the vesicle preparation procedure, the 
organic solvent used to dissolve copolymers was evaporated under stirring in a 
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cold room to avoid DPD inactivation. The resulting solution was purified by 
PD-10 column twice in order to remove free DPD and in the mean time 
minimize the inevitable dilution of vesicles. Disposable short PD-10 columns 
were used to separate free DPD away from vesicle-bound DPD, which resulted 
in less dilution of vesicles compared to separations on Sephadex G50 columns 
and also reduced vesicle leakage (4.2.4). Samples of vesicles containing DPD 
were therefore purified immediately before the microbial bioluminescence 
assays. 
The assays to evaluate DPD release from vesicles and any effects on 
bioluminescence were performed using three different experimental protocols. 
Assay-1: empty/blank vesicles at different polymer concentrations were tested 
in the MM32 bioluminescence assay as discussed before, but with a 
concentration of DPD in the extra-vesicular media (i.e. assay media) of 0.1 µM.  
Assay-2: DPD-loaded vesicles were incubated with the bacteria under the same 
conditions as the empty vesicles in Assay-1.  
Assay-3: DPD-loaded vesicles were incubated with the bacteria in an assay 
buffer containing no exogenous DPD; thus the only DPD source in the assay 
was that released from the vesicles compared to Assay-2.  
It should be noted that the DPD concentration (0.1 µM) in the assay media for 
Assay-1 was much lower than that employed in the experiments described 
earlier in this thesis (20 µM). This was because preliminary results showed that 
the maximum bioluminescence obtained in experiments with vesicle-
encapsulated DPD without exogenous DPD in the media was much smaller 
than that obtained in the prior experiments (i.e. those with an added DPD 
concentration of 20 µM). This was anticipated since prior experiments showed 
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that the maximum bioluminescence was related to DPD concentrations in the 
media (Figure 3-21 and Figure 3-22), although it should be noted that the data 
could have been skewed by surface-bound DPD on the vesicles. Therefore, by 
having a low amount of residual DPD in the media in Assays 1 and 2, the 
hypothesis was that the bacteria would be ÔprimedÕ by the 0.1 µM DPD, but 
would respond much more predictably to any further release from inside the 
vesicles, where the 3.7mM concentration of DPD was large enough even on 
dilution to activate further the MM32.  Specifically, it was assumed that DPD-
loaded vesicles would behave differently from their non-loaded vesicle 
counterparts even in the presence of 0.1 µM DPD in the media. 
In all the DPD release systems, the activation of MM32 light production was to 
be expected (Figure 4-22 and Figure 4-23), however, since the vesicles were 
able to bind AI-2 i.e. the borate ester of DPD, but not DPD itself, a time 
dependent variation of bioluminescence was observed. Specifically, according 
to the prior results of MM32 assay, the onset of light production was 4 h with 
exogenous DPD in the media. However, in the absence of exogenous DPD but 
with DPD loaded vesicles in the media, the light onset was delayed to 
approximate 6 h (Figure 4-22 and Figure 4-23, a). This may have been because 
the initial release of DPD did not cause light production because the bacteria 
needed some time to sense the signals and thus the MM32 cells did not 
produce light until AI-2 molecules accumulated to a threshold concentration. In 
the DPD release system, the DPD concentration increased with time, and thus 
the AI-2 formation rates were expected to be different compared to those with 
constant DPD concentrations. It was assumed that a proportion of AI-2 signal 
molecules could diffuse to reach the bacteria, but the majority of AI-2 might be 
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immediately sequestered by the vesicle diol groups. This process could 
continue until vesicle diol groups became saturated with bound AI-2, at which 
point further DPD release would activate MM32 until the threshold AI-2 
concentration was reached. Alternatively, the reversible binding of the vesicle 
diol groups to AI-2 molecules/boron might increase their local concentration 
around some of the bacteria, and therefore might cause some local response. 
On the other hand, according to the results (Figure 4-22 and Figure 4-23, a), in 
the absence of externally added DPD, only Vesicle 1a loaded with DPD caused 
bioluminescence, compared to control experiments where no investigated 
materials were added. These results were anticipated as the previous vesicle 
membrane permeability assays had shown that Vesicle 1a, with p(2-EHAm) as 
their hydrophobic blocks, were able to release their contents in diluted solution 
at pH 7.4. Vesicles prepared with p(PAm) as the hydrophobic chain had 
relatively stable and robust membrane structures. Although the reduction of 
light output was observed in the presence of empty/blank Vesicle 1a in MM32 
assays (Figure 4-13 and Figure 4-23, b) with exogenous DPD in the media 
which demonstrated the quenching ability of polymeric vesicles, the released 
DPD from DPD-loaded Vesicle 1a still triggered light production (Figure 4-22 
and Figure 4-23, a: 7h and 8h) without externally added DPD in the media. In 
contrast, no light production could be observed throughout the experiment in 
the presence of DPD-loaded Vesicle 2 and Vesicle 3a with robust membranes 
(Figure 4-22 and Figure 4-23, a), for the amount of DPD released from them 
were likely not sufficient to Ôswitch onÕ QS, especially in the presence of diol 
functionality on the vesicle surfaces.   
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In the presence of externally added DPD molecules (0.1 µM) in the media, the 
assay results showed that bioluminescence was completely quenched in all 
cases with blank vesicles (Figure 4-23, b). These results were in accord with 
those obtained previously with DPD concentrations of 20 µM. However, when 
the DPD-loaded vesicles were tested in the same conditions, more complex 
data patterns were observed (Figure 4-23, b). It was expected that similar 
trends should be observed to those obtained in Figure 4-23, a, for the 
bioluminescence of the control was fixed to be 100 % and light production in 
each assay was compared to that of the control. However, the assay results 
varied across experimental repeats, suggesting heterogeneity in the initial 
bacterial cultures for these assays. Future efforts should focus on synchronizing 
bacterial cultures in larger cell numbers, in addition to optimizing DPD 
encapsulation, vesicle purification and assay conditions in bioluminescence 
experiments.  
 
Figure 4-22. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of DPD loaded polymer 
vesicles in the media without exogenous DPD. 
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Figure 4-23. Effect of different DPD-loaded vesicles in the absence of DPD in 
assay media, a) and effect of different DPD-loaded vesicles, and non-loaded 
vesicles, in the presence of 0.1 µM DPD in assay media, b) 
 
This DPD release assay was also attempted with the vesicles self-assembled 
from commercial available lipids (Figure 4-24 and Figure 4-25) following the 
same protocols as mentioned above. It was demonstrated again that 
empty/blank Vesicle L1 and Vesicle L2 were able to quench light production 
of MM32 bacteria in proposed media (Figure 4-25, b), while release of DPD 
from the lipid vesicles was obtained during the testing duration as reported by 
the increased bioluminescence (Figure 4-24 and Figure 4-25). In order to 
understand better the activity of lipid vesicles compared to the polymersomes 
investigated in this study, membrane permeability assays for these lipidic 
systems should be carried out and further DPD release assays repeated under 
optimized conditions.  
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Figure 4-24. Light production curves and OD (600 nm), as a function of time 
for V. harveyi MM32 in the absence and presence of DPD loaded ligand 
vesicles in the media without exogenous DPD. 
 
Figure 4-25. Effect of different DPD loaded lipid vesicles in the absence of 
DPD in assay media, a) and effect of different DPD loaded lipid vesicles as 
well as their blank forms in the presence of 0.1 µM DPD in assay media, b) 
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4.3 Conclusions 
In this chapter, a series of amphiphilic block copolymers were successfully 
synthesized by using macro-diol-pendent polymers as chain transfer agent in 
RAFT polymerizations. All polymers were characterized by 1H-NMR and 
RAFT termini removed from polymers before each biological assay. The 
successfully prepared polymers were self-assembled into vesicles as 
characterized by DLS, TEM and zeta-potential analysis. The membrane 
permeability of vesicles was examined by testing release of encapsulated 
fluorescent dyes at neutral and alkaline pH via fluorescence spectrometry. The 
types of hydrophobic blocks were likely to have been contributing factors in 
the differing membrane permeabilities and vesicle stabilities. In order to test 
cell sequestration activity of the polymersomes, bacterial attachment assays 
were performed in AB-media at pH 7.4 with both vesicles and their 
corresponding diol-pendent linear polymers. In this case, designed vesicles 
were demonstrated to induce bacterial aggregation to a lesser extent than linear 
polymer analogues. The binding affinities for boric acid of the reported 
vesicles were not accessible by the AR-S assay because of the limitations of 
binding saturation and light scattering from the vesicles. Therefore, the 
research was moved to the in-vitro assays. 
In all cases, catechol-, carboxyl acid- and amine-pendent polymeric vesicles, as 
well as vesicles self-assembled from commercial available lipids, were 
demonstrated to reduce light production of V. harveyi bacteria in a dose-
dependent manner and even with higher potency than that of linear polymers. 
Also, these vesicles did not damage the cells as judged by continuing growth in 
optical density measurements.  
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In order to approach an extended aim of this project to establish artificial 
cellularity and Ôcross talkÕ with bacterial cells by using V. harveyi species 
MM32 as a model, DPD was selected as a QS mediator to be encapsulated in 
vesicle compartments. The DPD release assay gave some promising results as 
anticipated. However, there remain difficulties in repeating the experiments 
and so complete understanding of the interaction mechanisms is not possible at 
this stage. The light producing process was more complicated with DPD-
loaded vesicles than that with polymers/blank vesicles. There was insufficient 
time in the thesis period to conclude the experiments to probe release rates and 
bioluminescence profiles, but future work should consider simulations of rate 
equations computationally. 
In conclusion, vesicles with functionalities capable of binding QS signals have 
shown high potency in deactivating population bioluminescence responses, but 
low affinities to cell surfaces. Such vesicles are potentially useful as 
diagnostics and anti-microbials, while further work to control binding and 
release of contents from the vesicle interiors may allow their use as 
information carriers in synthetic biology studies. 
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Chapter 5. Conclusions and Future Work 
5.1 Conclusions 
Within this thesis two related concepts have been considered. The first 
concerns a possible new strategy for anti-infective drugs as it is known that 
existing antimicrobial agents including antibiotics, oxidants and biocides can 
act as a powerful selective force for promoting the emergence of resistant 
mutations in a population.[1] Although tremendous efforts have been made on 
prevention of resistance emergence and also management of its frequency as 
two pathways to treat bacterial infection,[1b] the selection pressure and 
resistance invoked by antimicrobial use still restrict curative effects against 
bacteria. The development of ÔintelligentÕ anti-infective materials via strategies 
that target bacterial communication is a potential means to avoid selection 
pressure. Therefore, the strategies in this research were: 1) interference with 
the bacterial communication system Quorum Sense (QS) network, which can 
be linked to bacterial virulence and biofilm formation,[2] and 2) prevention of 
bacterial-host adhesion, to prevent colonization[3] and subsequent formation of 
resistant biofilms.[4] The understanding of each individual mechanism within 
these strategies has been developed over several decades, but at the start of this 
thesis no research groups had previously reported materials with potential to 
interfere with both routes. 
Synthetic polymers were used for the interference strategy because they 
possess repeating structural units and their affinities with cell surface receptors 
can be tailored through multivalent ligand attachment. Also, the affinities of 
polymer-displayed receptors with both bacterial QS signals and host cell 
surfaces, the ability to solubilize these receptors at neutral pH through 
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attachment to a water soluble polymer, and the potential tuning of surface 
charge, morphology and self-assembly of polymers in solution were all 
advantageous factors for anti-infective strategies. Furthermore, the use of 
reversible addition-fragmentation chain transfer (RAFT) radical 
polymerization methods allowed fine control of macromolecular structure and 
architecture. This in turn enabled extension of the strategy into the synthesis of 
block copolymers with both hydrophilic and hydrophobic components to form 
polymersomes, potentially able to act both as containers for QS molecules, and 
sequestrants for QS signals.  
These polymersomes were intended as simple protocell mimics for QS 
interference, as it is difficult to contain all the key characters[5] of living cells in 
a single synthetic cell model. Micelles or vesicles have already been used in 
antimicrobial strategies, as they have been shown to be more efficient in 
disintegrating cell walls compared with individual molecules.[6] Accordingly, 
the thesis investigated the protocell concept combined with dual-action (ÔQS 
quenchingÕ and Ôbacterial sequestrationÕ) with a view to generating Ôdual-
actionÕ bacterial interference agents. Specifically, the polymersomes 
investigated here were designed to maintain the dual advantages of the linear 
polymers, while at the same time enhance their potency for antibacterial 
therapy by releasing encapsulated QS-mediators to disrupt the QS 
communication system. In such a way, a feedback/communication/interference 
loop between the real bacterial cells and the investigated polymersomes was to 
be established. Ultimately, the polymersomes were intended to respond to the 
QS signals as well as mimicking the behavior of the bacterial cell surfaces via 
binding (aggregation). 
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The project started by screening small molecules as monomer candidates with 
strong potency to interfere with bacterial communication. QS systems based on 
the active form of AI-2 signaling were chosen as these derive from furanosyl 
borate diester produced from 4,5-dihydroxy-2,3-pentanedione (DPD) and 
borate in marine environments. Representative diols were investigated as 
potential AI-2 scavengers, using an assay involving reversible ester formation 
with boric and boronic acids and Alizarin Red S (AR-S).[7] Binding affinities 
with diol species were examined by titration studies at pH 7.4 using the AR-S 
assay and evaluated using the Benesi-Hildebrand equations.[7] The relative 
order of binding affinities for different diols towards boron species were in 
accord with prior reports: linear diols < cyclic diols (sugars) < aromatic diols 
or catechols.[7-8] Even though DPD has a similar structure to carbohydrates, its 
affinity was much higher than that obtained for the other saccharides analyzed, 
and only the catechols gave comparable affinities. These observations were 
confirmed by mass spectrometry and 11B-NMR spectroscopy. 11B-NMR 
technique confirmed the presence of 1:1 and 1:2 complexes between boric acid 
and dopamine or 3,4-dihydroxy-L-phenylalanine methacrylamide (L-DOPA) 
depending on the ratio of sodium borate to catechols in solution. The 
competitive binding of the catechol molecules to quench the ÔactiveÕ AI-2 was 
also observed in the 11B-NMR spectrum, in which the addition of catechols 
completely suppressed the AI-2 signals while generating new signals assigned 
to catechol-boron complexes. These experiments suggested that monomers 
derived from dopamine and its derivative L-DOPA were the best candidates for 
polymeric QS control, showing a similar affinity for boron compared to DPD 
and the potential ability to decrease the concentration of AI-2 in solution.  
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Three types of polymers with diol structures to quench QS signals and 
functionality to mediate cell attachment were studied. First of all, a cationic 
statistical copolymer, poly{N-(3,4-dihydroxyphenethyl)methacrylamide -co-N-
[3-(dimethylamino)propyl] methacrylamide} (p(DMAm-c-DMAPMAm), 
Polymer 1) was prepared via RAFT polymerization. N-(3,4-
dihydroxyphenethyl)methacrylamide (DMAm) was synthesized[9] to give the 
polymer high affinity to boron, while N-[3-(dimethylamino)propyl] 
methacrylamide (DMAPMAm) was designed to confer water-solubility in 
neutral solution and also possess a positive charge to bind strongly to 
negatively charged bacterial surfaces.[10] Also, L-DOPA monomer was 
synthesized[9] and an anionic homopolymer poly(3,4-dihydroxy-L-
phenylalanine methacrylamide) (p(L-DMAm), Polymer 2) was also produced 
via RAFT polymerization. For this material, L-DOPA showed similar affinities 
for boron but improved water solubility for its homopolymer compared to 
p(DMAm) in neutral pH, and was expected to attach to the bacterial surfaces 
less readily because of charge-charge repulsion. Subsequently, p(DMAm-c-
DMAPMAm) and p(L-DMAm) with varying degrees of polymerization (DP) 
were successfully synthesized and characterized. In addition, carbohydrate-
based poly(β-D-glucosyloxyethyl methacrylate) (p(GlcEMA), Polymer 3), 
previously prepared in the group, was also evaluated in dual-action 
experiments, for its highly active bacterial sequestration ability,[11] but low 
affinity for boron had been demonstrated in prior AR-S assay. The binding 
affinities of the polymers on boronates were also established by AR-S assay 
and confirmed by 11B-NMR spectra. In all cases, polymers exhibited higher 
affinities to boron species than their corresponding monomer analogues. In 
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order to test cell sequestration function of the polymers, bacterial attachment 
assays were performed in both AB-media and PBS buffer at pH 7.4. All the 
data suggested that the tested polymers displayed dual-action in terms of AI-2 
binding and cell attachment, though to varying extents.  
Assays with Vibrio harveyi MM32, which is bioluminescent with active QS 
signaling, were performed in different conditions (batch of cells, protocols and 
batch of DPD), showed that the trends of light output in the presence of each 
individual polymer were constant in all the experiments. Significantly, this 
range of polymers was able to maintain bacterial capture and suppression of 
QS signaling without damaging the cells as judged by continuing growth in 
optical density (OD) measurements.  
 
Structures of dual-action polymers: 
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DMAm : DMAPMAm a: n = 15; b: n = 26 n = 16 
a: 14 : 86; b: 29 : 71   
 
The studies progressed to develop a more complex system in which simple 
cell-mimic polymersomes were evaluated in the presence of bacterial cells. A 
series of amphiphilic block copolymers with various DPs were successfully 
synthesized via RAFT polymerization process and characterized by 1H-NMR. 
Successfully assembled polymersomes were characterized by DLS, TEM, 
AFM and zeta-potential analysis. However, the dispersities of the prepared 
  238
particles were broad and spherical micelles as well as polymeric vesicles 
probably coexisted in the mixtures. The membrane permeability of vesicles 
was examined by encapsulating and releasing fluorescent dyes (model dye: 
5(6)-carboxyfluorescein and pyranine) at neutral and alkaline pH. The type of 
hydrophobic blocks was found to be important in determining membrane 
permeability and stability. Specifically, the dye release of polymersomes with 
PAm in their membrane structures was observed to be slower than those with 
2-EHAm. Again, to examine cell sequestration activity of the polymersomes, 
bacterial attachment assays were performed in AB-media at pH 7.4 with both 
vesicles and their corresponding diol-pendent linear polymers. The 
polymersomes were demonstrated to induce less bacterial aggregation than 
their linear polymer counterparts. 
 
Structures of copolymers with dual-action: 
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n = 13, m = 93 (Vesicle 2) 
 
 
In all cases, catechol-, carboxyl acid- and amine-pendent polymeric vesicles 
were demonstrated to reduce light production of V. harveyi bacteria in a dose-
dependent manner and with higher potency than that of corresponding linear 
polymers. In addition, vesicles self-assembled from commercially available 
hydroxyl-containing lipids also suppressed bioluminescence. As with the linear 
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polymers, no damage to bacterial cells, as judged by continuing growth in OD 
measurements, occurred in the bioluminescence assays.  
At the last stage, in attempts to Ôcross talkÕ with the V. harveyi MM32 strain, 
DPD was selected as a QS mediator and encapsulated in vesicle compartments. 
The DPD release assay indicated variations in bioluminescence but it was not 
possible to establish whether an equilibrium was established between DPD 
release, sequestration and QS interference. 
In summation, polymersomes with functionality for binding QS signals with 
high potency but with low affinities for cell surfaces were demonstrated. Such 
vesicles are not only potentially powerful diagnostics and anti-microbials, but 
might, if optimized for controlled release, act as information carriers and 
synthetic cell mimics.  
 
5.2 Future work 
Although the development of polymersomes with dual-action on bacterial 
infective behaviors seems promising to date, the study of establishing synthetic 
protocells is still on its early stage. First of all, the DPD loading content (LC) 
(Eq. 1) and loading efficiency (LE) (Eq. 2) for investigated polymersomes and 
also vesicles made from commercial lipids have not been quantified in this 
research thesis. In Eq. 1 and Eq. 2, where Wload represents weigh of loaded 
cargo, Wcarrier is the weight of polymer/lipid and Wfeed means weight of cargo in 
feed. 
Equation 1 Equation 2 
LC(wt%) =
W
load
W
carrier
!100%  LE(%) =
Wload
W feed
!100%  
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Obviously, this is one of the key issues to solve in the future. However, there 
are some difficulties in evaluating LC and LE of investigated polymersomes 
encapsulating with DPD molecules. DPD exists with tautomeric forms and 
binds boron to form boronate ester in solution. So, it is difficult to conjugate 
DPD with chromophores which give a readout way to evaluate the amount of 
DPD inside the polymersomes. Therefore, some efforts need to be made on 
investigation of the synthesis of chromophore labeled DPD molecules. An 
alternative approach might use model dyes instead of DPD itself in 
encapsulation and release experiments, which would be a roughly evaluation. 
However, according to some preliminary results (data not shown in this thesis) 
that LC and LE of p(L-DMAm)-p(PAm) polymersomes with pyranine were 
very low, it is necessary to improve the copolymer structures based on the 
specific membrane properties needed. Optimizing the RAFT polymerization 
conditions (CTA, solvents, temperature and pH environment) and vesicle 
preparation techniques might allow improvements in particle size, 
encapsulation efficiency and in vitro release.[12]  
Future work in the area of cell mimicry might envisage artificial metabolisms, 
in which synthetic polymersomes act as microreactors to generate metabolites 
(e.g. QS products) that could be released across the bilayer membrane to the 
external environment in a controlled manner. Collaborators in the Davis group 
at Oxford have shown that DPD derivatives can be produced by the formose 
reaction within vesicles made from commercial available lipids. When these 
are released from the compartments light output is induced from V. harveyi.[13] 
Functional polymersomes with the ability to enclose the formose reaction and 
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release the sugar products in a controlled manner are an ongoing investigation. 
These might not only contribute to antibacterial therapeutic studies, but also be 
a large step towards construction of a wholly synthetic biologic entity. 
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Appendix 
Materials 
All solvents and reagents were of analytical or HPLC grade and purchased 
from Sigma or Fisher Scientific without further purification unless otherwise 
stated. We thank Bonnie Bassler (Department of Molecular Biology, Princeton 
University) for the gift of Vibrio harveyi strain MM32.  
 
Supplier and purity detail of chemicals 
 Acetonitrile - Sigma Aldrich 
 Acryloyl chloride (96%) - Alfa Aesar 
 Alizarin Red S (AR-S, indicator) - Riedel-deHan 
 Amberlite IRA743 free base - Sigma Aldrich 
 Ammonium hydroxide (28% NH3 in H2O) - Sigma Aldrich 
 Azobisisobutyronitrile (2,2Õ-azobis(2-methylpropionitrile), AIBN, 98%) - 
Sigma Aldrich 
 Benzyl 2-hydroxyethyl carbonotrithioate (CTA 2 in Chapter 3) - 
synthesized by Francisco Fernandez-Trillo, School of Pharmacy, the 
University of Nottingham 
 Carbon disulfide (anhydrous, ≥ 99%) - Sigma Aldrich 
 Casamino acids - Acros Organics 
 Cesium carbonate (≥ 99%) - Fluka 
 Dopamine hydrochloride (99%) - Alfa Aesar 
 Dulbecco phosphate buffer saline (PBS, 10X without Ca2+ and Mg2+) - 
Lonza 
 Glycerol (for molecular biology, ≥ 99%) - Sigma Aldrich 
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 Hydrochloric acid (ACS reagent, 37%) - Sigma Aldrich 
 L-arginine (reagent grade, ≥ 98% (TLC), powder) - Sigma Aldrich  
 LB media with kanamycin (antibiotic, 30 g/mL) - prepared by Nigel 
Halliday, School of Molecular Medical Science, Centre for Biomolecular 
Sciences, the University of Nottingham 
 Magnesium sulfate (anhydrous, ≥99.5%) - Sigma Aldrich 
 Methacrylic anhydride - Sigma Aldrich 
 Methacryloyl chloride (≥97%) - Fluka 
 Nitric acid (70%) - Sigma Aldrich 
 N-[3-(dimethylamino)propyl]-methacrylamide (99%) - Sigma Aldrich  
 Phenylboronic acid (≥ 97%) - Fluka 
 Poly(β-D-glucosyloxyethyl methacrylate) (p(GlcEMA)) - synthesized by 
George Pasparakis, School of Pharmacy, the University of Nottingham 
 Phloroglucinol (99%, anhydrous) - Acros Organics 
 Poly(N-phenylacrylamide) - synthesized by Francisco Fernandez-Trillo, 
School of Pharmacy, the University of Nottingham 
 Poly(vinyl alcohol) (PVA, 87-89% hydrolyzed, Mw 13000-23000) - Sigma 
Aldrich 
 Potassium hydroxide (Na < 0.002%, ≥ 86%) - Fluka 
 Potassium phosphate tribasic (≥ 98%) - Sigma Aldrich 
 Pyranine - Sigma Aldrich 
 Sephadex G50 - (dry bead diameter: 20-80 µm, bed volum 9-11 mL/g) - 
Sigma Aldrich 
 Silica 60 (particle size 35-70 micron, chromatography grade) - Fisher 
Scientific 
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 Sodium bicarbonate (for molecular biology, 99.7%-100.3%) - Sigma 
Aldrich 
 Sodium borate - Sigma Aldrich 
 Sodium carbonate (≥99.0%, anhydrous) - Sigma Aldrich 
 Sodium chloride - Fisher Scientific 
 Sodium hydroxide (≥98%) - Sigma Aldrich 
 Sodium phosphate monobasic (≥ 99%) - Sigma Aldrich 
 Spectra/Por dialysis membrane (MWCO: 1000, 6000-8000) - Spectrum 
Laboratories, Inc. 
 (S)-4,5-dihydroxy-2,3-pentadione-(DPD) - Ommscientific or synthesized by 
Paul M. Gardner, Department of Chemistry, University of Oxford, 
Chemistry Research Laboratory 
 Triton X-100, toctylhenoxypolyethoxyethanol - Sigma Aldrich 
 V-501 (recrystallized from MeOH) - Fluka 
 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) - Fisher Scientific 
 1,2-dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt (DOPG) - 
Fisher Scientific 
 2-amino-1,3-propanediol (98%) - Alfa Aesar 
 2-bromoisobutyric acid - Alfa Aesar  
 2-(decylthiocarbonothioylthio)-2-methylpropanoic acid (CTA 3 in Chapter 
3) - synthesized by Francisco Fernandez-Trillo, School of Pharmacy, the 
University of Nottingham 
 2-ethylhexan-1-amine - Alfa Aesar 
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 2-(ethylthiocarbonothioylthio)-2-methylpropanoic acid (CTA 5 in Chpater 
3) - synthesized by Francisco Fernandez-Trillo, School of Pharmacy, the 
University of Nottingham 
 2-mercaptoethanol (≥ 99.0%) - Sigma Aldrich 
 2-methyl-1,3-propandiol (99%) - Sigma Aldrich 
 3,4-dihydroxyhydrozimtsure (98%) - Sigma Aldrich 
 3,4-dihydroxy-L-phenylalanine (≥ 98%) - Alfa Aesar 
 3-methoxy-1,2-propandiol (98%) - Sigma Aldrich 
 4-aminobutanoic acid (≥ 99%) - Acros Organics 
 4-cyano-4-(phenylcarbonothioylthio)pentanoic acid (CTP, CTA 4 in 
Chapter 3) - synthesized by Francisco Fernandez-Trillo, School of 
Pharmacy, the University of Nottingham 
 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES) (≥99.5%) - 
Sigma Aldrich 
 5(6)-carboxyfluorescein - Sigma Aldrich 
 
Instrumentation 
NMR Spectroscopy 
1H and 13C Nuclear magnetic resonance (NMR) spectra were recorded on a 
Bruker 400 MHz (1H) and 100 MHz (13C) spectrometers in DMSO-d6, D2O, 
chloroform-d or methanol-d. Chemical shifts are reported in ppm (δ units) 
relative to TMS.  
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Mass Spectroscopy 
Mass spectra (MS) (TOF-ESI) were recorded on a Waters 2795 separation 
module/micromass LCT platform, under positive scan mode (monomer 
characterization) or negative scan mode (binding analysis), with direct 
injection of the purified compounds. 
 
Infrared Spectroscopy (IR) 
IR spectrum of 3,4-dihydroxy-L-phenylamanine methacrylamide (L-DOPA 
methacrylamide, L-DMAm in Chapter 3) was recorded on KBr pellets on a 
Perkin Elmer Paragon 1000 FT-IR instrument. 
N-(2-Ethylhexyl) methacrylamide (2-EHMAm) (in Chapter 4) was dissolved 
in chloroform and spread on NaCl discs to remove the solvent. IR spectrum of 
the dry sample was recorded on a Perkin Elmer Paragon 1000 FT-IR 
instrument. 
 
Gel Permeation Chromatography (GPC) 
Aqueous GPC was performed on a Polymer Labs GPC50 Plus fitted with 
differential refractometer (RI), capillary viscometer (DP) and dual angle laser 
light-scattering (15¡ and 90¡) detectors. The eluent was DulbeccoÕs PBS 
without Ca2+ and Mg2+, at 30 ¡C and a flow rate of 1 mL/min. The instrument 
was fitted with a Polymer Labs aquagel-OH guard column (50 × 7.5 mm, 8 
µm) followed by a pair of PL aquagel-OH columns (30 and 40, 300 × 7.5 mm, 
8 µm). Calibration for detector response and inter-detector delays was achieved 
using a single, narrow PEO standard (Polymer Labs, Mp 128 kDa, [η] 1.2968 
dL/g) using a dn/dc value of 0.133 g/mL. 
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UV/Vis Spectroscopy 
UV/Vis spectroscopy was performed using a Bechman Coultier DU-800 UV 
spectrophotometer equipped with a temperature control. 
Specifically, aggregation experiments were performed in a Bechman DU 640 
UV spectrophotometer. 
 
Fluorescence Spectroscopy 
Fluorescence spectra were recorded on a Cary Eclipse fluorimeter equipped 
with a Peltier apparatus for temperature control. 
 
Dynamic Light Scattering (DLS) 
Dynamic Light Scattering (DLS) was measured using a Viscotec Model 802 
instrument equipped with an internal laser (825Ð832 nm) with a maximum 
radiation power of 60 mW. At least ten measurements of each sample were 
taken. The mean and standard deviation were calculated. Data processing was 
performed with the software program OmniSize2.  
 
Transmission Electron Microscopy (TEM) 
TEM samples were examined using a transmission electron microscope (TEM) 
(JEOL JEM 1010 electron microscope, Japan) with ITEM Olympus software. 
The accelerating voltage was 100.0 kV and magnification was x10K to x50K.  
Negative-stained TEM samples were prepared as following procedure. 
1. Suspend (coated) grid over edge of petri dish using forceps with locking 
ring, coated side up. 
2. Add one drop of concentrated particulate suspension to the grid. 
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3. Remove most of the suspension by wicking with filter-paper after 3mins. 
4. Add one drop of uranyl acetate (UA, 0.2-4.0% aqueous solution pH 4~5) to 
the grid coated with a formvar carbon film. 
5. Dry grid by wicking with filter-paper after 1 min. 
6. Slide fresh filter-paper between jaws of forceps to push dried grip (sample-
side up) onto a clean dry part of the filter paper in the bottom of a petri-dish. 
7. Let the grid dry for at least 15mins (we do overnight) before imaging on 
the TEM. 
 
Atomic Force Microscopy (AFM) 
AFM topography images and particle analysis of block copolymer vesicles 
were obtained in liquid at room temperature using a Multimode 8 Scanning 
Probe Microscopy station, operating in PeakForce Tappingª mode. Images 
were acquired using an E-scanner, at scan rates between 1-2 Hz. MgCl2 (10 
mM) solution was incubated with the freshly cleaved mica for 10 min, and then 
the mica was washed with distilled water several times and blown dry 
completely with nitrogen at room temperature.  
The samples used in AFM studies were prepared with the concentration of 1 
mg/mL in HEPES buffer (10 mM HEPES, 10mM NaCl, pH 7.4, filtered by 0.2 
µm syringe filter).  
The experiments were designed to assess the morphology and the size of block 
copolymer vesicles. The diameters of the block copolymer structures were 
determined by grain analysis. Image data were analysed using NanoScope 
Analysis software (Version 1.20 - Bruker). 
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Zeta Potential 
Zeta potential measurements of polymeric vesicles were performed by laser 
Doppler anemometry using a Malvern Zetasizer 2000 equipped with a 10 mW 
He-Ne laser operating at a wavelength of 633 nm. Measurements were 
performed at 25 ± 0.10 ¡C, on samples appropriately diluted with H2O. The 
mean value and standard deviation for each sample was calculated from at least 
three measurements. 
 
Tecan Microplate Reader 
Bioluminescence assays were performed using a Tecan Infinite 200 microplate 
reader. 
 
Optical Microscopy 
A Nikon optical microscope equipped with a camera connected to a personal 
computer was used for optical microscopy studies. 
 
Chromatography Fraction Collector 
An Amersham BioScience RediFrac chromatography fraction collector with a 
Pharmacia LKB Uvicord SII and a Pharmacia LKB Pump P-1 was used to 
remove boron from media for MM32 assay. 
 
Freeze Drier 
Water was removed by immersing reagent tubes containing the samples in 
liquid nitrogen, once frozen the samples were placed on an Edwards Modulyo 
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freeze drier equipped with an Edwards high vacuum pump and the water 
removed. 
 
Rotary Evaporator 
Solvent was evaporated under reduced pressure on a Buchi Rotavapor R-200 
equipped with a B490 heating bath. 
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Chapter 2 
One example of calculation of binding affinity for PBA-Dopamine 
a. Determination of binding constant (Ka1) of AR with PBA 
 
Figure A-1. Fluorescence profile of AR and phenylboronic acid (PBA) [AR]0 
= 0.009 mM, [PBA]0 = 2 mM. [PO4
-] = 100 mM 
Table A-1 Row data analysis 
 
 A B C D E F G H 
 PBA 
mM 
I  
(572) 
I  
(592) 
I  
(Av573-614) 
ΔI  
(572) 
ΔI  
(592) 
ΔI  
(Av573-614) 
eq per 
AR 
9 2.000 138.5773 148.4355 142.3242 45.1307 48.1032 45.2885 222.7171 
8 1.800 136.9506 141.7629 139.0949 43.5039 41.4306 42.0592 200.4454 
7 1.620 131.8352 138.1750 134.9886 38.3885 37.8427 37.9529 180.4009 
6 1.458 126.7838 135.1427 130.0652 33.3372 34.8105 33.0296 162.3608 
5 1.312 121.2769 129.8374 124.7907 27.8303 29.5051 27.7550 146.1247 
4 1.181 116.0158 122.2126 118.7287 22.5691 21.8803 21.6930 131.5122 
3 1.063 108.7451 115.8925 112.6737 15.2984 15.5602 15.6380 118.3610 
2 0.957 104.4109 111.2752 107.2686 10.9643 10.9429 10.2329 106.5249 
1 0.861 99.5566 106.0199 102.7327 6.1100 5.6876 5.6970 95.8724 
0 0.775 93.4466 100.3323 97.0357 0.0000 0.0000 0.0000 86.2852 
 
 
 
Equation 1. Equation 2. 
!I = I " I
0
 eq perAR( ) =
[Boron]
[AR]
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Table A-2 Analyzed data 
 
 A B C D 
 
1/[Boron] (M) 
1/ΔI  
(572) 
1/ΔI  
(592) 
1/ΔI  
(Av573-614) 
9 500.0000 0.0222 0.0208 0.0221 
8 555.5556 0.0230 0.0241 0.0238 
7 617.2840 0.0260 0.0264 0.0263 
6 685.8711 0.0300 0.0287 0.0303 
5 762.0790 0.0359 0.0339 0.0360 
4 846.7544 0.0443 0.0457 0.0461 
3 940.8382 0.0654 0.0643 0.0639 
2 1045.3758 0.0912 0.0914 0.0977 
1 1161.5287 0.1637 0.1758 0.1755 
0 1290.5874 0.0000 0.0000 0.0000 
 
Equation 3. 
1
!I
=
1
!k " p
0
"[AR]
0
"Ka1
"
1
[Boron]
+
1
!k " p
0
"[AR]
0
 
y =
1
!I
; x =
1
[Boron]
; 
a =
1
!k " p
0
"[AR]
0
;
1
!k " p
0
"[AR]
0
"Ka1
= a "
1
Ka1
 
y = a !
1
K
a1
! x + a  
 
 
Figure A-2. The corresponding fitting plots of AR and phenylboronic acid 
(PBA) [AR]0 = 0.009 mM, [PBA]0 = 2 mM, [PO4
-] = 100 mM Ka1
 
(PBA) = 
477.8 ± 10.3 M-1  
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b. Determination of binding constant (Ka) of Dopamine with PBA 
 
Figure A-3. Fluorescence profile of PBA and Dopamine Hydrochloride 
(Dopamine) titration [AR]0 = 0.12 mM, [PBA]0 = 1 mM, [Dopamine]0 = 9.5 
mM, [PO4
-] = 200 mM 
 
Table A-3 Row data analysis 
 
Diol 
mM 
I  
(572) 
I  
(592) 
I  
(Av573-614) 
ΔI  
(572) 
ΔI  
(592) 
ΔI  
(Av573-614) 
9.49167 181.9394 198.3201 192.6344 353.7722 398.0732 381.2248 
8.54250 195.8346 212.7969 205.1471 339.8770 383.5964 368.7121 
7.68825 209.1834 226.4885 219.8799 326.5282 369.9047 353.9793 
6.91943 222.0738 241.6397 234.4157 313.6378 354.7535 339.4435 
6.22748 238.4105 259.2784 252.0162 297.3011 337.1149 321.8429 
5.60474 252.1991 277.4991 268.3772 283.5126 318.8942 305.4820 
5.04426 270.2956 295.1168 285.8995 265.4160 301.2764 287.9597 
4.53984 284.1180 310.2656 300.7638 251.5937 286.1276 273.0954 
4.08585 304.3359 334.4363 324.6095 231.3757 261.9569 249.2497 
3.67727 318.2632 351.3763 339.1521 217.4484 245.0170 234.7071 
0.00000 535.7116 596.3932 573.8591 0.0000 0.0000 0.0000 
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Table A-4 Analyzed data 
 
 Average 573-614 
M 
Diol I 
[AR-PBA] 
mM [AR] mM Q P Q [Dopamine]0/P 
0.0095 192.6344 4.028E-05 7.972E-05 1.9790 
-
0.0002 1.9790 -45.2931 
0.0085 205.1471 4.290E-05 7.710E-05 1.7973 
-
0.0003 1.7973 -28.7289 
0.0077 219.8799 4.598E-05 7.402E-05 1.6099 
-
0.0005 1.6099 -19.6367 
0.0069 234.4157 4.902E-05 7.098E-05 1.4480 
-
0.0006 1.4480 -14.6692 
0.0062 252.0162 5.270E-05 6.730E-05 1.2771 
-
0.0009 1.2771 -10.9773 
0.0056 268.3772 5.612E-05 6.388E-05 1.1383 
-
0.0011 1.1383 -8.7154 
0.0050 285.8995 5.978E-05 6.022E-05 1.0072 
-
0.0014 1.0072 -6.9934 
0.0045 300.7638 6.289E-05 5.711E-05 0.9080 
-
0.0016 0.9080 -5.8905 
0.0041 324.6095 6.788E-05 5.212E-05 0.7678 
-
0.0021 0.7678 -4.5600 
0.0037 339.1521 7.092E-05 4.908E-05 0.6920 
-
0.0024 0.6920 -3.9308 
0.0000 573.8591 1.200E-04 0.000E+00 0.0000 0.0000 0.0000 0.0000 
 
 592 nm 
M 
Diol I 
[AR-PBA] 
mM [AR] mM Q P Q [Dopamine]0/P 
0.0095 198.3201 3.990E-05 8.010E-05 2.0072 
-
0.0002 2.0072 -49.2448 
0.0085 212.7969 4.282E-05 7.718E-05 1.8026 
-
0.0003 1.8026 -29.0714 
0.0077 226.4885 4.557E-05 7.443E-05 1.6332 
-
0.0005 1.6332 -20.5263 
0.0069 241.6397 4.862E-05 7.138E-05 1.4681 
-
0.0006 1.4681 -15.1914 
0.0062 259.2784 5.217E-05 6.783E-05 1.3002 
-
0.0008 1.3002 -11.4097 
0.0056 277.4991 5.584E-05 6.416E-05 1.1492 
-
0.0011 1.1492 -8.8751 
0.0050 295.1168 5.938E-05 6.062E-05 1.0209 
-
0.0013 1.0209 -7.1577 
0.0045 310.2656 6.243E-05 5.757E-05 0.9222 
-
0.0016 0.9222 -6.0393 
0.0041 334.4363 6.729E-05 5.271E-05 0.7833 
-
0.0020 0.7833 -4.6952 
0.0037 351.3763 7.070E-05 4.930E-05 0.6973 
-
0.0024 0.6973 -3.9727 
0.0000 596.3932 1.200E-04 0.000E+00 0.0000 0.0000 0.0000 0.0000 
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       572 nm 
M 
Diol I 
[AR-PBA] 
mM [AR] mM Q P Q [Dopamine]0/P 
0.0095 181.9394 4.075E-05 7.925E-05 1.9445 
-
0.0002 1.9445 -41.1226 
0.0085 195.8346 4.387E-05 7.613E-05 1.7355 
-
0.0004 1.7355 -25.1646 
0.0077 209.1834 4.686E-05 7.314E-05 1.5610 
-
0.0005 1.5610 -17.9332 
0.0069 222.0738 4.974E-05 7.026E-05 1.4123 
-
0.0007 1.4123 -13.7920 
0.0062 238.4105 5.340E-05 6.660E-05 1.2470 
-
0.0009 1.2470 -10.4413 
0.0056 252.1991 5.649E-05 6.351E-05 1.1242 
-
0.0011 1.1242 -8.5133 
0.0050 270.2956 6.055E-05 5.945E-05 0.9819 
-
0.0014 0.9819 -6.6980 
0.0045 284.1180 6.364E-05 5.636E-05 0.8855 
-
0.0017 0.8855 -5.6606 
0.0041 304.3359 6.817E-05 5.183E-05 0.7603 
-
0.0021 0.7603 -4.4944 
0.0037 318.2632 7.129E-05 4.871E-05 0.6832 
-
0.0025 0.6832 -3.8613 
0.0000 535.7116 1.200E-04 0.000E+00 0.0000 0.0000 0.0000 0.0000 
 
Equation 4. Equation 5. Equation 6. 
Q =
[AR]
[AR
_
PBA]
 P = [PBA]0 !
1
Q "K
a1
!
[AR]
0
Q +1
 
[Dopamine]
0
P
=
Ka1
Ka
Q +1  
[AR
_
PBA]= [AR]
0
!"I  
[AR]= [AR]
0
! [AR
_
PBA]  
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Figure A-4. The corresponding fitting plot of PBA and Dopamine 
Hydrochloride (Dopamine) [AR]0 = 0.12 mM, [PBA]0 = 1 mM, [Dopamine]0 
= 9.5 mM, [PO4
-] = 200 mM; Ka = 36.4 ± 0.9 M
-1 
 
Monomer: N-(3,4-dihydroxyphenethyl)methacrylamide (DMAm) 
Proton NMR 
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Monomer: 3,4-dihydroxy-L-phenylamanine methacrylamide (L-DOPA 
metacrylamide, L-DMAm) 
FT-IR 
 
Mass spectrum 
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Chapter 3 
CTA - 1: 2-((2-hydroxyethylthio)carbonothioylthio)-2-methylpropanoic 
acid  
Proton NMR 
 
Polymer: p(DMAm14-c-DMAPMAm86) - Polymer 1a 
Proton NMR 
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GPC (aqueous solution) 
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Polymer: p(L-DMAm)15 - Polymer 2a 
Proton NMR 
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Chapter 4 
Monomer: N-(2-ethylhexyl) methacrylamide (2-EHMAm) 
FT-IR 
 
Mass spectrum 
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Monomer: N-(2-ethylhexyl) acrylamide (2-EHAm) 
Proton NMR 
 
Monomer: 4-acrylamidobutanoic acid (4-AmBA) 
Proton NMR 
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Copolymer: p(L-DMAm)16-b-p(EHAm)73 - Copolymer C1c 
Proton NMR 
 
Polymer: p(L-DMAm)13-b-p(PAm)93 - Copolymer C2 
Proton NMR 
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Polymer: p(4-AmBA) - Polymer 4 
Proton NMR 
 
Polymer: p(4-AmBA)27-b-p(PAm)90 - Copolymer C3 
Proton NMR 
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Polymer: p(DMAm14-c-DMAPMAm86)-b-p(PAm)237 - Copolymer C4 
Proton NMR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
